p.value	odds_ratio	overlap	adj_p.value	genes
Cell Cycle, Mitotic R-HSA-69278	2.98436950799047e-09	4.10836079628885	32/341	7.92051667420671e-06	BUB3;CDK1;PTTG1;CCNA2;MAPRE1;CEP78;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL;NCAPG;E2F5;TOP2A;E2F4
Cell Cycle R-HSA-1640170	1.5029816388203e-07	3.39354231347352	32/400	0.000122812039891069	BUB3;CDK1;PTTG1;CCNA2;MAPRE1;CEP78;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL;NCAPG;E2F5;TOP2A;E2F4
G0 and Early G1 R-HSA-1538133	1.30555502623504e-07	19.3591504495907	8/22	0.000122812039891069	CDK1;CCNA2;TFDP1;E2F1;CDC6;E2F5;TOP2A;E2F4
G1/S-Specific Transcription R-HSA-69205	1.85097271878024e-07	26.118321293073	7/16	0.000122812039891069	CDK1;TFDP1;E2F1;CDC45;CDC6;E2F5;E2F4
Cell Cycle Checkpoints R-HSA-69620	3.00139595292582e-07	4.56105383932003	20/180	0.000159314097181303	BUB3;CDK1;CCNA2;MAPRE1;H2BC13;H2BC17;H2BC12;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1
Activation of ATR in response to replication stress R-HSA-176187	5.57952775808097e-07	33.3006662688286	6/12	0.00021154380957067	MCM6;CDC45;CDC6;CDC7;MCM3;MCM4
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 R-HSA-1362300	5.57952775808097e-07	33.3006662688286	6/12	0.00021154380957067	CDK1;CCNA2;TFDP1;E2F1;E2F5;E2F4
Activation of the pre-replicative complex R-HSA-68962	1.72457880920851e-06	24.9978633730032	6/14	0.000508559128848821	MCM6;CDC45;CDC6;CDC7;MCM3;MCM4
Transcription of E2F targets under negative control by DREAM complex R-HSA-1362277	1.72457880920851e-06	24.9978633730032	6/14	0.000508559128848821	TFDP1;E2F1;CDC6;E2F5;TOP2A;E2F4
Peptide ligand-binding receptors R-HSA-375276	2.92805271485765e-06	7.02372621766991	11/65	0.00077710519052322	CXCL8;C3;CCR5;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal R-HSA-141444	4.27760931956069e-06	10.8209754478517	8/33	0.000946064594509506	BUB3;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1
Amplification of signal from the kinetochores R-HSA-141424	4.27760931956069e-06	10.8209754478517	8/33	0.000946064594509506	BUB3;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1
Mitotic G1 phase and G1/S transition R-HSA-453279	5.92326086639464e-06	4.95491289057581	14/113	0.00120925648764703	CDK1;CCNA2;E2F3;TFDP1;E2F1;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4;E2F5;TOP2A;E2F4
Unwinding of DNA R-HSA-176974	1.16685907439292e-05	65.4545171365919	4/6	0.00221203141674201	MCM6;CDC45;MCM3;MCM4
Resolution of Sister Chromatid Cohesion R-HSA-2500257	1.53310705465242e-05	6.45136769062594	10/63	0.00271257741536501	BUB3;CDK1;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL
Chromatin modifying enzymes R-HSA-3247509	2.34911153740151e-05	3.69585097031042	17/180	0.0032813379054019	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;MTA1;GATAD2A;NFKB2;EHMT2;H2AC12;ATXN7;HCFC1;H2AC13
Chromatin organization R-HSA-4839726	2.34911153740151e-05	3.69585097031042	17/180	0.0032813379054019	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;MTA1;GATAD2A;NFKB2;EHMT2;H2AC12;ATXN7;HCFC1;H2AC13
Class A/1 (Rhodopsin-like receptors) R-HSA-373076	2.32698655661955e-05	5.47766810708876	11/80	0.0032813379054019	CXCL8;C3;CCR5;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1
HDACs deacetylate histones R-HSA-3214815	2.05951537805426e-05	5.5594688653262	11/79	0.0032813379054019	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;MTA1;GATAD2A;H2AC12;H2AC13
Chemokine receptors bind chemokines R-HSA-380108	2.9076154555159e-05	9.77924699563525	7/31	0.00338826001219486	CXCL8;CCR5;CCL4;CXCR3;CXCL9;CXCL11;CXCL10
G1/S Transition R-HSA-69206	2.61788601689256e-05	4.93449632606267	12/96	0.00338826001219486	CDK1;CCNA2;TFDP1;E2F1;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4;E2F5;E2F4
Mitotic Prometaphase R-HSA-68877	2.91125962443011e-05	4.87491776237462	12/97	0.00338826001219486	BUB3;CDK1;MAPRE1;CEP78;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL;NCAPG
RHO GTPase Effectors R-HSA-195258	2.93632178901589e-05	3.47985168991903	18/202	0.00338826001219486	BUB3;MAPRE1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14;CDC42;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;PFN1;IQGAP3
RHO GTPases Activate Formins R-HSA-5663220	4.50716392404033e-05	5.59419268841131	10/71	0.00498417210600127	BUB3;MAPRE1;CDC42;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;PFN1
Interleukin-1 processing R-HSA-448706	5.19223861120035e-05	32.7698642994756	4/8	0.00551208050965029	NFKB1;RELA;IL1B;NFKB2
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582	7.12276518916293e-05	4.39813886376163	12/106	0.0072706995430917	CCNA2;CXCL8;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;NFKB1;RELA;STAT3;EHMT2
Interleukin-10 signaling R-HSA-6783783	8.13282950546651e-05	8.0880484682361	7/36	0.00799427018796597	CXCL8;STAT3;CCR5;IL1B;CCL4;CXCL10;TYK2
G alpha (i) signalling events R-HSA-418594	9.38524965969448e-05	4.25896833712685	12/109	0.00889587592743898	GNB2;CXCL8;C3;CCR5;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1;CCL4L2
Mitotic Spindle Checkpoint R-HSA-69618	0.000107148215783409	6.41770645463117	8/50	0.00947904548963892	BUB3;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1
Signaling by Rho GTPases R-HSA-194315	0.000105657428703474	2.61007791320729	25/374	0.00947904548963892	BUB3;MAPRE1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14;CDC42;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;ARHGEF11;NGEF;PFN1;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L;STMN2
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542	0.000120360735788629	2.58567078170773	25/377	0.0103044320252588	BUB3;MAPRE1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14;CDC42;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;ARHGEF11;NGEF;PFN1;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L;STMN2
Transcriptional regulation of granulopoiesis R-HSA-9616222	0.000157312898769567	4.72772086600205	10/82	0.013047138541701	TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;STAT3;SPI1
EML4 and NUDC in mitotic spindle formation R-HSA-9648025	0.000163862745040265	5.98569670768378	8/53	0.0131785371314201	BUB3;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1
Cellular Senescence R-HSA-2559583	0.000196020614998191	3.30618425712811	15/173	0.0153011385942706	CCNA2;CXCL8;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;NFKB1;RELA;STAT3;EHMT2
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression R-HSA-427389	0.000201879870582805	5.07515991031567	9/69	0.015308262186479	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MTA1;GATAD2A;EHMT2
GPCR downstream signalling R-HSA-388396	0.000210358148589811	3.03037020084655	17/214	0.0155080701765933	GNB2;CXCL8;C3;CDC42;ARHGEF11;NGEF;CCR5;MCF2L;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1;CCL4L2
GPCR ligand binding R-HSA-500792	0.000219466864964411	3.85126096876796	12/119	0.0155119204899151	GNB2;CXCL8;C3;CCR5;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1
Interleukin-6 signaling R-HSA-1059683	0.00022794457389099	18.7430997118534	4/11	0.0155119204899151	STAT1;STAT3;CBL;TYK2
M Phase R-HSA-68886	0.000223867039095481	2.82605566696179	19/257	0.0155119204899151	BUB3;CDK1;PTTG1;MAPRE1;CEP78;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL;NCAPG
G2 Phase R-HSA-68911	0.000262656741680994	48.6972034713534	3/5	0.017427274810534	CCNA2;E2F3;E2F1
HCMV Late Events R-HSA-9610379	0.000346368598297415	4.6792806115984	9/74	0.0219344302140205	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;CEBPD;H2AC12;H2AC13
Signal Transduction R-HSA-162582	0.000347116077237702	1.91091225755178	58/1306	0.0219344302140205	GNB2;BUB3;CDK1;CXCL8;MAPRE1;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14;FGF5;C3;HDAC3;NFKB1;RELA;SPTBN2;CDC42;KIF2A;MTA1;GATAD2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;STAT1;STAT3;ULK1;ARHGEF11;NGEF;PFN1;CBL;CCR5;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L;E2F5;E2F4;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1;TYK2;CCL4L2;PIP5K1A;STMN1;STMN2
DNA strand elongation R-HSA-69190	0.000471018129928904	14.5756148564079	4/13	0.0290716771356119	MCM6;CDC45;MCM3;MCM4
CLEC7A/inflammasome pathway R-HSA-5660668	0.000513644892618058	32.5097829088514	3/6	0.0306657151449511	NFKB1;RELA;IL1B
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350	0.000519953723256518	9.17332487090149	5/23	0.0306657151449511	INPP5D;STAT1;STAT3;CBL;INPPL1
DNA Replication R-HSA-69306	0.000538557880978769	3.26260773580482	13/150	0.0310724481764707	CCNA2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4
HCMV Infection R-HSA-9609646	0.000551021812482586	3.67545272104086	11/113	0.0311151466027401	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;CEBPD;H2AC12;H2AC13
Cell recruitment (pro-inflammatory response) R-HSA-9664424	0.000640948718056952	8.68914444176444	5/24	0.0347158754637378	C3;NFKB1;RELA;IL1B;NFKB2
Purinergic signaling in leishmaniasis infection R-HSA-9660826	0.000640948718056952	8.68914444176444	5/24	0.0347158754637378	C3;NFKB1;RELA;IL1B;NFKB2
DNA Replication Pre-Initiation R-HSA-69002	0.000661401503851924	3.36466780963209	12/134	0.034881717716151	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4
HATs acetylate histones R-HSA-3214847	0.00068243813806863	3.85233479290136	10/98	0.034881717716151	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;H2AC12;ATXN7;HCFC1;H2AC13
Pre-NOTCH Transcription and Translation R-HSA-1912408	0.000683439834679672	4.21746962158364	9/81	0.034881717716151	E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  R-HSA-3134963	0.00087893893993285	24.3988203334309	3/7	0.0416554276175319	NFKB1;RELA;NFKB2
G2/M Checkpoints R-HSA-69481	0.000856034091612985	3.46561660993616	11/119	0.0416554276175319	CDK1;H2BC13;H2BC17;H2BC12;H2BC14;MCM6;CDC45;CDC6;CDC7;MCM3;MCM4
IkBA variant leads to EDA-ID R-HSA-5603029	0.00087893893993285	24.3988203334309	3/7	0.0416554276175319	NFKB1;RELA;NFKB2
Signaling by GPCR R-HSA-372790	0.000850473015931627	2.64590742013068	17/241	0.0416554276175319	GNB2;CXCL8;C3;CDC42;ARHGEF11;NGEF;CCR5;MCF2L;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;GHRL;ANXA1;CCL4L2
HCMV Early Events R-HSA-9609690	0.000936518742107275	3.68132981825706	10/102	0.0436056270447844	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;H2AC12;H2AC13
RNA Polymerase I Promoter Clearance R-HSA-73854	0.00106003967425101	3.93877473631179	9/86	0.0485059533700376	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MTA1;GATAD2A;EHMT2
CDC42 GTPase cycle R-HSA-9013148	0.00113240038626223	4.3263434296586	8/70	0.0500898437523326	CDC42;ARHGEF11;NGEF;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L
S Phase R-HSA-69242	0.00112873009483322	3.33843615293818	11/123	0.0500898437523326	CCNA2;TFDP1;E2F1;MCM6;CDC45;CDC6;MCM3;MCM4;WAPL;E2F5;E2F4
RNA Polymerase I Transcription R-HSA-73864	0.00115250466959955	3.88734199900404	9/87	0.0501433998871673	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MTA1;GATAD2A;EHMT2
Positive epigenetic regulation of rRNA expression R-HSA-5250913	0.00125139955867555	3.83721943203993	9/88	0.0535679746568534	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MTA1;GATAD2A;EHMT2
Pre-NOTCH Expression and Processing R-HSA-1912422	0.00135704909866872	3.78835820102841	9/89	0.0562751298104185	E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Sensory processing of sound by inner hair cells of the cochlea R-HSA-9662360	0.00134439208689278	7.17121600832967	5/28	0.0562751298104185	VAMP2;CACNA1D;ESPNL;XIRP2;LHFPL5
RAC1 GTPase cycle R-HSA-9013149	0.00194229693451026	3.93923663381008	8/76	0.0793054779106189	CDC42;ARHGEF11;NGEF;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 R-HSA-5625886	0.00205437032114411	4.40077377142397	7/60	0.0826105883684313	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14
Sensory processing of sound R-HSA-9659379	0.00216073198586306	6.34071184171963	5/31	0.085590786425083	VAMP2;CACNA1D;ESPNL;XIRP2;LHFPL5
Interleukin-6 family signaling R-HSA-6783589	0.00221605295671091	8.73981318657042	4/19	0.0864912433398641	STAT1;STAT3;CBL;TYK2
Condensation of Prophase Chromosomes R-HSA-2299718	0.00272948928212472	4.16200495126768	7/63	0.103486636496557	CDK1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes R-HSA-170145	0.00269846250419566	64.3820944170761	2/3	0.103486636496557	CDK1;CCNA2
Interleukin-27 signaling R-HSA-9020956	0.00378913160255222	12.2036304839151	3/11	0.1396716010163	STAT1;STAT3;TYK2
Peptide hormone metabolism R-HSA-2980736	0.00374647064890259	5.49030283761878	5/35	0.1396716010163	VAMP2;CTSZ;GHRL;DPP4;PLA2G7
Adipogenesis R-HSA-9843745	0.00421906436773686	3.81636493012423	7/68	0.153388997698269	HDAC3;NFKB1;RELA;PPARA;MTA1;CEBPD;GATAD2A
Mitotic Anaphase R-HSA-68882	0.0044324995659212	2.75327759460347	11/146	0.156851384639398	BUB3;CDK1;PTTG1;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL
Mitotic Metaphase and Anaphase R-HSA-2555396	0.0044324995659212	2.75327759460347	11/146	0.156851384639398	BUB3;CDK1;PTTG1;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL
Assembly of the pre-replicative complex R-HSA-68867	0.00484162456942362	2.87601943142794	10/127	0.163913477336816	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MCM6;CDC6;MCM3;MCM4
Interleukin-35 Signalling R-HSA-8984722	0.00494087346908263	10.8462546390573	3/12	0.163913477336816	STAT1;STAT3;TYK2
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters R-HSA-164938	0.00494087346908263	10.8462546390573	3/12	0.163913477336816	AP1M1;AP1S1;CD8B
Separation of Sister Chromatids R-HSA-2467813	0.00484162456942362	2.87601943142794	10/127	0.163913477336816	BUB3;PTTG1;MAPRE1;KIF2A;RCC2;NSL1;ZWINT;NDEL1;BUB1;WAPL
TP53 Regulates Transcription of Cell Cycle Genes R-HSA-6791312	0.00479271586613031	5.14468205158899	5/37	0.163913477336816	CDK1;CCNA2;TFDP1;E2F1;E2F4
Lysosome Vesicle Biogenesis R-HSA-432720	0.00540184757228846	6.54871408373452	4/24	0.176993869837698	VAMP2;AP1M1;AP1S1;CTSZ
Oxidative Stress Induced Senescence R-HSA-2559580	0.00580194218869891	2.98458401588356	9/110	0.187784811814718	E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Epigenetic regulation of gene expression R-HSA-212165	0.00602745369007354	2.77808085064384	10/131	0.188327486914135	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;MTA1;GATAD2A;EHMT2;HCFC1
p75 NTR receptor-mediated signalling R-HSA-193704	0.00600086892131965	4.04964317114155	6/55	0.188327486914135	HDAC3;NFKB1;RELA;ARHGEF11;NGEF;MCF2L
trans-Golgi Network Vesicle Budding R-HSA-199992	0.00603158869167351	4.84019485367952	5/39	0.188327486914135	VAMP2;AP1M1;AP1S1;CTSZ;GAK
Cleavage of the damaged purine R-HSA-110331	0.00748045526881943	4.56909869815654	5/41	0.215794872646161	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
DNA methylation R-HSA-5334118	0.00715030671753834	3.88904663164199	6/57	0.215794872646161	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Depurination R-HSA-73927	0.00748045526881943	4.56909869815654	5/41	0.215794872646161	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Packaging Of Telomere Ends R-HSA-171306	0.00748045526881943	4.56909869815654	5/41	0.215794872646161	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
RNA Polymerase I Promoter Opening R-HSA-73728	0.00715030671753834	3.88904663164199	6/57	0.215794872646161	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Recognition and association of DNA glycosylase with site containing an affected purine R-HSA-110330	0.00748045526881943	4.56909869815654	5/41	0.215794872646161	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Transcriptional Regulation by E2F6 R-HSA-8953750	0.00725222490902252	5.95098380726539	4/26	0.215794872646161	TFDP1;E2F1;CDC7;EHMT2
Assembly of the ORC complex at the origin of replication R-HSA-68616	0.0077812845101364	3.81341088341993	6/58	0.218449890209408	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
E2F mediated regulation of DNA replication R-HSA-113510	0.00781941958172334	8.87272970393959	3/14	0.218449890209408	CDK1;TFDP1;E2F1
SIRT1 negatively regulates rRNA expression R-HSA-427359	0.0077812845101364	3.81341088341993	6/58	0.218449890209408	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Activation of NOXA and translocation to mitochondria R-HSA-111448	0.00864068270560498	21.5200667789819	2/5	0.2210616673722	TFDP1;E2F1
Base-Excision Repair, AP Site Formation R-HSA-73929	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Chromatin modifications during the maternal to zygotic transition (MZT) R-HSA-9821002	0.00916231477428107	3.6697826831921	6/60	0.2210616673722	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Cleavage of the damaged pyrimidine  R-HSA-110329	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Cyclin D associated events in G1 R-HSA-69231	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	E2F3;TFDP1;E2F1;E2F5;E2F4
Depyrimidination R-HSA-73928	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Formyl peptide receptors bind formyl peptides and many other ligands R-HSA-444473	0.00864068270560498	21.5200667789819	2/5	0.2210616673722	FPR3;ANXA1
G1 Phase R-HSA-69236	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	E2F3;TFDP1;E2F1;E2F5;E2F4
Golgi Associated Vesicle Biogenesis R-HSA-432722	0.00831669212948026	5.69041148009304	4/27	0.2210616673722	VAMP2;AP1M1;AP1S1;GAK
N-glycan antennae elongation in the medial/trans-Golgi R-HSA-975576	0.00864068270560498	21.5200667789819	2/5	0.2210616673722	MAN2A2;B4GALT2
Nef mediated downregulation of MHC class I complex cell surface expression R-HSA-164940	0.00864068270560498	21.5200667789819	2/5	0.2210616673722	AP1M1;AP1S1
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function R-HSA-8936459	0.00895374475080534	3.27053083534163	7/78	0.2210616673722	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;GP1BA
Recognition and association of DNA glycosylase with site containing an affected pyrimidine R-HSA-110328	0.00915613559796219	4.32721056180338	5/43	0.2210616673722	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Signaling by Interleukins R-HSA-449147	0.00885166814507208	1.97454252613705	19/351	0.2210616673722	CXCL8;VAMP2;H3C1;NFKB1;RELA;CDC42;INPP5D;CEBPD;STAT1;STAT3;CBL;CCR5;IL1B;NFKB2;CCL4;CXCL10;ANXA1;INPPL1;TYK2
Synthesis of PIPs at the plasma membrane R-HSA-1660499	0.00831669212948026	5.69041148009304	4/27	0.2210616673722	INPP5D;INPPL1;PIP5K1A;PI4K2A
Regulation of insulin secretion R-HSA-422356	0.00947874213657817	5.45261596221638	4/28	0.226534515730099	GNB2;VAMP2;CACNA1D;SYT5
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest R-HSA-6804114	0.0095598589908708	8.13285335867179	3/15	0.226534515730099	CDK1;TFDP1;E2F4
RHO GTPases activate PKNs R-HSA-5625740	0.0102422391187057	3.17932763981232	7/80	0.240556660363229	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14
Defective pyroptosis R-HSA-9710421	0.0115508413439338	3.47444722740109	6/63	0.266573329798264	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
The NLRP3 inflammasome R-HSA-844456	0.011508245969036	7.50709704918585	3/16	0.266573329798264	NFKB1;RELA;NFKB2
Interleukin-2 family signaling R-HSA-451927	0.0121085755651622	5.0317663131992	4/30	0.277035858189142	INPP5D;STAT1;STAT3;INPPL1
Condensation of Prometaphase Chromosomes R-HSA-2514853	0.0127042016120985	16.141264091512	2/6	0.288179069047089	CDK1;NCAPG
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787	0.0136686364671691	6.96778413341318	3/17	0.299806290775759	E2F3;TFDP1;E2F1
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069	0.0136686364671691	6.96778413341318	3/17	0.299806290775759	E2F3;TFDP1;E2F1
PRC2 methylates histones and DNA R-HSA-212300	0.013369127187573	3.35500707046278	6/65	0.299806290775759	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
RIP-mediated NFkB activation via ZBP1 R-HSA-1810476	0.0136686364671691	6.96778413341318	3/17	0.299806290775759	NFKB1;RELA;NFKB2
Deposition of new CENPA-containing nucleosomes at the centromere R-HSA-606279	0.0144412962344605	3.81925487525715	5/48	0.309090324244018	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Nucleosome assembly R-HSA-774815	0.0144412962344605	3.81925487525715	5/48	0.309090324244018	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
RHOA GTPase cycle R-HSA-8980692	0.0143496854130549	3.29827049995655	6/66	0.309090324244018	ARHGEF11;NGEF;IQGAP3;ARHGAP30;ARAP1;MCF2L
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586	0.0153794133856197	3.24339273945056	6/67	0.326535705003478	CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952	0.0160441182401265	6.50248301544974	3/18	0.337945157216633	AP1M1;AP1S1;CD8B
Meiotic recombination R-HSA-912446	0.0164594471615439	3.19028403323655	6/68	0.343963565092421	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Activation of PUMA and translocation to mitochondria R-HSA-139915	0.0174343066809647	12.9176299081264	2/7	0.358687208769615	TFDP1;E2F1
Interleukin-23 signaling R-HSA-9020933	0.0174343066809647	12.9176299081264	2/7	0.358687208769615	STAT3;TYK2
Inflammasomes R-HSA-622312	0.0186368804807669	6.09497624224568	3/19	0.369099252482929	NFKB1;RELA;NFKB2
RNA Polymerase I Promoter Escape R-HSA-73772	0.0187748300999229	3.08905654728546	6/70	0.369099252482929	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Replacement of protamines by nucleosomes in the male pronucleus R-HSA-9821993	0.0186702810642308	4.35619228532076	4/34	0.369099252482929	H2BC13;H2BC17;H2BC12;H2BC14
Transcriptional regulation of brown and beige adipocyte differentiation R-HSA-9843743	0.0186368804807669	6.09497624224568	3/19	0.369099252482929	PPARA;MTA1;GATAD2A
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 R-HSA-9844594	0.0186368804807669	6.09497624224568	3/19	0.369099252482929	PPARA;MTA1;GATAD2A
ZBP1(DAI) mediated induction of type I IFNs R-HSA-1606322	0.0186368804807669	6.09497624224568	3/19	0.369099252482929	NFKB1;RELA;NFKB2
Death Receptor Signaling R-HSA-73887	0.0209551195236563	2.72224721776107	7/92	0.408932994233705	HDAC3;NFKB1;RELA;ULK1;ARHGEF11;NGEF;MCF2L
Base Excision Repair R-HSA-73884	0.0214687558324305	3.41708475216041	5/53	0.409914230066695	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
FGFR1 mutant receptor activation R-HSA-1839124	0.0214482797419188	5.73454926451862	3/20	0.409914230066695	FGF5;STAT1;STAT3
Sensory processing of sound by outer hair cells of the cochlea R-HSA-9662361	0.0214482797419188	5.73454926451862	3/20	0.409914230066695	ESPNL;XIRP2;LHFPL5
Mitotic Prophase R-HSA-68875	0.0221054695999624	2.68991182201532	7/93	0.419056545130716	CDK1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Deubiquitination R-HSA-5688426	0.0231031316261662	2.12723400298978	11/184	0.41997062558798	CDK1;CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14;H2AC12;ATXN7;HCFC1;H2AC13
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 R-HSA-8849469	0.0227873592838778	10.765022908994	2/8	0.41997062558798	CBL;ARAP1
Regulation of NFE2L2 gene expression R-HSA-9818749	0.0227873592838778	10.765022908994	2/8	0.41997062558798	NFKB1;RELA
Synthesis of IP3 and IP4 in the cytosol R-HSA-1855204	0.0227873592838778	10.765022908994	2/8	0.41997062558798	INPP5D;INPPL1
Telomere Maintenance R-HSA-157579	0.0226518519401991	2.94853719812861	6/73	0.41997062558798	CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Transcriptional regulation of white adipocyte differentiation R-HSA-381340	0.0231002859526425	3.34652797213365	5/54	0.41997062558798	HDAC3;NFKB1;RELA;PPARA;CEBPD
Activation of HOX genes during differentiation R-HSA-5619507	0.0245365711287948	2.62744796770025	7/95	0.43606850462534	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3
Activation of anterior HOX genes in hindbrain development during early embryogenesis R-HSA-5617472	0.0245365711287948	2.62744796770025	7/95	0.43606850462534	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3
CD209 (DC-SIGN) signaling R-HSA-5621575	0.0244789023163436	5.41554983900952	3/21	0.43606850462534	NFKB1;RELA;RELB
Meiotic synapsis R-HSA-1221632	0.0248102276557748	3.27879114842407	5/55	0.43606850462534	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
PKMTs methylate histone lysines R-HSA-3214841	0.0248102276557748	3.27879114842407	5/55	0.43606850462534	H3C1;NFKB1;RELA;NFKB2;EHMT2
B-WICH complex positively regulates rRNA expression R-HSA-5250924	0.025517209726223	2.86164333355048	6/75	0.445543911930236	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Membrane Trafficking R-HSA-199991	0.0261435041279265	1.86297978956642	15/287	0.453495816702725	VAMP2;AP1M1;SEC23A;SPTBN2;AP1S1;CD3D;KIF2A;COPB1;MAN2A2;CTSZ;COG1;ULK1;CBL;GAK;TBC1D14
Inhibition of DNA recombination at telomere R-HSA-9670095	0.0265997328062395	3.2137087283191	5/56	0.458413577063374	H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
G alpha (12/13) signalling events R-HSA-416482	0.0270870783146086	3.84056236162193	4/38	0.460827601583149	GNB2;ARHGEF11;NGEF;MCF2L
Interleukin-12 family signaling R-HSA-447115	0.0270870783146086	3.84056236162193	4/38	0.460827601583149	CDC42;STAT1;STAT3;TYK2
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807	0.0299394739049423	2.51051102654705	7/99	0.472061707185869	CXCL8;CEBPD;STAT1;STAT3;IL1B;ANXA1;TYK2
Interleukin-9 signaling R-HSA-8985947	0.0287217217192183	9.22715392424026	2/9	0.472061707185869	STAT1;STAT3
Ketone body metabolism R-HSA-74182	0.0304154302670624	Inf	1/1	0.472061707185869	ACSS3
Leishmania infection R-HSA-9658195	0.0299394739049423	2.51051102654705	7/99	0.472061707185869	GNB2;C3;NFKB1;RELA;CDC42;IL1B;NFKB2
MAPK3 (ERK1) activation R-HSA-110056	0.0287217217192183	9.22715392424026	2/9	0.472061707185869	CDK1;TYK2
Metabolism of folate and pterines R-HSA-196757	0.0287217217192183	9.22715392424026	2/9	0.472061707185869	MTHFS;SLC19A1
PI Metabolism R-HSA-1483255	0.0294934199858012	3.7301203286809	4/39	0.472061707185869	INPP5D;INPPL1;PIP5K1A;PI4K2A
Parasitic Infection Pathways R-HSA-9824443	0.0299394739049423	2.51051102654705	7/99	0.472061707185869	GNB2;C3;NFKB1;RELA;CDC42;IL1B;NFKB2
Regulated proteolysis of p75NTR R-HSA-193692	0.0287217217192183	9.22715392424026	2/9	0.472061707185869	NFKB1;RELA
SUMOylation of immune response proteins R-HSA-4755510	0.0287217217192183	9.22715392424026	2/9	0.472061707185869	RELA;NFKB2
Synthesis of Ketone Bodies R-HSA-77111	0.0304154302670624	Inf	1/1	0.472061707185869	ACSS3
Toxicity of botulinum toxin type D (botD) R-HSA-5250955	0.0304154302670624	Inf	1/1	0.472061707185869	VAMP2
Toxicity of botulinum toxin type F (botF) R-HSA-5250981	0.0304154302670624	Inf	1/1	0.472061707185869	VAMP2
Toxicity of tetanus toxin (tetX) R-HSA-5250982	0.0304154302670624	Inf	1/1	0.472061707185869	VAMP2
Transport to the Golgi and subsequent modification R-HSA-948021	0.0299394739049423	2.51051102654705	7/99	0.472061707185869	SEC23A;SPTBN2;COPB1;MAN2A2;CTSZ;B4GALT2;COG1
TRAF6 mediated NF-kB activation R-HSA-933542	0.0311966620588955	4.87229947457468	3/23	0.481371750606446	NFKB1;RELA;NFKB2
E3 ubiquitin ligases ubiquitinate target proteins R-HSA-8866654	0.0320228325647714	3.62505937837788	4/40	0.48564912929659	H2BC13;H2BC17;H2BC12;H2BC14
NoRC negatively regulates rRNA expression R-HSA-427413	0.031952962671002	2.70213214147237	6/79	0.48564912929659	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Transcriptional regulation by small RNAs R-HSA-5578749	0.031952962671002	2.70213214147237	6/79	0.48564912929659	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Ub-specific processing proteases R-HSA-5689880	0.0324061868489113	2.18011117373759	9/146	0.488670567596651	CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14;H2AC12;ATXN7;H2AC13
Chromosome Maintenance R-HSA-73886	0.0355355547544973	2.62875695427184	6/81	0.504338835927464	CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
Diseases associated with the TLR signaling cascade R-HSA-5602358	0.0348816355569822	4.63891260629896	3/24	0.504338835927464	NFKB1;RELA;NFKB2
Diseases of Immune System R-HSA-5260271	0.0348816355569822	4.63891260629896	3/24	0.504338835927464	NFKB1;RELA;NFKB2
Formation of the beta-catenin:TCF transactivating complex R-HSA-201722	0.0355355547544973	2.62875695427184	6/81	0.504338835927464	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Inhibition of replication initiation of damaged DNA by RB1/E2F1 R-HSA-113501	0.0351976774548844	8.07403556238578	2/10	0.504338835927464	TFDP1;E2F1
Interleukin-21 signaling R-HSA-9020958	0.0351976774548844	8.07403556238578	2/10	0.504338835927464	STAT1;STAT3
Meiosis R-HSA-1500620	0.0355355547544973	2.62875695427184	6/81	0.504338835927464	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Metalloprotease DUBs R-HSA-5689901	0.0348816355569822	4.63891260629896	3/24	0.504338835927464	H2AC8;H2AC12;H2AC13
Negative epigenetic regulation of rRNA expression R-HSA-5250941	0.0337132916076746	2.66494945303123	6/80	0.504338835927464	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Orc1 removal from chromatin R-HSA-68949	0.0345734899979612	2.9770597521359	5/60	0.504338835927464	CCNA2;MCM6;CDC6;MCM3;MCM4
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest R-HSA-6804116	0.0351976774548844	8.07403556238578	2/10	0.504338835927464	CCNA2;E2F1
Signaling by NOTCH R-HSA-157118	0.0358449627521094	1.971771370801	11/197	0.50602410183031	E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;STAT1
G2/M DNA damage checkpoint R-HSA-69473	0.03906149862144	2.87118516353579	5/62	0.53994384031928	CDK1;H2BC13;H2BC17;H2BC12;H2BC14
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462	0.0387816075088244	4.42726647176198	3/25	0.53994384031928	STAT1;STAT3;TYK2
Interleukin-20 family signaling R-HSA-8854691	0.0387816075088244	4.42726647176198	3/25	0.53994384031928	STAT1;STAT3;TYK2
Processing of DNA double-strand break ends R-HSA-5693607	0.03906149862144	2.87118516353579	5/62	0.53994384031928	CCNA2;H2BC13;H2BC17;H2BC12;H2BC14
G beta:gamma signalling through CDC42 R-HSA-8964616	0.0421773543109582	7.17457244650534	2/11	0.568216742849153	GNB2;CDC42
Other interleukin signaling R-HSA-449836	0.0421773543109582	7.17457244650534	2/11	0.568216742849153	VAMP2;TYK2
STAT3 nuclear events downstream of ALK signaling R-HSA-9701898	0.0421773543109582	7.17457244650534	2/11	0.568216742849153	HDAC3;STAT3
Synthesis, secretion, and deacylation of Ghrelin R-HSA-422085	0.0421773543109582	7.17457244650534	2/11	0.568216742849153	GHRL;PLA2G7
Vesicle-mediated transport R-HSA-5653656	0.0417953106914241	1.73868503876004	15/305	0.568216742849153	VAMP2;AP1M1;SEC23A;SPTBN2;AP1S1;CD3D;KIF2A;COPB1;MAN2A2;CTSZ;COG1;ULK1;CBL;GAK;TBC1D14
Oncogene Induced Senescence R-HSA-2559585	0.0428941356740159	4.23391620649899	3/26	0.57206550793386	E2F3;TFDP1;E2F1
Signaling by FGFR1 in disease R-HSA-5655302	0.0428941356740159	4.23391620649899	3/26	0.57206550793386	FGF5;STAT1;STAT3
Amyloid fiber formation R-HSA-977225	0.0434555491229694	2.49302197198285	6/85	0.576655136861804	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Sensory Perception R-HSA-9709957	0.043890440192989	2.77248502464822	5/64	0.579528498866631	VAMP2;CACNA1D;ESPNL;XIRP2;LHFPL5
Diseases of programmed cell death R-HSA-9645723	0.0455957914244321	2.46128042771854	6/86	0.599065497229915	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Infectious disease R-HSA-5663205	0.0459252805408648	1.49681772460541	28/673	0.600422140667267	GNB2;VAMP2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;C3;HDAC3;NFKB1;RELA;AP1M1;SEC23A;CDC42;AP1S1;CD8B;MTA1;CEBPD;GATAD2A;STAT1;CBL;CCR5;IL1B;NFKB2;H2AC12;H2AC13;TYK2
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-198933	0.0465351931228994	3.17936223338707	4/45	0.60541373798125	C3;CD8B;CD3D;CD1C
MHC class II antigen presentation R-HSA-2132295	0.0490637352000293	2.6802540665471	5/66	0.630161829531822	AP1M1;SEC23A;SPTBN2;AP1S1;KIF2A
NF-kB is activated and signals survival R-HSA-209560	0.0496246504793334	6.45701616794794	2/12	0.630161829531822	NFKB1;RELA
RAF-independent MAPK1/3 activation R-HSA-112409	0.0496246504793334	6.45701616794794	2/12	0.630161829531822	CDK1;TYK2
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770	0.0496246504793334	6.45701616794794	2/12	0.630161829531822	STAT1;STAT3
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767	0.0496246504793334	6.45701616794794	2/12	0.630161829531822	STAT1;STAT3
Maternal to zygotic transition (MZT) R-HSA-9816359	0.0500714441613162	2.40007528448779	6/88	0.632807680019682	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
NRAGE signals death through JNK R-HSA-193648	0.0517448249947434	3.89361756020877	3/28	0.650856708701654	ARHGEF11;NGEF;MCF2L
Gene Silencing by RNA R-HSA-211000	0.0524074927761588	2.37056633843369	6/89	0.656082480320403	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Reproduction R-HSA-1474165	0.0548093715250455	2.34175553053236	6/90	0.682929915621929	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Adrenaline,noradrenaline inhibits insulin secretion R-HSA-400042	0.0575051632808797	5.86969830484888	2/13	0.685384704470934	GNB2;CACNA1D
Alternative complement activation R-HSA-173736	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	C3
Cytokine Signaling in Immune system R-HSA-1280215	0.055580231634989	1.51416875764804	23/540	0.685384704470934	CDK1;CXCL8;VAMP2;H3C1;NFKB1;RELA;CDC42;INPP5D;CEBPD;STAT1;STAT3;CBL;CCR5;RELB;IL1B;NFKB2;CCL4;CXCL10;ANXA1;INPPL1;TYK2;IRF8;IRF1
Defective F9 activation R-HSA-9673221	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	GP1BA
FGFR3 ligand binding and activation R-HSA-190239	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	FGF5
FGFR3 mutant receptor activation R-HSA-2033514	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	FGF5
FGFR3c ligand binding and activation R-HSA-190372	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	FGF5
G2/M DNA replication checkpoint R-HSA-69478	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	CDK1
Integration of energy metabolism R-HSA-163685	0.0567375288898766	2.96044543324479	4/48	0.685384704470934	GNB2;VAMP2;CACNA1D;SYT5
Interaction between L1 and Ankyrins R-HSA-445095	0.0575051632808797	5.86969830484888	2/13	0.685384704470934	SPTBN2;SCN8A
MET activates STAT3 R-HSA-8875791	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	STAT3
RNA Polymerase I Transcription Initiation R-HSA-73762	0.0564759579288363	3.74322421711803	3/29	0.685384704470934	MTA1;GATAD2A;EHMT2
Reactions specific to the complex N-glycan synthesis pathway R-HSA-975578	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	MAN2A2
Signaling by CSF3 (G-CSF) R-HSA-9674555	0.0564759579288363	3.74322421711803	3/29	0.685384704470934	STAT1;STAT3;TYK2
Signaling by activated point mutants of FGFR1 R-HSA-1839122	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	FGF5
Signaling by activated point mutants of FGFR3 R-HSA-1839130	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	FGF5
Signalling to STAT3 R-HSA-198745	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	STAT3
Synthesis of DNA R-HSA-69239	0.0598113887677748	2.28599740962376	6/92	0.685384704470934	CCNA2;MCM6;CDC45;CDC6;MCM3;MCM4
Toxicity of botulinum toxin type G (botG) R-HSA-5250989	0.0599130563064268	32.0001295436249	1/2	0.685384704470934	VAMP2
Protein ubiquitination R-HSA-8852135	0.0603852320153365	2.89395567775919	4/49	0.68782148398585	H2BC13;H2BC17;H2BC12;H2BC14
Nonhomologous End-Joining (NHEJ) R-HSA-5693571	0.06415508764139	2.83035543737506	4/50	0.727639327351492	H2BC13;H2BC17;H2BC12;H2BC14
Pyroptosis R-HSA-5620971	0.0657861205640724	5.37909022303998	2/14	0.739815101597662	IL1B;IRF1
Signaling by PDGFR in disease R-HSA-9671555	0.0657861205640724	5.37909022303998	2/14	0.739815101597662	STAT1;STAT3
Cyclin E associated events during G1/S transition  R-HSA-69202	0.0666637585446714	2.43653034773153	5/72	0.74652158302767	CCNA2;TFDP1;E2F1;E2F5;E2F4
Immune System R-HSA-168256	0.0669775144555632	1.37877903208077	38/998	0.746883711617919	CDK1;CXCL8;VAMP2;H3C1;C3;REL;NFKBIE;NFKB1;RELA;LPCAT1;AP1M1;SEC23A;SPTBN2;CDC42;INPP5D;AP1S1;CD8B;CD3D;KIF2A;CD1C;CEBPD;STAT1;STAT3;COPB1;CTSZ;CBL;CCR5;RELB;IL1B;NFKB2;CCL4;CXCL10;ANXA1;CPN2;INPPL1;TYK2;IRF8;IRF1
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer R-HSA-2173793	0.0680460811931424	2.76946012647745	4/51	0.755624684044351	TFDP1;STAT1;E2F5;E2F4
Transcriptional Regulation by VENTX R-HSA-8853884	0.0718431126066134	3.35335022965983	3/32	0.794465086908133	NFKB1;RELA;EHMT2
Cyclin A/B1/B2 associated events during G2/M transition R-HSA-69273	0.0744363146522572	4.96490445416481	2/15	0.806342771784043	CDK1;CCNA2
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656	0.0732219628566161	2.36474974640659	5/74	0.806342771784043	CCNA2;TFDP1;E2F1;E2F5;E2F4
Inositol phosphate metabolism R-HSA-1483249	0.0744363146522572	4.96490445416481	2/15	0.806342771784043	INPP5D;INPPL1
RUNX1 regulates transcription of genes involved in differentiation of HSCs R-HSA-8939236	0.073905835845462	2.01472158042834	7/121	0.806342771784043	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;SPI1
p75NTR signals via NF-kB R-HSA-193639	0.0744363146522572	4.96490445416481	2/15	0.806342771784043	NFKB1;RELA
Interleukin receptor SHC signaling R-HSA-912526	0.0834260387498603	4.60892858353969	2/16	0.892793172750521	INPP5D;INPPL1
Signaling by SCF-KIT R-HSA-1433557	0.0830191840378502	3.13552747352349	3/34	0.892793172750521	STAT1;STAT3;CBL
TBC/RABGAPs R-HSA-8854214	0.0834260387498603	4.60892858353969	2/16	0.892793172750521	ULK1;TBC1D14
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139	0.0888713637269254	3.03682773593988	3/35	0.896823571601749	E2F3;TFDP1;E2F1
CDC6 association with the ORC:origin complex R-HSA-68689	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	CDC6
FGFR1 ligand binding and activation R-HSA-190242	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	FGF5
FGFR1c ligand binding and activation R-HSA-190373	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	FGF5
FGFR2c ligand binding and activation R-HSA-190375	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	FGF5
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988	0.0888713637269254	3.03682773593988	3/35	0.896823571601749	INPP5D;CBL;INPPL1
N-Glycan antennae elongation R-HSA-975577	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	B4GALT2
NR1D1 (REV-ERBA) represses gene expression R-HSA-1368071	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	HDAC3
Neurotoxicity of clostridium toxins R-HSA-168799	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	VAMP2
PTK6 Activates STAT3 R-HSA-8849474	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	STAT3
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	FGF5
Phospholipase C-mediated cascade; FGFR3 R-HSA-5654227	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	FGF5
Pyrimidine salvage R-HSA-73614	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	TYMP
Toxicity of botulinum toxin type B (botB) R-HSA-5250958	0.0885203532075426	16.0177835765028	1/3	0.896823571601749	VAMP2
Transcriptional activation of mitochondrial biogenesis R-HSA-2151201	0.0888713637269254	3.03682773593988	3/35	0.896823571601749	HDAC3;PPARA;HCFC1
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) R-HSA-5693567	0.0911029985515709	2.20222165443055	5/79	0.912405125116488	CCNA2;H2BC13;H2BC17;H2BC12;H2BC14
Phospholipid metabolism R-HSA-1483257	0.0911029985515709	2.20222165443055	5/79	0.912405125116488	LPCAT1;INPP5D;INPPL1;PIP5K1A;PI4K2A
Cargo concentration in the ER R-HSA-5694530	0.0927270257208857	4.30096796426751	2/17	0.914860692428367	SEC23A;CTSZ
Negative regulation of FGFR1 signaling R-HSA-5654726	0.0927270257208857	4.30096796426751	2/17	0.914860692428367	FGF5;CBL
Negative regulation of FGFR3 signaling R-HSA-5654732	0.0927270257208857	4.30096796426751	2/17	0.914860692428367	FGF5;CBL
Signaling by cytosolic FGFR1 fusion mutants R-HSA-1839117	0.0927270257208857	4.30096796426751	2/17	0.914860692428367	STAT1;STAT3
Diseases of mitotic cell cycle R-HSA-9675126	0.0948924332778486	2.94410805480218	3/36	0.919140576348212	E2F3;TFDP1;E2F1
Loss of Nlp from mitotic centrosomes R-HSA-380259	0.0948924332778486	2.94410805480218	3/36	0.919140576348212	CDK1;MAPRE1;CEP78
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284	0.0948924332778486	2.94410805480218	3/36	0.919140576348212	CDK1;MAPRE1;CEP78
RHOB GTPase cycle R-HSA-9013026	0.0948924332778486	2.94410805480218	3/36	0.919140576348212	ARHGEF11;IQGAP3;MCF2L
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-2173796	0.0948924332778486	2.94410805480218	3/36	0.919140576348212	TFDP1;E2F5;E2F4
Homology Directed Repair R-HSA-5693538	0.0988364411368658	2.14308524237445	5/81	0.95040548832334	CCNA2;H2BC13;H2BC17;H2BC12;H2BC14
Switching of origins to a post-replicative state R-HSA-69052	0.0988364411368658	2.14308524237445	5/81	0.95040548832334	CCNA2;MCM6;CDC6;MCM3;MCM4
AURKA Activation by TPX2 R-HSA-8854518	0.101076807638712	2.85684032266876	3/37	0.968439882574519	CDK1;MAPRE1;CEP78
Interferon alpha/beta signaling R-HSA-909733	0.103368730484479	2.36195668059399	4/59	0.98683672915758	STAT1;TYK2;IRF8;IRF1
2-LTR circle formation R-HSA-164843	1	0	0/5	1	
5-Phosphoribose 1-diphosphate biosynthesis R-HSA-73843	1	0	0/0	1	
A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-1971475	1	0	0/10	1	
ABC transporter disorders R-HSA-5619084	1	0	0/63	1	
ABC transporters in lipid homeostasis R-HSA-1369062	1	0	0/10	1	
ABC-family proteins mediated transport R-HSA-382556	1	0	0/77	1	
ABO blood group biosynthesis R-HSA-9033807	1	0	0/2	1	
ADORA2B mediated anti-inflammatory cytokines production R-HSA-9660821	0.47809710350936	1.59852000850236	1/21	1	GNB2
ADP signalling through P2Y purinoceptor 1 R-HSA-418592	0.351526138395097	2.4631234253845	1/14	1	GNB2
ADP signalling through P2Y purinoceptor 12 R-HSA-392170	0.288365431745851	3.20406387724278	1/11	1	GNB2
AKT phosphorylates targets in the cytosol R-HSA-198323	1	0	0/12	1	
AKT phosphorylates targets in the nucleus R-HSA-198693	1	0	0/10	1	
AKT-mediated inactivation of FOXO1A R-HSA-211163	1	0	0/4	1	
ALK mutants bind TKIs R-HSA-9700645	1	0	0/3	1	
ALKBH2 mediated reversal of alkylation damage R-HSA-112122	1	0	0/0	1	
ALKBH3 mediated reversal of alkylation damage R-HSA-112126	1	0	0/0	1	
AMPK inhibits chREBP transcriptional activation activity R-HSA-163680	1	0	0/6	1	
APC truncation mutants are not K63 polyubiquitinated R-HSA-5467333	1	0	0/1	1	
APC truncation mutants have impaired AXIN binding R-HSA-5467337	1	0	0/10	1	
APC-Cdc20 mediated degradation of Nek2A R-HSA-179409	0.494053866191027	1.52202475174719	1/22	1	BUB3
APC/C-mediated degradation of cell cycle proteins R-HSA-174143	0.225090154250366	1.70028433027889	4/80	1	BUB3;CDK1;PTTG1;CCNA2
APC/C:Cdc20 mediated degradation of Cyclin B R-HSA-174048	0.509526609716264	1.45249715242618	1/23	1	CDK1
APC/C:Cdc20 mediated degradation of Securin R-HSA-174154	0.871958877241893	0.486318002787028	1/66	1	PTTG1
APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176409	0.168680152704898	1.93310961770635	4/71	1	BUB3;CDK1;PTTG1;CCNA2
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 R-HSA-174178	0.890575988702246	0.450999629139426	1/71	1	PTTG1
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint R-HSA-179419	0.350557993683664	1.46004196596012	3/69	1	BUB3;CDK1;CCNA2
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway R-HSA-5649702	1	0	0/2	1	
APOBEC3G mediated resistance to HIV-1 infection R-HSA-180689	1	0	0/5	1	
ARL13B-mediated ciliary trafficking of INPP5E R-HSA-5624958	1	0	0/0	1	
ARMS-mediated activation R-HSA-170984	1	0	0/4	1	
ASP-3026-resistant ALK mutants R-HSA-9717264	1	0	0/0	1	
ATF4 activates genes in response to endoplasmic reticulum  stress R-HSA-380994	0.524529899197712	1.38901487616444	1/24	1	CXCL8
ATF6 (ATF6-alpha) activates chaperone genes R-HSA-381183	1	0	0/9	1	
ATF6 (ATF6-alpha) activates chaperones R-HSA-381033	1	0	0/11	1	
ATF6B (ATF6-beta) activates chaperones R-HSA-8874177	1	0	0/4	1	
ATP sensitive Potassium channels R-HSA-1296025	1	0	0/1	1	
AUF1 (hnRNP D0) binds and destabilizes mRNA R-HSA-450408	1	0	0/53	1	
AXIN missense mutants destabilize the destruction complex R-HSA-5467340	1	0	0/10	1	
Abacavir ADME R-HSA-2161522	1	0	0/3	1	
Abacavir metabolism R-HSA-2161541	1	0	0/1	1	
Abacavir transmembrane transport R-HSA-2161517	1	0	0/2	1	
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway R-HSA-73930	1	0	0/1	1	
Aberrant regulation of mitotic exit in cancer due to RB1 defects R-HSA-9687136	1	0	0/19	1	
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate R-HSA-2978092	1	0	0/0	1	
Abortive elongation of HIV-1 transcript in the absence of Tat R-HSA-167242	1	0	0/19	1	
Acetylation R-HSA-156582	1	0	0/2	1	
Acetylcholine Neurotransmitter Release Cycle R-HSA-264642	0.143169804536155	8.01619116439233	1/5	1	VAMP2
Acetylcholine binding and downstream events R-HSA-181431	1	0	0/5	1	
Acetylcholine inhibits contraction of outer hair cells R-HSA-9667769	1	0	0/1	1	
Acetylcholine regulates insulin secretion R-HSA-399997	1	0	0/4	1	
Acrosome Reaction and Sperm:Oocyte Membrane Binding R-HSA-1300645	1	0	0/1	1	
Activated NOTCH1 Transmits Signal to the Nucleus R-HSA-2122948	1	0	0/15	1	
Activated NTRK2 signals through CDK5 R-HSA-9032845	1	0	0/5	1	
Activated NTRK2 signals through FRS2 and FRS3 R-HSA-9028731	1	0	0/7	1	
Activated NTRK2 signals through FYN R-HSA-9032500	1	0	0/4	1	
Activated NTRK2 signals through PI3K R-HSA-9028335	1	0	0/5	1	
Activated NTRK2 signals through PLCG1 R-HSA-9026527	1	0	0/2	1	
Activated NTRK2 signals through RAS R-HSA-9026519	1	0	0/6	1	
Activated NTRK3 signals through PI3K R-HSA-9603381	1	0	0/4	1	
Activated NTRK3 signals through PLCG1 R-HSA-9034793	1	0	0/1	1	
Activated NTRK3 signals through RAS R-HSA-9034864	1	0	0/5	1	
Activated point mutants of FGFR2 R-HSA-2033519	0.116263980170045	10.686886668013	1/4	1	FGF5
Activation and oligomerization of BAK protein R-HSA-111452	1	0	0/1	1	
Activation of AKT2 R-HSA-165158	1	0	0/3	1	
Activation of AMPA receptors R-HSA-399710	1	0	0/0	1	
Activation of AMPK downstream of NMDARs R-HSA-9619483	1	0	0/26	1	
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176814	0.174681117067264	1.90421313133206	4/72	1	BUB3;CDK1;PTTG1;CCNA2
Activation of BAD and translocation to mitochondria  R-HSA-111447	1	0	0/14	1	
Activation of BH3-only proteins R-HSA-114452	0.175378720698121	2.80010201131709	2/25	1	TFDP1;E2F1
Activation of BIM and translocation to mitochondria  R-HSA-111446	1	0	0/3	1	
Activation of BMF and translocation to mitochondria R-HSA-139910	1	0	0/1	1	
Activation of C3 and C5 R-HSA-174577	0.143169804536155	8.01619116439233	1/5	1	C3
Activation of Ca-permeable Kainate Receptor R-HSA-451308	1	0	0/4	1	
Activation of G protein gated Potassium channels R-HSA-1296041	0.288365431745851	3.20406387724278	1/11	1	GNB2
Activation of GABAB receptors R-HSA-991365	0.427170246365634	1.88200018344424	1/18	1	GNB2
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) R-HSA-936964	1	0	0/14	1	
Activation of Matrix Metalloproteinases R-HSA-1592389	0.310069139133716	2.91223689743989	1/12	1	KLK2
Activation of NF-kappaB in B cells R-HSA-1169091	0.139871699538414	2.0916240872268	4/66	1	REL;NFKBIE;NFKB1;RELA
Activation of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767	0.116263980170045	10.686886668013	1/4	1	CDK1
Activation of NMDA receptors and postsynaptic events R-HSA-442755	1	0	0/59	1	
Activation of Na-permeable kainate receptors R-HSA-451307	1	0	0/0	1	
Activation of PPARGC1A (PGC-1alpha) by phosphorylation R-HSA-2151209	1	0	0/7	1	
Activation of RAC1 R-HSA-428540	1	0	0/10	1	
Activation of RAC1 downstream of NMDARs R-HSA-9619229	1	0	0/5	1	
Activation of RAS in B cells R-HSA-1169092	1	0	0/5	1	
Activation of SMO R-HSA-5635838	1	0	0/7	1	
Activation of TRKA receptors R-HSA-187015	1	0	0/3	1	
Activation of caspases through apoptosome-mediated cleavage R-HSA-111459	1	0	0/2	1	
Activation of gene expression by SREBF (SREBP) R-HSA-2426168	0.524529899197712	1.38901487616444	1/24	1	PPARA
Activation of kainate receptors upon glutamate binding R-HSA-451326	0.310069139133716	2.91223689743989	1/12	1	GNB2
Activation of the AP-1 family of transcription factors R-HSA-450341	1	0	0/10	1	
Activation of the TFAP2 (AP-2) family of transcription factors R-HSA-8866907	1	0	0/6	1	
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S R-HSA-72662	1	0	0/49	1	
Activation of the phototransduction cascade R-HSA-2485179	1	0	0/6	1	
Activation, myristolyation of BID and translocation to mitochondria R-HSA-75108	1	0	0/3	1	
Activation, translocation and oligomerization of BAX R-HSA-114294	1	0	0/2	1	
Acyl chain remodeling of CL R-HSA-1482798	1	0	0/4	1	
Acyl chain remodeling of DAG and TAG R-HSA-1482883	1	0	0/3	1	
Acyl chain remodelling of PC R-HSA-1482788	0.265984697433587	3.56074569329776	1/10	1	LPCAT1
Acyl chain remodelling of PE R-HSA-1482839	1	0	0/9	1	
Acyl chain remodelling of PG R-HSA-1482925	0.169262925120966	6.41229475066507	1/6	1	LPCAT1
Acyl chain remodelling of PI R-HSA-1482922	1	0	0/7	1	
Acyl chain remodelling of PS R-HSA-1482801	1	0	0/6	1	
Adaptive Immune System R-HSA-1280218	0.211047958052579	1.30171134082602	15/393	1	C3;REL;NFKBIE;NFKB1;RELA;AP1M1;SEC23A;SPTBN2;CDC42;INPP5D;AP1S1;CD8B;CD3D;KIF2A;CD1C
Adenosine P1 receptors R-HSA-417973	1	0	0/2	1	
Adenylate cyclase activating pathway R-HSA-170660	1	0	0/5	1	
Adenylate cyclase inhibitory pathway R-HSA-170670	1	0	0/7	1	
Adherens junctions interactions R-HSA-418990	1	0	0/23	1	
Adrenaline signalling through Alpha-2 adrenergic receptor R-HSA-392023	1	0	0/2	1	
Adrenoceptors R-HSA-390696	1	0	0/3	1	
Advanced glycosylation endproduct receptor signaling R-HSA-879415	1	0	0/11	1	
Aerobic respiration and respiratory electron transport R-HSA-1428517	1	0	0/109	1	
Aflatoxin activation and detoxification R-HSA-5423646	1	0	0/6	1	
Aggrephagy R-HSA-9646399	1	0	0/33	1	
Agmatine biosynthesis R-HSA-351143	1	0	0/0	1	
Alanine metabolism R-HSA-8964540	1	0	0/0	1	
Alpha-defensins R-HSA-1462054	1	0	0/3	1	
Alpha-oxidation of phytanate R-HSA-389599	1	0	0/3	1	
Alpha-protein kinase 1 signaling pathway R-HSA-9645460	1	0	0/9	1	
Alternative Lengthening of Telomeres (ALT) R-HSA-9006821	1	0	0/1	1	
Amine Oxidase reactions R-HSA-140179	1	0	0/1	1	
Amine ligand-binding receptors R-HSA-375280	1	0	0/3	1	
Amino Acid conjugation R-HSA-156587	1	0	0/4	1	
Amino acid transport across the plasma membrane R-HSA-352230	1	0	0/10	1	
Amino acids regulate mTORC1 R-HSA-9639288	1	0	0/40	1	
Anchoring fibril formation R-HSA-2214320	1	0	0/13	1	
Anchoring of the basal body to the plasma membrane R-HSA-5620912	0.155730857365533	2.30818155713983	3/45	1	CDK1;MAPRE1;CEP78
Androgen biosynthesis R-HSA-193048	1	0	0/2	1	
Antagonism of Activin by Follistatin R-HSA-2473224	1	0	0/2	1	
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851	0.728557208074531	0.775731488317379	1/42	1	GNB2
Antigen Presentation: Folding, assembly and peptide loading of class I MHC R-HSA-983170	0.461641308516191	1.68306147966003	1/20	1	SEC23A
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers R-HSA-983695	1	0	0/16	1	
Antigen processing-Cross presentation R-HSA-1236975	1	0	0/86	1	
Antigen processing: Ubiquitination & Proteasome degradation R-HSA-983168	1	0	0/152	1	
Antimicrobial peptides R-HSA-6803157	1	0	0/16	1	
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410	0.651242162392661	0.899785471493387	3/109	1	CDK1;STAT1;STAT3
Apoptosis R-HSA-109581	0.764330345757553	0.746891354423056	3/130	1	TFDP1;E2F1;STAT3
Apoptosis induced DNA fragmentation R-HSA-140342	1	0	0/10	1	
Apoptotic cleavage of cell adhesion  proteins R-HSA-351906	1	0	0/4	1	
Apoptotic cleavage of cellular proteins R-HSA-111465	1	0	0/20	1	
Apoptotic execution phase R-HSA-75153	1	0	0/31	1	
Apoptotic factor-mediated response R-HSA-111471	1	0	0/9	1	
Aquaporin-mediated transport R-HSA-445717	0.47809710350936	1.59852000850236	1/21	1	GNB2
Arachidonate production from DAG R-HSA-426048	1	0	0/4	1	
Arachidonic acid metabolism R-HSA-2142753	1	0	0/21	1	
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 R-HSA-211957	1	0	0/0	1	
Aryl hydrocarbon receptor signalling R-HSA-8937144	1	0	0/6	1	
Asparagine N-linked glycosylation R-HSA-446203	0.147059974657949	1.66647950010084	7/144	1	SEC23A;SPTBN2;COPB1;MAN2A2;CTSZ;B4GALT2;COG1
Aspartate and asparagine metabolism R-HSA-8963693	1	0	0/4	1	
Aspirin ADME R-HSA-9749641	1	0	0/12	1	
Assembly Of The HIV Virion R-HSA-175474	1	0	0/9	1	
Assembly and cell surface presentation of NMDA receptors R-HSA-9609736	1	0	0/31	1	
Assembly and release of respiratory syncytial virus (RSV) virions R-HSA-9820962	1	0	0/2	1	
Assembly of Viral Components at the Budding Site R-HSA-168316	1	0	0/2	1	
Assembly of active LPL and LIPC lipase complexes R-HSA-8963889	1	0	0/9	1	
Assembly of collagen fibrils and other multimeric structures R-HSA-2022090	1	0	0/38	1	
Association of TriC/CCT with target proteins during biosynthesis R-HSA-390471	0.14300508719434	3.22228301561122	2/22	1	HDAC3;STAT3
Astrocytic Glutamate-Glutamine Uptake And Metabolism R-HSA-210455	1	0	0/2	1	
Asymmetric localization of PCP proteins R-HSA-4608870	1	0	0/58	1	
Atorvastatin ADME R-HSA-9754706	1	0	0/3	1	
Attachment and Entry R-HSA-9678110	1	0	0/1	1	
Attachment and Entry R-HSA-9694614	1	0	0/7	1	
Attachment of GPI anchor to uPAR R-HSA-162791	1	0	0/2	1	
Attenuation phase R-HSA-3371568	1	0	0/19	1	
Autodegradation of Cdh1 by Cdh1:APC/C R-HSA-174084	1	0	0/63	1	
Autodegradation of the E3 ubiquitin ligase COP1 R-HSA-349425	1	0	0/51	1	
Autointegration results in viral DNA circles R-HSA-177539	1	0	0/3	1	
Autophagy R-HSA-9612973	0.776816898003575	0.703628703679153	2/92	1	ULK1;ATG101
Axon guidance R-HSA-422475	0.908389695577232	0.643917031242506	7/343	1	SPTBN2;CDC42;CACNA1D;ARHGEF11;NGEF;PFN1;SCN8A
Axonal growth inhibition (RHOA activation) R-HSA-193634	1	0	0/2	1	
Axonal growth stimulation R-HSA-209563	1	0	0/2	1	
Azathioprine ADME R-HSA-9748787	0.288365431745851	3.20406387724278	1/11	1	NME1
BBSome-mediated cargo-targeting to cilium R-HSA-5620922	1	0	0/11	1	
BDNF activates NTRK2 (TRKB) signaling R-HSA-9024909	1	0	0/1	1	
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members R-HSA-111453	0.219107742800551	4.57941075774204	1/8	1	STAT3
BMAL1:CLOCK,NPAS2 activates circadian gene expression R-HSA-1368108	0.461641308516191	1.68306147966003	1/20	1	PPARA
Bacterial Infection Pathways R-HSA-9824439	0.35605600593182	1.64499612792387	2/41	1	VAMP2;CBL
Basigin interactions R-HSA-210991	1	0	0/11	1	
Beta defensins R-HSA-1461957	1	0	0/6	1	
Beta oxidation of butanoyl-CoA to acetyl-CoA R-HSA-77352	1	0	0/5	1	
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA R-HSA-77346	1	0	0/2	1	
Beta oxidation of hexanoyl-CoA to butanoyl-CoA R-HSA-77350	1	0	0/3	1	
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA R-HSA-77310	1	0	0/3	1	
Beta oxidation of myristoyl-CoA to lauroyl-CoA R-HSA-77285	1	0	0/1	1	
Beta oxidation of octanoyl-CoA to hexanoyl-CoA R-HSA-77348	1	0	0/2	1	
Beta oxidation of palmitoyl-CoA to myristoyl-CoA R-HSA-77305	1	0	0/0	1	
Beta-catenin independent WNT signaling R-HSA-3858494	0.836091497192112	0.612745781365519	2/105	1	GNB2;PFN1
Beta-catenin phosphorylation cascade R-HSA-196299	1	0	0/11	1	
Beta-oxidation of pristanoyl-CoA R-HSA-389887	1	0	0/3	1	
Beta-oxidation of very long chain fatty acids R-HSA-390247	1	0	0/4	1	
Bicarbonate transporters R-HSA-425381	1	0	0/3	1	
Bile acid and bile salt metabolism R-HSA-194068	1	0	0/13	1	
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782	1	0	0/20	1	
Binding and entry of HIV virion R-HSA-173107	0.116263980170045	10.686886668013	1/4	1	CCR5
Binding of TCF/LEF:CTNNB1 to target gene promoters R-HSA-4411364	1	0	0/8	1	
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB R-HSA-141333	1	0	0/1	1	
Biological oxidations R-HSA-211859	1	0	0/74	1	
Biosynthesis of A2E, implicated in retinal degradation R-HSA-2466712	1	0	0/0	1	
Biosynthesis of D-series resolvins R-HSA-9018676	1	0	0/2	1	
Biosynthesis of DHA-derived SPMs R-HSA-9018677	1	0	0/5	1	
Biosynthesis of DHA-derived sulfido conjugates R-HSA-9026395	1	0	0/0	1	
Biosynthesis of DPA-derived SPMs R-HSA-9018683	1	0	0/3	1	
Biosynthesis of DPAn-3 SPMs R-HSA-9025094	1	0	0/3	1	
Biosynthesis of DPAn-3-derived 13-series resolvins R-HSA-9026403	1	0	0/1	1	
Biosynthesis of DPAn-3-derived maresins R-HSA-9026290	1	0	0/1	1	
Biosynthesis of DPAn-3-derived protectins and resolvins R-HSA-9026286	1	0	0/2	1	
Biosynthesis of DPAn-6 SPMs R-HSA-9025106	1	0	0/1	1	
Biosynthesis of E-series 18(R)-resolvins R-HSA-9023661	1	0	0/3	1	
Biosynthesis of E-series 18(S)-resolvins R-HSA-9018896	1	0	0/3	1	
Biosynthesis of EPA-derived SPMs R-HSA-9018679	1	0	0/4	1	
Biosynthesis of aspirin-triggered D-series resolvins R-HSA-9020265	1	0	0/2	1	
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives R-HSA-9027604	1	0	0/2	1	
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) R-HSA-9026762	1	0	0/0	1	
Biosynthesis of maresin-like SPMs R-HSA-9027307	1	0	0/0	1	
Biosynthesis of maresins R-HSA-9018682	1	0	0/2	1	
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) R-HSA-9026766	1	0	0/0	1	
Biosynthesis of protectins R-HSA-9018681	1	0	0/1	1	
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678	1	0	0/6	1	
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein R-HSA-446193	1	0	0/21	1	
Biotin transport and metabolism R-HSA-196780	1	0	0/6	1	
Blockage of phagosome acidification R-HSA-9636467	1	0	0/0	1	
Blood group systems biosynthesis R-HSA-9033658	1	0	0/4	1	
Branched-chain amino acid catabolism R-HSA-70895	1	0	0/10	1	
Breakdown of the nuclear lamina R-HSA-352238	1	0	0/1	1	
Budding and maturation of HIV virion R-HSA-162588	1	0	0/16	1	
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA R-HSA-450385	1	0	0/15	1	
Butyrophilin (BTN) family interactions R-HSA-8851680	1	0	0/4	1	
C-type lectin receptors (CLRs) R-HSA-5621481	0.288936588408046	1.42776350931966	5/118	1	NFKB1;RELA;RELB;IL1B;NFKB2
C6 deamination of adenosine R-HSA-75102	1	0	0/0	1	
CASP8 activity is inhibited R-HSA-5218900	1	0	0/10	1	
CD163 mediating an anti-inflammatory response R-HSA-9662834	1	0	0/6	1	
CD22 mediated BCR regulation R-HSA-5690714	1	0	0/4	1	
CD28 co-stimulation R-HSA-389356	0.55318421545593	1.27728821101974	1/26	1	CDC42
CD28 dependent PI3K/Akt signaling R-HSA-389357	1	0	0/17	1	
CD28 dependent Vav1 pathway R-HSA-389359	0.242905995435717	4.00656868135255	1/9	1	CDC42
CDH11 homotypic and heterotypic interactions R-HSA-9833576	1	0	0/5	1	
CDK-mediated phosphorylation and removal of Cdc6 R-HSA-69017	0.650052482368673	0.909346948967421	2/72	1	CCNA2;CDC6
CHL1 interactions R-HSA-447041	1	0	0/5	1	
CLEC7A (Dectin-1) induces NFAT activation R-HSA-5607763	1	0	0/9	1	
CLEC7A (Dectin-1) signaling R-HSA-5607764	0.1421697855352	1.88917004625934	5/91	1	NFKB1;RELA;RELB;IL1B;NFKB2
COPI-dependent Golgi-to-ER retrograde traffic R-HSA-6811434	0.50294416502729	1.20623698765238	2/55	1	KIF2A;COPB1
COPI-independent Golgi-to-ER retrograde traffic R-HSA-6811436	1	0	0/36	1	
COPI-mediated anterograde transport R-HSA-6807878	0.350557993683664	1.46004196596012	3/69	1	SPTBN2;COPB1;COG1
COPII-mediated vesicle transport R-HSA-204005	0.254147963263314	2.14314560142854	2/32	1	SEC23A;CTSZ
COX reactions R-HSA-140180	1	0	0/1	1	
CREB phosphorylation R-HSA-199920	1	0	0/7	1	
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling R-HSA-442742	1	0	0/21	1	
CREB1 phosphorylation through the activation of Adenylate Cyclase R-HSA-442720	1	0	0/7	1	
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde R-HSA-442729	1	0	0/6	1	
CREB3 factors activate genes R-HSA-8874211	1	0	0/4	1	
CRMPs in Sema3A signaling R-HSA-399956	1	0	0/8	1	
CS/DS degradation R-HSA-2024101	1	0	0/6	1	
CTLA4 inhibitory signaling R-HSA-389513	1	0	0/15	1	
CTNNB1 S33 mutants aren't phosphorylated R-HSA-5358747	1	0	0/11	1	
CTNNB1 S37 mutants aren't phosphorylated R-HSA-5358749	1	0	0/11	1	
CTNNB1 S45 mutants aren't phosphorylated R-HSA-5358751	1	0	0/11	1	
CTNNB1 T41 mutants aren't phosphorylated R-HSA-5358752	1	0	0/11	1	
CYP2E1 reactions R-HSA-211999	1	0	0/3	1	
Ca-dependent events R-HSA-111996	1	0	0/23	1	
Ca2+ activated K+ channels R-HSA-1296052	1	0	0/2	1	
Ca2+ pathway R-HSA-4086398	0.640631955377151	0.996158732799185	1/33	1	GNB2
CaM pathway R-HSA-111997	1	0	0/21	1	
CaMK IV-mediated phosphorylation of CREB R-HSA-111932	1	0	0/8	1	
Calcineurin activates NFAT R-HSA-2025928	1	0	0/9	1	
Calcitonin-like ligand receptors R-HSA-419812	1	0	0/5	1	
Calmodulin induced events R-HSA-111933	1	0	0/21	1	
Calnexin/calreticulin cycle R-HSA-901042	1	0	0/14	1	
Cam-PDE 1 activation R-HSA-111957	1	0	0/2	1	
Cap-dependent Translation Initiation R-HSA-72737	1	0	0/97	1	
Carboxyterminal post-translational modifications of tubulin R-HSA-8955332	1	0	0/23	1	
Cardiac conduction R-HSA-5576891	0.795101624791598	0.634644967427019	1/51	1	SCN8A
Cardiogenesis R-HSA-9733709	1	0	0/18	1	
Cargo recognition for clathrin-mediated endocytosis R-HSA-8856825	0.266552678900415	1.72514198601905	3/59	1	VAMP2;CD3D;CBL
Cargo trafficking to the periciliary membrane R-HSA-5620920	1	0	0/21	1	
Carnitine metabolism R-HSA-200425	1	0	0/8	1	
Carnitine synthesis R-HSA-71262	1	0	0/1	1	
Caspase activation via Death Receptors in the presence of ligand R-HSA-140534	1	0	0/13	1	
Caspase activation via Dependence Receptors in the absence of ligand R-HSA-418889	1	0	0/3	1	
Caspase activation via extrinsic apoptotic signalling pathway R-HSA-5357769	1	0	0/16	1	
Caspase-mediated cleavage of cytoskeletal proteins R-HSA-264870	1	0	0/7	1	
Catecholamine biosynthesis R-HSA-209905	1	0	0/1	1	
Cation-coupled Chloride cotransporters R-HSA-426117	1	0	0/4	1	
Cdc20:Phospho-APC/C mediated degradation of Cyclin A R-HSA-174184	0.350557993683664	1.46004196596012	3/69	1	BUB3;CDK1;CCNA2
Cell death signalling via NRAGE, NRIF and NADE R-HSA-204998	0.127331973640782	2.55375756187567	3/41	1	ARHGEF11;NGEF;MCF2L
Cell junction organization R-HSA-446728	1	0	0/46	1	
Cell surface interactions at the vascular wall R-HSA-202733	0.871958877241893	0.486318002787028	1/66	1	INPP5D
Cell-Cell communication R-HSA-1500931	1	0	0/70	1	
Cell-cell junction organization R-HSA-421270	1	0	0/29	1	
Cell-extracellular matrix interactions R-HSA-446353	1	0	0/13	1	
Cellular hexose transport R-HSA-189200	1	0	0/5	1	
Cellular response to chemical stress R-HSA-9711123	0.590865642439873	0.97070753423674	5/169	1	HDAC3;NFKB1;RELA;PPARA;STAT3
Cellular response to heat stress R-HSA-3371556	1	0	0/55	1	
Cellular response to hypoxia R-HSA-1234174	1	0	0/66	1	
Cellular response to mitochondrial stress R-HSA-9840373	1	0	0/7	1	
Cellular response to starvation R-HSA-9711097	1	0	0/132	1	
Cellular responses to stimuli R-HSA-8953897	0.71936072975042	0.882505107467545	17/620	1	CCNA2;CXCL8;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;PPARA;STAT3;EHMT2
Cellular responses to stress R-HSA-2262752	0.71936072975042	0.882505107467545	17/620	1	CCNA2;CXCL8;E2F3;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;PPARA;STAT3;EHMT2
Centrosome maturation R-HSA-380287	0.127331973640782	2.55375756187567	3/41	1	CDK1;MAPRE1;CEP78
Ceramide signalling R-HSA-193681	1	0	0/2	1	
ChREBP activates metabolic gene expression R-HSA-163765	1	0	0/3	1	
Chaperone Mediated Autophagy R-HSA-9613829	1	0	0/15	1	
Chaperonin-mediated protein folding R-HSA-390466	0.274882679040778	1.69444780773197	3/60	1	GNB2;HDAC3;STAT3
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex R-HSA-75035	0.288365431745851	3.20406387724278	1/11	1	CDK1
Cholesterol biosynthesis R-HSA-191273	1	0	0/6	1	
Cholesterol biosynthesis via desmosterol R-HSA-6807047	1	0	0/0	1	
Cholesterol biosynthesis via lathosterol R-HSA-6807062	1	0	0/0	1	
Choline catabolism R-HSA-6798163	1	0	0/2	1	
Chondroitin sulfate biosynthesis R-HSA-2022870	1	0	0/10	1	
Chondroitin sulfate/dermatan sulfate metabolism R-HSA-1793185	1	0	0/21	1	
Chylomicron assembly R-HSA-8963888	1	0	0/5	1	
Chylomicron clearance R-HSA-8964026	1	0	0/1	1	
Chylomicron remodeling R-HSA-8963901	1	0	0/6	1	
Cilium Assembly R-HSA-5617833	0.564389849872715	1.02903304763575	3/96	1	CDK1;MAPRE1;CEP78
Ciprofloxacin ADME R-HSA-9793528	1	0	0/2	1	
Circadian Clock R-HSA-400253	0.473206431282382	1.27957997235896	2/52	1	HDAC3;PPARA
Citric acid cycle (TCA cycle) R-HSA-71403	1	0	0/12	1	
Class B/2 (Secretin family receptors) R-HSA-373080	0.692480154387814	0.86046333162253	1/38	1	GNB2
Class C/3 (Metabotropic glutamate/pheromone receptors) R-HSA-420499	1	0	0/1	1	
Class I MHC mediated antigen processing & presentation R-HSA-983169	0.998111973342149	0.154981847848486	1/198	1	SEC23A
Class I peroxisomal membrane protein import R-HSA-9603798	1	0	0/8	1	
Classical Kir channels R-HSA-1296053	1	0	0/1	1	
Classical antibody-mediated complement activation R-HSA-173623	1	0	0/3	1	
Clathrin-mediated endocytosis R-HSA-8856828	0.238255162579616	1.65583896398389	4/82	1	VAMP2;CD3D;CBL;GAK
Cobalamin (Cbl) metabolism R-HSA-9759218	1	0	0/4	1	
Cobalamin (Cbl, vitamin B12) transport and metabolism R-HSA-196741	1	0	0/7	1	
Coenzyme A biosynthesis R-HSA-196783	1	0	0/1	1	
Cohesin Loading onto Chromatin R-HSA-2470946	0.265984697433587	3.56074569329776	1/10	1	WAPL
Collagen biosynthesis and modifying enzymes R-HSA-1650814	1	0	0/31	1	
Collagen chain trimerization R-HSA-8948216	1	0	0/22	1	
Collagen degradation R-HSA-1442490	1	0	0/34	1	
Collagen formation R-HSA-1474290	1	0	0/45	1	
Common Pathway of Fibrin Clot Formation R-HSA-140875	1	0	0/11	1	
Competing endogenous RNAs (ceRNAs) regulate PTEN translation R-HSA-8948700	1	0	0/1	1	
Complement cascade R-HSA-166658	0.175378720698121	2.80010201131709	2/25	1	C3;CPN2
Complex I biogenesis R-HSA-6799198	1	0	0/41	1	
Conjugation of benzoate with glycine R-HSA-177135	1	0	0/2	1	
Conjugation of carboxylic acids R-HSA-159424	1	0	0/4	1	
Conjugation of phenylacetate with glutamine R-HSA-177162	1	0	0/1	1	
Conjugation of salicylate with glycine R-HSA-177128	1	0	0/4	1	
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400	1	0	0/25	1	
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530	0.736899902578986	0.757069815975627	1/43	1	FGF5
Constitutive Signaling by EGFRvIII R-HSA-5637810	0.331116137121452	2.66887927516196	1/13	1	CBL
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382	0.409122587631764	2.00003463165419	1/17	1	CBL
Constitutive Signaling by NOTCH1 HD Domain Mutants R-HSA-2691232	1	0	0/9	1	
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants R-HSA-2894862	0.788591033174282	0.647762265480832	1/50	1	HDAC3
Constitutive Signaling by NOTCH1 PEST Domain Mutants R-HSA-2644606	0.788591033174282	0.647762265480832	1/50	1	HDAC3
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660826	1	0	0/4	1	
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285	1	0	0/7	1	
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase R-HSA-176407	1	0	0/18	1	
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding R-HSA-6814122	0.509526609716264	1.45249715242618	1/23	1	GNB2
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding R-HSA-389958	1	0	0/33	1	
Costimulation by the CD28 family R-HSA-388841	0.463061452308441	1.30602289621601	2/51	1	CDC42;CD3D
Creatine metabolism R-HSA-71288	1	0	0/1	1	
Creation of C4 and C2 activators R-HSA-166786	1	0	0/7	1	
Cristae formation R-HSA-8949613	1	0	0/25	1	
Cross-presentation of particulate exogenous antigens (phagosomes) R-HSA-1236973	1	0	0/5	1	
Cross-presentation of soluble exogenous antigens (endosomes) R-HSA-1236978	1	0	0/45	1	
Crosslinking of collagen fibrils R-HSA-2243919	1	0	0/14	1	
Cysteine formation from homocysteine R-HSA-1614603	1	0	0/1	1	
Cytochrome P450 - arranged by substrate type R-HSA-211897	1	0	0/16	1	
Cytochrome c-mediated apoptotic response R-HSA-111461	1	0	0/5	1	
Cytoprotection by HMOX1 R-HSA-9707564	0.193660323022215	2.06011727739823	3/50	1	HDAC3;PPARA;STAT3
Cytosolic iron-sulfur cluster assembly R-HSA-2564830	1	0	0/2	1	
Cytosolic sensors of pathogen-associated DNA  R-HSA-1834949	0.141287419614727	2.42477512779573	3/43	1	NFKB1;RELA;NFKB2
Cytosolic sulfonation of small molecules R-HSA-156584	1	0	0/11	1	
Cytosolic tRNA aminoacylation R-HSA-379716	1	0	0/7	1	
DAG and IP3 signaling R-HSA-1489509	1	0	0/25	1	
DAP12 interactions R-HSA-2172127	1	0	0/23	1	
DAP12 signaling R-HSA-2424491	1	0	0/21	1	
DARPP-32 events R-HSA-180024	1	0	0/14	1	
DCC mediated attractive signaling R-HSA-418885	0.242905995435717	4.00656868135255	1/9	1	CDC42
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928	0.342138484783288	1.48287981325852	3/68	1	NFKB1;RELA;NFKB2
DNA Damage Bypass R-HSA-73893	1	0	0/25	1	
DNA Damage Recognition in GG-NER R-HSA-5696394	1	0	0/18	1	
DNA Damage Reversal R-HSA-73942	1	0	0/0	1	
DNA Double Strand Break Response R-HSA-5693606	0.113300748607229	2.27779712792881	4/61	1	H2BC13;H2BC17;H2BC12;H2BC14
DNA Double-Strand Break Repair R-HSA-5693532	0.187068908283421	1.70621967758548	5/100	1	CCNA2;H2BC13;H2BC17;H2BC12;H2BC14
DNA Repair R-HSA-73894	0.458880955241567	1.11773415725261	6/178	1	CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14
DNA replication initiation R-HSA-68952	1	0	0/3	1	
DSCAM interactions R-HSA-376172	1	0	0/1	1	
Dasatinib-resistant KIT mutants R-HSA-9669914	1	0	0/1	1	
Deactivation of the beta-catenin transactivating complex R-HSA-3769402	1	0	0/29	1	
Deadenylation of mRNA R-HSA-429947	1	0	0/18	1	
Deadenylation-dependent mRNA decay R-HSA-429914	1	0	0/39	1	
Dectin-1 mediated noncanonical NF-kB signaling R-HSA-5607761	0.266552678900415	1.72514198601905	3/59	1	RELA;RELB;NFKB2
Dectin-2 family R-HSA-5621480	1	0	0/12	1	
Defective ABCA1 causes TGD R-HSA-5682113	1	0	0/2	1	
Defective ABCA12 causes ARCI4B R-HSA-5682294	1	0	0/1	1	
Defective ABCA3 causes SMDP3 R-HSA-5683678	1	0	0/0	1	
Defective ABCA3 causes SMDP3 R-HSA-5688399	1	0	0/0	1	
Defective ABCB11 causes PFIC2 and BRIC2 R-HSA-5678520	1	0	0/1	1	
Defective ABCB4 causes PFIC3, ICP3 and GBD1 R-HSA-5678771	1	0	0/0	1	
Defective ABCB6 causes MCOPCB7 R-HSA-5683371	1	0	0/0	1	
Defective ABCC2 causes DJS R-HSA-5679001	1	0	0/0	1	
Defective ABCC6 causes PXE R-HSA-5690338	1	0	0/0	1	
Defective ABCC8 can cause hypo- and hyper-glycemias R-HSA-5683177	1	0	0/0	1	
Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome R-HSA-5678420	1	0	0/1	1	
Defective ABCD1 causes ALD R-HSA-5684045	1	0	0/0	1	
Defective ABCD4 causes MAHCJ R-HSA-5683329	1	0	0/2	1	
Defective ABCG5 causes sitosterolemia R-HSA-5679096	1	0	0/0	1	
Defective ABCG8 causes GBD4 and sitosterolemia R-HSA-5679090	1	0	0/0	1	
Defective ACTH causes obesity and POMCD R-HSA-5579031	1	0	0/1	1	
Defective ACY1 causes encephalopathy R-HSA-5579007	1	0	0/0	1	
Defective ADA disrupts (deoxy)adenosine deamination R-HSA-9734735	1	0	0/0	1	
Defective AHCY causes HMAHCHD R-HSA-5578997	1	0	0/1	1	
Defective ALG1 causes CDG-1k R-HSA-4549380	1	0	0/0	1	
Defective ALG11 causes CDG-1p R-HSA-4551295	1	0	0/0	1	
Defective ALG12 causes CDG-1g R-HSA-4720489	1	0	0/0	1	
Defective ALG14 causes ALG14-CMS R-HSA-5633231	1	0	0/0	1	
Defective ALG2 causes CDG-1i R-HSA-4549349	1	0	0/0	1	
Defective ALG3 causes CDG-1d R-HSA-4720475	1	0	0/1	1	
Defective ALG6 causes CDG-1c R-HSA-4724289	1	0	0/0	1	
Defective ALG8 causes CDG-1h R-HSA-4724325	1	0	0/0	1	
Defective ALG9 causes CDG-1l R-HSA-4720454	1	0	0/0	1	
Defective AMN causes MGA1 R-HSA-3359462	1	0	0/0	1	
Defective APRT disrupts adenine salvage R-HSA-9734195	1	0	0/1	1	
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-5619099	1	0	0/0	1	
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-9036092	1	0	0/1	1	
Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-4420332	1	0	0/7	1	
Defective B3GALTL causes PpS R-HSA-5083635	1	0	0/14	1	
Defective B3GAT3 causes JDSSDHD R-HSA-3560801	1	0	0/8	1	
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) R-HSA-3656244	1	0	0/4	1	
Defective B4GALT1 causes CDG-2d R-HSA-4793953	1	0	0/0	1	
Defective B4GALT7 causes EDS, progeroid type R-HSA-3560783	1	0	0/7	1	
Defective BTD causes biotidinase deficiency R-HSA-3371598	1	0	0/1	1	
Defective Base Excision Repair Associated with MUTYH R-HSA-9605310	1	0	0/0	1	
Defective Base Excision Repair Associated with NEIL1 R-HSA-9616334	1	0	0/1	1	
Defective Base Excision Repair Associated with NEIL3 R-HSA-9629232	1	0	0/0	1	
Defective Base Excision Repair Associated with NTHL1 R-HSA-9616333	1	0	0/0	1	
Defective Base Excision Repair Associated with OGG1 R-HSA-9656249	1	0	0/0	1	
Defective C1GALT1C1 causes TNPS R-HSA-5083632	1	0	0/10	1	
Defective CBLIF causes IFD R-HSA-3359457	1	0	0/0	1	
Defective CD320 causes MMATC R-HSA-3359485	1	0	0/0	1	
Defective CFTR causes cystic fibrosis R-HSA-5678895	1	0	0/56	1	
Defective CHST14 causes EDS, musculocontractural type R-HSA-3595174	1	0	0/3	1	
Defective CHST3 causes SEDCJD R-HSA-3595172	1	0	0/4	1	
Defective CHST6 causes MCDC1 R-HSA-3656225	1	0	0/4	1	
Defective CHSY1 causes TPBS R-HSA-3595177	1	0	0/3	1	
Defective CP causes aceruloplasminemia (ACERULOP) R-HSA-5619060	1	0	0/1	1	
Defective CSF2RA causes SMDP4 R-HSA-5688890	1	0	0/2	1	
Defective CSF2RB causes SMDP5 R-HSA-5688849	1	0	0/2	1	
Defective CUBN causes MGA1 R-HSA-3359463	1	0	0/0	1	
Defective CYP11A1 causes AICSR R-HSA-5579026	1	0	0/0	1	
Defective CYP11B1 causes AH4 R-HSA-5579017	1	0	0/0	1	
Defective CYP11B2 causes CMO-1 deficiency R-HSA-5579009	1	0	0/0	1	
Defective CYP17A1 causes AH5 R-HSA-5579028	1	0	0/0	1	
Defective CYP19A1 causes AEXS R-HSA-5579030	1	0	0/0	1	
Defective CYP1B1 causes Glaucoma R-HSA-5579000	1	0	0/0	1	
Defective CYP21A2 causes AH3 R-HSA-5579021	1	0	0/0	1	
Defective CYP24A1 causes HCAI R-HSA-5579010	1	0	0/0	1	
Defective CYP26B1 causes RHFCA R-HSA-5579015	1	0	0/0	1	
Defective CYP26C1 causes FFDD4 R-HSA-5579004	1	0	0/0	1	
Defective CYP27A1 causes CTX R-HSA-5578996	1	0	0/1	1	
Defective CYP27B1 causes VDDR1A R-HSA-5579014	1	0	0/0	1	
Defective CYP27B1 causes VDDR1B R-HSA-5579027	1	0	0/0	1	
Defective CYP2U1 causes SPG56 R-HSA-5579011	1	0	0/1	1	
Defective CYP4F22 causes ARCI5 R-HSA-5579005	1	0	0/0	1	
Defective CYP7B1 causes SPG5A and CBAS3 R-HSA-5579013	1	0	0/0	1	
Defective DHDDS causes RP59 R-HSA-4755609	1	0	0/0	1	
Defective DNA double strand break response due to BARD1 loss of function R-HSA-9699150	1	0	0/1	1	
Defective DNA double strand break response due to BRCA1 loss of function R-HSA-9663199	1	0	0/1	1	
Defective DOLK causes DOLK-CDG R-HSA-4755583	1	0	0/0	1	
Defective DPAGT1 causes CDG-1j, CMSTA2 R-HSA-4549356	1	0	0/1	1	
Defective DPM1 causes DPM1-CDG R-HSA-4717374	1	0	0/2	1	
Defective DPM2 causes DPM2-CDG R-HSA-4719377	1	0	0/2	1	
Defective DPM3 causes DPM3-CDG R-HSA-4719360	1	0	0/2	1	
Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656253	1	0	0/4	1	
Defective EXT2 causes exostoses 2 R-HSA-3656237	1	0	0/4	1	
Defective F8 accelerates dissociation of the A2 domain R-HSA-9672387	1	0	0/1	1	
Defective F8 binding to the cell membrane R-HSA-9672395	1	0	0/1	1	
Defective F8 binding to von Willebrand factor R-HSA-9672393	1	0	0/2	1	
Defective F8 cleavage by thrombin R-HSA-9672391	1	0	0/3	1	
Defective F8 secretion R-HSA-9672397	1	0	0/1	1	
Defective F8 sulfation at Y1699 R-HSA-9674519	1	0	0/1	1	
Defective F9 secretion R-HSA-9673218	1	0	0/0	1	
Defective F9 variant does not activate FX R-HSA-9673202	1	0	0/1	1	
Defective FMO3 causes TMAU R-HSA-5579019	1	0	0/0	1	
Defective GALE causes EDG R-HSA-5609977	1	0	0/0	1	
Defective GALK1 causes GALCT2 R-HSA-5609976	1	0	0/0	1	
Defective GALNT12 causes CRCS1 R-HSA-5083636	1	0	0/8	1	
Defective GALNT3 causes HFTC R-HSA-5083625	1	0	0/8	1	
Defective GALT can cause GALCT R-HSA-5609978	1	0	0/0	1	
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) R-HSA-5619073	1	0	0/0	1	
Defective GCLC causes HAGGSD R-HSA-5578999	1	0	0/2	1	
Defective GFPT1 causes CMSTA1 R-HSA-4085023	1	0	0/0	1	
Defective GGT1 causes GLUTH R-HSA-5579022	1	0	0/0	1	
Defective GGT1 in aflatoxin detoxification causes GLUTH R-HSA-9035968	1	0	0/0	1	
Defective GNE causes sialuria, NK and IBM2 R-HSA-4085011	1	0	0/1	1	
Defective GSS causes GSS deficiency R-HSA-5579006	1	0	0/1	1	
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function R-HSA-9704331	1	0	0/14	1	
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function R-HSA-9704646	1	0	0/14	1	
Defective HEXA causes GM2G1 R-HSA-3656234	1	0	0/1	1	
Defective HEXB causes GM2G2 R-HSA-3656248	1	0	0/1	1	
Defective HK1 causes hexokinase deficiency (HK deficiency) R-HSA-5619056	1	0	0/1	1	
Defective HLCS causes multiple carboxylase deficiency R-HSA-3371599	1	0	0/3	1	
Defective HPRT1 disrupts guanine and hypoxanthine salvage R-HSA-9734281	1	0	0/0	1	
Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations R-HSA-9670615	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations R-HSA-9670613	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere R-HSA-9670621	1	0	0/1	1	
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function R-HSA-9645722	1	0	0/2	1	
Defective Intrinsic Pathway for Apoptosis R-HSA-9734009	1	0	0/16	1	
Defective LARGE causes MDDGA6 and MDDGB6 R-HSA-5083627	1	0	0/0	1	
Defective LFNG causes SCDO3 R-HSA-5083630	1	0	0/5	1	
Defective MAN1B1 causes MRT15 R-HSA-4793950	1	0	0/0	1	
Defective MAOA causes BRUNS R-HSA-5579012	1	0	0/1	1	
Defective MAT1A causes MATD R-HSA-5579024	1	0	0/1	1	
Defective MGAT2 causes CDG-2a R-HSA-4793952	1	0	0/0	1	
Defective MMAA causes MMA, cblA type R-HSA-3359475	1	0	0/2	1	
Defective MMAB causes MMA, cblB type R-HSA-3359471	1	0	0/0	1	
Defective MMACHC causes MAHCC R-HSA-3359474	1	0	0/1	1	
Defective MMADHC causes MMAHCD R-HSA-3359473	1	0	0/1	1	
Defective MOGS causes CDG-2b R-HSA-4793954	1	0	0/0	1	
Defective MPDU1 causes CDG-1f R-HSA-4687000	1	0	0/0	1	
Defective MPI causes MPI-CDG R-HSA-4043916	1	0	0/0	1	
Defective MTR causes HMAG R-HSA-3359469	1	0	0/1	1	
Defective MTRR causes HMAE R-HSA-3359467	1	0	0/1	1	
Defective MUT causes MMAM R-HSA-3359478	1	0	0/2	1	
Defective MUTYH substrate binding R-HSA-9608287	1	0	0/0	1	
Defective MUTYH substrate processing R-HSA-9608290	1	0	0/0	1	
Defective Mismatch Repair Associated With MLH1 R-HSA-5545483	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH2 R-HSA-5632928	1	0	0/1	1	
Defective Mismatch Repair Associated With MSH3 R-HSA-5632927	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH6 R-HSA-5632968	1	0	0/1	1	
Defective Mismatch Repair Associated With PMS2 R-HSA-5632987	1	0	0/0	1	
Defective NEU1 causes sialidosis R-HSA-4341670	1	0	0/2	1	
Defective NTHL1 substrate binding R-HSA-9630222	1	0	0/0	1	
Defective NTHL1 substrate processing R-HSA-9630221	1	0	0/0	1	
Defective OGG1 Localization R-HSA-9657050	1	0	0/0	1	
Defective OGG1 Substrate Binding R-HSA-9656255	1	0	0/0	1	
Defective OGG1 Substrate Processing R-HSA-9656256	1	0	0/0	1	
Defective OPLAH causes OPLAHD R-HSA-5578998	1	0	0/1	1	
Defective PAPSS2 causes SEMD-PA R-HSA-3560796	1	0	0/0	1	
Defective PGM1 causes PGM1-CDG R-HSA-5609974	1	0	0/1	1	
Defective PMM2 causes PMM2-CDG R-HSA-4043911	1	0	0/1	1	
Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine R-HSA-9735763	1	0	0/1	1	
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 R-HSA-5083628	1	0	0/0	1	
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 R-HSA-5083633	1	0	0/1	1	
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 R-HSA-5083629	1	0	0/1	1	
Defective RFT1 causes CDG-1n R-HSA-4570571	1	0	0/0	1	
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) R-HSA-5619042	1	0	0/0	1	
Defective RIPK1-mediated regulated necrosis R-HSA-9693928	1	0	0/7	1	
Defective SERPING1 causes hereditary angioedema R-HSA-9657689	1	0	0/3	1	
Defective SFTPA2 causes IPF R-HSA-5687868	1	0	0/0	1	
Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) R-HSA-5619048	1	0	0/1	1	
Defective SLC12A1 causes Bartter syndrome 1 (BS1) R-HSA-5619104	1	0	0/1	1	
Defective SLC12A3 causes Gitelman syndrome (GS) R-HSA-5619087	1	0	0/0	1	
Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) R-HSA-5619039	1	0	0/1	1	
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) R-HSA-5619070	1	0	0/2	1	
Defective SLC17A5 causes Salla disease (SD) and ISSD R-HSA-5619035	1	0	0/1	1	
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) R-HSA-5619076	1	0	0/0	1	
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) R-HSA-5619067	1	0	0/0	1	
Defective SLC1A3 causes episodic ataxia 6 (EA6) R-HSA-5619062	1	0	0/1	1	
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) R-HSA-5619111	1	0	0/1	1	
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) R-HSA-5619071	1	0	0/0	1	
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) R-HSA-5619066	1	0	0/0	1	
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) R-HSA-5619053	1	0	0/1	1	
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) R-HSA-5619077	1	0	0/1	1	
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) R-HSA-5619055	1	0	0/0	1	
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) R-HSA-5619036	1	0	0/0	1	
Defective SLC26A2 causes chondrodysplasias R-HSA-3560792	1	0	0/1	1	
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) R-HSA-5619085	1	0	0/0	1	
Defective SLC26A4 causes Pendred syndrome (PDS) R-HSA-5619046	1	0	0/0	1	
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) R-HSA-5619108	1	0	0/1	1	
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) R-HSA-5619063	1	0	0/0	1	
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) R-HSA-5619043	1	0	0/0	1	
Defective SLC2A10 causes arterial tortuosity syndrome (ATS) R-HSA-5619068	1	0	0/0	1	
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) R-HSA-5619098	1	0	0/0	1	
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) R-HSA-5619047	1	0	0/0	1	
Defective SLC33A1 causes spastic paraplegia 42 (SPG42) R-HSA-5619061	1	0	0/0	1	
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) R-HSA-5619040	1	0	0/1	1	
Defective SLC34A2 causes PALM R-HSA-5687583	1	0	0/0	1	
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) R-HSA-5619045	1	0	0/0	1	
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) R-HSA-5619097	1	0	0/0	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5619037	1	0	0/1	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5663020	1	0	0/1	1	
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) R-HSA-5619072	1	0	0/1	1	
Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) R-HSA-5619083	1	0	0/0	1	
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) R-HSA-5619078	1	0	0/0	1	
Defective SLC35D1 causes SCHBCKD R-HSA-5579020	1	0	0/0	1	
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) R-HSA-5619041	1	0	0/0	1	
Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) R-HSA-5619088	1	0	0/0	1	
Defective SLC3A1 causes cystinuria (CSNU) R-HSA-5619113	1	0	0/1	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) R-HSA-5655799	1	0	0/2	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) R-HSA-5619049	1	0	0/1	1	
Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) R-HSA-5619050	1	0	0/1	1	
Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) R-HSA-5619054	1	0	0/0	1	
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) R-HSA-5656364	1	0	0/1	1	
Defective SLC5A2 causes renal glucosuria (GLYS1) R-HSA-5658208	1	0	0/0	1	
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) R-HSA-5619096	1	0	0/1	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5619114	1	0	0/0	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5658471	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5619079	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5659729	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5619044	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5659735	1	0	0/0	1	
Defective SLC6A2 causes orthostatic intolerance (OI) R-HSA-5619109	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5619081	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5660724	1	0	0/0	1	
Defective SLC6A5 causes hyperekplexia 3 (HKPX3) R-HSA-5619089	1	0	0/0	1	
Defective SLC7A7 causes lysinuric protein intolerance (LPI) R-HSA-5660862	1	0	0/1	1	
Defective SLC7A9 causes cystinuria (CSNU) R-HSA-5660883	1	0	0/1	1	
Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) R-HSA-5619092	1	0	0/1	1	
Defective SLC9A9 causes autism 16 (AUTS16) R-HSA-5619052	1	0	0/1	1	
Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619110	1	0	0/0	1	
Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619058	1	0	0/0	1	
Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) R-HSA-5619095	1	0	0/0	1	
Defective SRD5A3 causes SRD5A3-CDG, KHRZ R-HSA-4755579	1	0	0/1	1	
Defective ST3GAL3 causes MCT12 and EIEE15 R-HSA-3656243	1	0	0/5	1	
Defective TBXAS1 causes GHDD R-HSA-5579032	1	0	0/0	1	
Defective TCN2 causes TCN2 deficiency R-HSA-3359454	1	0	0/0	1	
Defective TPMT causes TPMT deficiency R-HSA-5578995	1	0	0/1	1	
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) R-HSA-5619107	1	0	0/10	1	
Defective UGT1A1 causes hyperbilirubinemia R-HSA-5579002	1	0	0/0	1	
Defective UGT1A4 causes hyperbilirubinemia R-HSA-5579016	1	0	0/0	1	
Defective VWF binding to collagen type I  R-HSA-9845622	1	0	0/3	1	
Defective VWF cleavage by ADAMTS13 variant R-HSA-9845621	1	0	0/4	1	
Defective binding of VWF variant to GPIb:IX:V R-HSA-9846298	0.116263980170045	10.686886668013	1/4	1	GP1BA
Defective cofactor function of FVIIIa variant R-HSA-9672396	1	0	0/1	1	
Defective factor IX causes hemophilia B R-HSA-9668250	0.116263980170045	10.686886668013	1/4	1	GP1BA
Defective factor IX causes thrombophilia R-HSA-9672383	1	0	0/1	1	
Defective factor VIII causes hemophilia A R-HSA-9662001	1	0	0/3	1	
Defective factor XII causes hereditary angioedema R-HSA-9657688	1	0	0/3	1	
Defective gamma-carboxylation of F9 R-HSA-9673240	1	0	0/1	1	
Defective homologous recombination repair (HRR) due to BRCA1 loss of function R-HSA-9701192	1	0	0/14	1	
Defective homologous recombination repair (HRR) due to BRCA2 loss of function R-HSA-9701190	1	0	0/16	1	
Defective homologous recombination repair (HRR) due to PALB2 loss of function R-HSA-9701193	1	0	0/14	1	
Defective pro-SFTPB causes SMDP1 and RDS R-HSA-5688031	1	0	0/1	1	
Defective pro-SFTPC causes SMDP2 and RDS R-HSA-5688354	1	0	0/0	1	
Defective regulation of TLR7 by endogenous ligand R-HSA-9824856	1	0	0/1	1	
Defective translocation of RB1 mutants to the nucleus R-HSA-9661070	1	0	0/1	1	
Defects in biotin (Btn) metabolism R-HSA-3323169	1	0	0/4	1	
Defects in cobalamin (B12) metabolism R-HSA-3296469	1	0	0/6	1	
Defects in vitamin and cofactor metabolism R-HSA-3296482	1	0	0/10	1	
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) R-HSA-9651496	0.242905995435717	4.00656868135255	1/9	1	GP1BA
Defects of platelet adhesion to exposed collagen R-HSA-9823587	0.143169804536155	8.01619116439233	1/5	1	GP1BA
Defensins R-HSA-1461973	1	0	0/9	1	
Degradation of AXIN R-HSA-4641257	1	0	0/52	1	
Degradation of DVL R-HSA-4641258	1	0	0/52	1	
Degradation of GABA R-HSA-916853	1	0	0/1	1	
Degradation of GLI1 by the proteasome R-HSA-5610780	1	0	0/58	1	
Degradation of GLI2 by the proteasome R-HSA-5610783	1	0	0/59	1	
Degradation of beta-catenin by the destruction complex R-HSA-195253	1	0	0/77	1	
Degradation of cysteine and homocysteine R-HSA-1614558	1	0	0/5	1	
Degradation of the extracellular matrix R-HSA-1474228	0.845432286651883	0.536596112522698	1/60	1	KLK2
Deletions in the AMER1 gene destabilize the destruction complex R-HSA-5467343	1	0	0/1	1	
Deletions in the AXIN1 gene destabilize the destruction complex R-HSA-5467345	1	0	0/1	1	
Depolymerization of the Nuclear Lamina R-HSA-4419969	0.194567694860967	5.34322317913915	1/7	1	CDK1
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models R-HSA-8862803	1	0	0/13	1	
Dermatan sulfate biosynthesis R-HSA-2022923	1	0	0/4	1	
Detoxification of Reactive Oxygen Species R-HSA-3299685	1	0	0/18	1	
Developmental Biology R-HSA-1266738	0.28784919759469	1.16570592632059	24/699	1	TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;PPARA;SPTBN2;CDC42;MTA1;CEBPD;GATAD2A;CACNA1D;STAT3;ARHGEF11;NGEF;PFN1;SCN8A;SPI1
Developmental Cell Lineages R-HSA-9734767	1	0	0/5	1	
Differentiation of keratinocytes in interfollicular epidermis in mammalian skin R-HSA-9725554	1	0	0/5	1	
Digestion R-HSA-8935690	1	0	0/2	1	
Digestion and absorption R-HSA-8963743	1	0	0/4	1	
Digestion of dietary carbohydrate R-HSA-189085	1	0	0/1	1	
Digestion of dietary lipid R-HSA-192456	1	0	0/1	1	
Dimerization of procaspase-8 R-HSA-69416	1	0	0/10	1	
Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-4641262	1	0	0/20	1	
Disease R-HSA-1643685	0.438053087441027	1.05137457714313	34/1079	1	GNB2;E2F3;TFDP1;E2F1;VAMP2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;FGF5;C3;HDAC3;NFKB1;RELA;AP1M1;SEC23A;CDC42;AP1S1;CD8B;MTA1;CEBPD;GATAD2A;STAT1;STAT3;CBL;CCR5;IL1B;NFKB2;H2AC12;H2AC13;TYK2;GP1BA
Diseases associated with N-glycosylation of proteins R-HSA-3781860	1	0	0/4	1	
Diseases associated with O-glycosylation of proteins R-HSA-3906995	1	0	0/30	1	
Diseases associated with glycosaminoglycan metabolism R-HSA-3560782	1	0	0/17	1	
Diseases associated with glycosylation precursor biosynthesis R-HSA-5609975	1	0	0/6	1	
Diseases associated with surfactant metabolism R-HSA-5687613	1	0	0/2	1	
Diseases associated with visual transduction R-HSA-2474795	1	0	0/1	1	
Diseases of Base Excision Repair R-HSA-9605308	1	0	0/1	1	
Diseases of Cellular Senescence R-HSA-9630747	1	0	0/3	1	
Diseases of DNA Double-Strand Break Repair R-HSA-9675136	1	0	0/16	1	
Diseases of DNA repair R-HSA-9675135	1	0	0/18	1	
Diseases of Mismatch Repair (MMR) R-HSA-5423599	1	0	0/1	1	
Diseases of Telomere Maintenance R-HSA-9673013	1	0	0/1	1	
Diseases of carbohydrate metabolism R-HSA-5663084	1	0	0/17	1	
Diseases of cellular response to stress R-HSA-9675132	1	0	0/3	1	
Diseases of glycosylation R-HSA-3781865	1	0	0/57	1	
Diseases of hemostasis R-HSA-9671793	0.310069139133716	2.91223689743989	1/12	1	GP1BA
Diseases of metabolism R-HSA-5668914	1	0	0/99	1	
Diseases of mitochondrial beta oxidation R-HSA-9759774	1	0	0/2	1	
Diseases of nucleotide metabolism R-HSA-9735804	1	0	0/2	1	
Diseases of propionyl-CoA catabolism R-HSA-9759785	1	0	0/2	1	
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202	0.928100947925345	0.597415492283375	6/316	1	FGF5;HDAC3;STAT1;STAT3;CBL;TYK2
Diseases of the neuronal system R-HSA-9675143	1	0	0/1	1	
Disinhibition of SNARE formation R-HSA-114516	1	0	0/4	1	
Disorders of Developmental Biology R-HSA-9675151	0.265984697433587	3.56074569329776	1/10	1	HDAC3
Disorders of Nervous System Development R-HSA-9697154	0.265984697433587	3.56074569329776	1/10	1	HDAC3
Disorders of transmembrane transporters R-HSA-5619115	1	0	0/100	1	
Displacement of DNA glycosylase by APEX1 R-HSA-110357	1	0	0/2	1	
Dissolution of Fibrin Clot R-HSA-75205	1	0	0/10	1	
Dopamine Neurotransmitter Release Cycle R-HSA-212676	0.143169804536155	8.01619116439233	1/5	1	VAMP2
Dopamine clearance from the synaptic cleft R-HSA-379401	1	0	0/1	1	
Dopamine receptors R-HSA-390651	1	0	0/0	1	
Downregulation of ERBB2 signaling R-HSA-8863795	1	0	0/19	1	
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803	1	0	0/8	1	
Downregulation of ERBB4 signaling R-HSA-1253288	1	0	0/8	1	
Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173795	0.617543544157383	1.0630640972903	1/31	1	STAT1
Downregulation of TGF-beta receptor signaling R-HSA-2173788	1	0	0/26	1	
Downstream TCR signaling R-HSA-202424	0.31328223586254	1.44708983173807	4/93	1	NFKB1;RELA;INPP5D;CD3D
Downstream signal transduction R-HSA-186763	0.220052670683796	2.38304343136663	2/29	1	STAT1;STAT3
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372	0.225090154250366	1.70028433027889	4/80	1	REL;NFKBIE;NFKB1;RELA
Downstream signaling of activated FGFR1 R-HSA-5654687	0.310069139133716	2.91223689743989	1/12	1	FGF5
Downstream signaling of activated FGFR2 R-HSA-5654696	0.351526138395097	2.4631234253845	1/14	1	FGF5
Downstream signaling of activated FGFR3 R-HSA-5654708	0.310069139133716	2.91223689743989	1/12	1	FGF5
Downstream signaling of activated FGFR4 R-HSA-5654716	1	0	0/12	1	
Drug ADME R-HSA-9748784	0.692480154387814	0.86046333162253	1/38	1	NME1
Drug resistance in ERBB2 KD mutants R-HSA-9665230	1	0	0/2	1	
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737	1	0	0/2	1	
Drug resistance of ALK mutants R-HSA-9700649	1	0	0/0	1	
Drug resistance of FLT3 mutants R-HSA-9702506	1	0	0/0	1	
Drug resistance of KIT mutants R-HSA-9669937	1	0	0/1	1	
Drug resistance of PDGFR mutants R-HSA-9674415	1	0	0/1	1	
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119	1	0	0/5	1	
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282	1	0	0/2	1	
Drug-mediated inhibition of MET activation R-HSA-9734091	1	0	0/1	1	
Dual Incision in GG-NER R-HSA-5696400	1	0	0/17	1	
Dual incision in TC-NER R-HSA-6782135	1	0	0/35	1	
E2F-enabled inhibition of pre-replication complex formation R-HSA-113507	0.116263980170045	10.686886668013	1/4	1	CDK1
ECM proteoglycans R-HSA-3000178	1	0	0/40	1	
EGFR Transactivation by Gastrin R-HSA-2179392	1	0	0/9	1	
EGFR downregulation R-HSA-182971	0.164450951642977	2.92804075517087	2/24	1	CDC42;CBL
EGFR interacts with phospholipase C-gamma R-HSA-212718	1	0	0/9	1	
EGR2 and SOX10-mediated initiation of Schwann cell myelination R-HSA-9619665	1	0	0/13	1	
EPH-Ephrin signaling R-HSA-2682334	0.50294416502729	1.20623698765238	2/55	1	CDC42;NGEF
EPH-ephrin mediated repulsion of cells R-HSA-3928665	1	0	0/25	1	
EPHA-mediated growth cone collapse R-HSA-3928663	0.351526138395097	2.4631234253845	1/14	1	NGEF
EPHB-mediated forward signaling R-HSA-3928662	0.580124869365433	1.18209488026364	1/28	1	CDC42
ER Quality Control Compartment (ERQC) R-HSA-901032	1	0	0/10	1	
ER to Golgi Anterograde Transport R-HSA-199977	0.156570242853288	1.82415758015229	5/94	1	SEC23A;SPTBN2;COPB1;CTSZ;COG1
ER-Phagosome pathway R-HSA-1236974	1	0	0/81	1	
ERBB2 Activates PTK6 Signaling R-HSA-8847993	1	0	0/8	1	
ERBB2 Regulates Cell Motility R-HSA-6785631	1	0	0/9	1	
ERK/MAPK targets R-HSA-198753	1	0	0/16	1	
ERKs are inactivated R-HSA-202670	1	0	0/7	1	
ESR-mediated signaling R-HSA-8939211	0.316545607071269	1.29163136820466	7/182	1	GNB2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Early Phase of HIV Life Cycle R-HSA-162594	0.265984697433587	3.56074569329776	1/10	1	CCR5
Early SARS-CoV-2 Infection Events R-HSA-9772572	1	0	0/16	1	
Effects of PIP2 hydrolysis R-HSA-114508	1	0	0/12	1	
Eicosanoid ligand-binding receptors R-HSA-391903	1	0	0/1	1	
Eicosanoids R-HSA-211979	1	0	0/3	1	
Elastic fibre formation R-HSA-1566948	1	0	0/22	1	
Electric Transmission Across Gap Junctions R-HSA-112303	1	0	0/1	1	
Electron transport from NADPH to Ferredoxin R-HSA-2395516	1	0	0/0	1	
Elevation of cytosolic Ca2+ levels R-HSA-139853	1	0	0/5	1	
Endogenous sterols R-HSA-211976	1	0	0/8	1	
Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729	1	0	0/17	1	
Endosomal/Vacuolar pathway R-HSA-1236977	1	0	0/7	1	
Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-380972	1	0	0/24	1	
Enhanced binding of GP1BA variant to VWF multimer:collagen  R-HSA-9845620	0.116263980170045	10.686886668013	1/4	1	GP1BA
Enhanced cleavage of VWF variant by ADAMTS13 R-HSA-9845619	1	0	0/4	1	
Entry of Influenza Virion into Host Cell via Endocytosis R-HSA-168275	1	0	0/2	1	
Enzymatic degradation of Dopamine by monoamine oxidase R-HSA-379398	1	0	0/1	1	
Enzymatic degradation of dopamine by COMT R-HSA-379397	1	0	0/1	1	
Ephrin signaling R-HSA-3928664	1	0	0/11	1	
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919	1	0	0/3	1	
Erythrocytes take up carbon dioxide and release oxygen R-HSA-1237044	1	0	0/7	1	
Erythrocytes take up oxygen and release carbon dioxide R-HSA-1247673	1	0	0/7	1	
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276	1	0	0/9	1	
Erythropoietin activates Phospholipase C gamma (PLCG) R-HSA-9027277	1	0	0/4	1	
Erythropoietin activates RAS R-HSA-9027284	1	0	0/10	1	
Erythropoietin activates STAT5 R-HSA-9027283	1	0	0/5	1	
Essential fructosuria R-HSA-5657562	1	0	0/1	1	
Essential pentosuria R-HSA-5662853	1	0	0/0	1	
Establishment of Sister Chromatid Cohesion R-HSA-2468052	0.242905995435717	4.00656868135255	1/9	1	WAPL
Estrogen biosynthesis R-HSA-193144	1	0	0/0	1	
Estrogen-dependent gene expression R-HSA-9018519	0.212076212461479	1.54434527715082	6/132	1	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638	1	0	0/24	1	
Estrogen-stimulated signaling through PRKCZ R-HSA-9634635	1	0	0/6	1	
Ethanol oxidation R-HSA-71384	1	0	0/4	1	
Eukaryotic Translation Elongation R-HSA-156842	1	0	0/83	1	
Eukaryotic Translation Initiation R-HSA-72613	1	0	0/97	1	
Eukaryotic Translation Termination R-HSA-72764	1	0	0/81	1	
Evasion by RSV of host interferon responses R-HSA-9833109	0.651652217029758	0.965730946513807	1/34	1	TYK2
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791	1	0	0/2	1	
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794	1	0	0/3	1	
Evasion of Oncogene Induced Senescence Due to p14ARF Defects R-HSA-9646303	1	0	0/1	1	
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697	1	0	0/2	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects R-HSA-9646304	1	0	0/1	1	
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693	1	0	0/3	1	
Events associated with phagocytolytic activity of PMN cells R-HSA-8941413	1	0	0/0	1	
Export of Viral Ribonucleoproteins from Nucleus R-HSA-168274	1	0	0/12	1	
Expression and Processing of Neurotrophins R-HSA-9036866	1	0	0/2	1	
Expression and translocation of olfactory receptors R-HSA-9752946	1	0	0/1	1	
Extension of Telomeres R-HSA-180786	0.409122587631764	2.00003463165419	1/17	1	CCNA2
Extra-nuclear estrogen signaling R-HSA-9009391	0.830192627304675	0.565777798120714	1/57	1	GNB2
Extracellular matrix organization R-HSA-1474244	0.984666092339395	0.235329894534386	1/133	1	KLK2
Extrinsic Pathway of Fibrin Clot Formation R-HSA-140834	1	0	0/3	1	
FASTK family proteins regulate processing and stability of mitochondrial RNAs R-HSA-9837092	1	0	0/0	1	
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis R-HSA-8854050	1	0	0/53	1	
FBXW7 Mutants and NOTCH1 in Cancer R-HSA-2644605	1	0	0/5	1	
FCERI mediated Ca+2 mobilization R-HSA-2871809	1	0	0/19	1	
FCERI mediated MAPK activation R-HSA-2871796	1	0	0/23	1	
FCERI mediated NF-kB activation R-HSA-2871837	0.672146234767872	0.871304971093496	2/75	1	NFKB1;RELA
FCGR activation R-HSA-2029481	1	0	0/10	1	
FCGR3A-mediated IL10 synthesis R-HSA-9664323	1	0	0/25	1	
FCGR3A-mediated phagocytosis R-HSA-9664422	0.672697020436742	0.910090238988284	1/36	1	CDC42
FGFR1b ligand binding and activation R-HSA-190370	1	0	0/2	1	
FGFR1c and Klotho ligand binding and activation R-HSA-190374	1	0	0/0	1	
FGFR2 alternative splicing R-HSA-6803529	1	0	0/20	1	
FGFR2 ligand binding and activation R-HSA-190241	0.116263980170045	10.686886668013	1/4	1	FGF5
FGFR2 mutant receptor activation R-HSA-1839126	0.444671006349992	1.77698744688802	1/19	1	FGF5
FGFR2b ligand binding and activation R-HSA-190377	1	0	0/3	1	
FGFR3b ligand binding and activation R-HSA-190371	1	0	0/0	1	
FGFR4 ligand binding and activation R-HSA-190322	1	0	0/2	1	
FGFR4 mutant receptor activation R-HSA-1839128	1	0	0/1	1	
FGFRL1 modulation of FGFR1 signaling R-HSA-5658623	0.116263980170045	10.686886668013	1/4	1	FGF5
FLT3 Signaling R-HSA-9607240	0.605453555961896	1.10002715662674	1/30	1	CBL
FLT3 mutants bind TKIs R-HSA-9702509	1	0	0/0	1	
FLT3 signaling by CBL mutants R-HSA-9706377	0.143169804536155	8.01619116439233	1/5	1	CBL
FLT3 signaling in disease R-HSA-9682385	0.494053866191027	1.52202475174719	1/22	1	CBL
FLT3 signaling through SRC family kinases R-HSA-9706374	1	0	0/4	1	
FMO oxidises nucleophiles R-HSA-217271	1	0	0/0	1	
FOXO-mediated transcription R-HSA-9614085	1	0	0/49	1	
FOXO-mediated transcription of cell cycle genes R-HSA-9617828	1	0	0/11	1	
FOXO-mediated transcription of cell death genes R-HSA-9614657	1	0	0/14	1	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9615017	1	0	0/21	1	
FRS-mediated FGFR1 signaling R-HSA-5654693	0.219107742800551	4.57941075774204	1/8	1	FGF5
FRS-mediated FGFR2 signaling R-HSA-5654700	0.265984697433587	3.56074569329776	1/10	1	FGF5
FRS-mediated FGFR3 signaling R-HSA-5654706	0.219107742800551	4.57941075774204	1/8	1	FGF5
FRS-mediated FGFR4 signaling R-HSA-5654712	1	0	0/8	1	
Factors involved in megakaryocyte development and platelet production R-HSA-983231	0.355216578733266	1.35360853740115	4/99	1	H3C1;CDC42;KIF2A;IRF1
Fanconi Anemia Pathway R-HSA-6783310	1	0	0/23	1	
FasL/ CD95L signaling R-HSA-75157	1	0	0/4	1	
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion R-HSA-434316	1	0	0/3	1	
Fatty acid metabolism R-HSA-8978868	1	0	0/74	1	
Fatty acids R-HSA-211935	1	0	0/5	1	
Fatty acyl-CoA biosynthesis R-HSA-75105	1	0	0/14	1	
Fc epsilon receptor (FCERI) signaling R-HSA-2454202	0.868446158904196	0.56218400792369	2/114	1	NFKB1;RELA
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480	0.813463809110129	0.598262594489136	1/54	1	CDC42
Fertilization R-HSA-1187000	1	0	0/4	1	
Fibronectin matrix formation R-HSA-1566977	1	0	0/3	1	
Ficolins bind to repetitive carbohydrate structures on the target cell surface R-HSA-2855086	1	0	0/3	1	
Folding of actin by CCT/TriC R-HSA-390450	1	0	0/10	1	
Formation of ATP by chemiosmotic coupling R-HSA-163210	1	0	0/15	1	
Formation of Fibrin Clot (Clotting Cascade) R-HSA-140877	0.494053866191027	1.52202475174719	1/22	1	GP1BA
Formation of HIV elongation complex in the absence of HIV Tat R-HSA-167152	1	0	0/28	1	
Formation of HIV-1 elongation complex containing HIV-1 Tat R-HSA-167200	1	0	0/26	1	
Formation of Incision Complex in GG-NER R-HSA-5696395	1	0	0/21	1	
Formation of RNA Pol II elongation complex  R-HSA-112382	1	0	0/34	1	
Formation of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584	1	0	0/16	1	
Formation of TC-NER Pre-Incision Complex R-HSA-6781823	1	0	0/32	1	
Formation of WDR5-containing histone-modifying complexes R-HSA-9772755	0.55318421545593	1.27728821101974	1/26	1	HCFC1
Formation of a pool of free 40S subunits R-HSA-72689	1	0	0/88	1	
Formation of annular gap junctions R-HSA-196025	1	0	0/9	1	
Formation of apoptosome R-HSA-111458	1	0	0/5	1	
Formation of axial mesoderm R-HSA-9796292	1	0	0/11	1	
Formation of definitive endoderm R-HSA-9823730	1	0	0/10	1	
Formation of editosomes by ADAR proteins R-HSA-77042	1	0	0/0	1	
Formation of intermediate mesoderm R-HSA-9761174	1	0	0/3	1	
Formation of lateral plate mesoderm R-HSA-9758920	1	0	0/1	1	
Formation of paraxial mesoderm R-HSA-9793380	1	0	0/58	1	
Formation of the Early Elongation Complex R-HSA-113418	1	0	0/22	1	
Formation of the Editosome R-HSA-75094	1	0	0/0	1	
Formation of the HIV-1 Early Elongation Complex R-HSA-167158	1	0	0/22	1	
Formation of the active cofactor, UDP-glucuronate R-HSA-173599	1	0	0/0	1	
Formation of the anterior neural plate R-HSA-9823739	1	0	0/4	1	
Formation of the cornified envelope R-HSA-6809371	1	0	0/11	1	
Formation of the nephric duct R-HSA-9830364	1	0	0/9	1	
Formation of the posterior neural plate R-HSA-9832991	1	0	0/5	1	
Formation of the ternary complex, and subsequently, the 43S complex R-HSA-72695	1	0	0/43	1	
Formation of the ureteric bud R-HSA-9830674	1	0	0/8	1	
Formation of tubulin folding intermediates by CCT/TriC R-HSA-389960	1	0	0/26	1	
Formation of xylulose-5-phosphate R-HSA-5661270	1	0	0/1	1	
Free fatty acid receptors R-HSA-444209	1	0	0/0	1	
Free fatty acids regulate insulin secretion R-HSA-400451	1	0	0/4	1	
Frs2-mediated activation R-HSA-170968	1	0	0/7	1	
Fructose biosynthesis R-HSA-5652227	1	0	0/1	1	
Fructose catabolism R-HSA-70350	1	0	0/2	1	
Fructose metabolism R-HSA-5652084	1	0	0/3	1	
G alpha (q) signalling events R-HSA-416476	0.425453237606594	1.28190992306224	3/78	1	GNB2;GHRL;ANXA1
G alpha (s) signalling events R-HSA-418555	0.760432204684361	0.7060603571744	1/46	1	GNB2
G alpha (z) signalling events R-HSA-418597	0.539077864968528	1.3308330535302	1/25	1	GNB2
G beta:gamma signalling through BTK R-HSA-8964315	0.242905995435717	4.00656868135255	1/9	1	GNB2
G beta:gamma signalling through PI3Kgamma R-HSA-392451	0.371318268662442	2.28665514754916	1/15	1	GNB2
G beta:gamma signalling through PLC beta R-HSA-418217	0.219107742800551	4.57941075774204	1/8	1	GNB2
G protein gated Potassium channels R-HSA-1296059	0.288365431745851	3.20406387724278	1/11	1	GNB2
G-protein activation R-HSA-202040	0.331116137121452	2.66887927516196	1/13	1	GNB2
G-protein beta:gamma signalling R-HSA-397795	0.112156566647182	3.79370227959189	2/19	1	GNB2;CDC42
G-protein mediated events R-HSA-112040	1	0	0/30	1	
G1/S DNA Damage Checkpoints R-HSA-69615	0.863661088983754	0.502009888541485	1/64	1	CCNA2
G2/M Transition R-HSA-69275	0.581774901919317	0.988081842584339	4/133	1	CDK1;CCNA2;MAPRE1;CEP78
GAB1 signalosome R-HSA-180292	1	0	0/15	1	
GABA B receptor activation R-HSA-977444	0.427170246365634	1.88200018344424	1/18	1	GNB2
GABA receptor activation R-HSA-977443	0.427170246365634	1.88200018344424	1/18	1	GNB2
GABA synthesis R-HSA-888568	1	0	0/0	1	
GABA synthesis, release, reuptake and degradation R-HSA-888590	0.169262925120966	6.41229475066507	1/6	1	VAMP2
GDP-fucose biosynthesis R-HSA-6787639	1	0	0/1	1	
GLI proteins bind promoters of Hh responsive genes to promote transcription R-HSA-5635851	1	0	0/7	1	
GLI3 is processed to GLI3R by the proteasome R-HSA-5610785	1	0	0/59	1	
GP1b-IX-V activation signalling R-HSA-430116	0.242905995435717	4.00656868135255	1/9	1	GP1BA
GPER1 signaling R-HSA-9634597	0.494053866191027	1.52202475174719	1/22	1	GNB2
GPVI-mediated activation cascade R-HSA-114604	0.55318421545593	1.27728821101974	1/26	1	CDC42
GRB2 events in EGFR signaling R-HSA-179812	1	0	0/13	1	
GRB2 events in ERBB2 signaling R-HSA-1963640	1	0	0/11	1	
GRB2:SOS provides linkage to MAPK signaling for Integrins  R-HSA-354194	1	0	0/7	1	
GRB7 events in ERBB2 signaling R-HSA-1306955	1	0	0/2	1	
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 R-HSA-9762114	1	0	0/51	1	
GTP hydrolysis and joining of the 60S ribosomal subunit R-HSA-72706	1	0	0/95	1	
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842	1	0	0/5	1	
Galactose catabolism R-HSA-70370	1	0	0/1	1	
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation R-HSA-163841	1	0	0/21	1	
Gamma-carboxylation of protein precursors R-HSA-159740	1	0	0/3	1	
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins R-HSA-159854	1	0	0/4	1	
Gap junction assembly R-HSA-190861	1	0	0/21	1	
Gap junction degradation R-HSA-190873	1	0	0/9	1	
Gap junction trafficking R-HSA-190828	1	0	0/29	1	
Gap junction trafficking and regulation R-HSA-157858	1	0	0/30	1	
Gap-filling DNA repair synthesis and ligation in GG-NER R-HSA-5696397	1	0	0/12	1	
Gap-filling DNA repair synthesis and ligation in TC-NER R-HSA-6782210	1	0	0/34	1	
Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-881907	1	0	0/16	1	
Gastrulation R-HSA-9758941	1	0	0/87	1	
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation R-HSA-8950505	0.47809710350936	1.59852000850236	1/21	1	CDC42
Gene expression (Transcription) R-HSA-74160	0.497658652201512	1.02327777197158	24/775	1	CDK1;CCNA2;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;CDC7;HDAC3;NFKB1;RELA;PPARA;MTA1;GATAD2A;STAT1;E2F5;E2F4;EHMT2;HCFC1;GP1BA;SPI1
Generation of second messenger molecules R-HSA-202433	0.524529899197712	1.38901487616444	1/24	1	CD3D
Generic Transcription Pathway R-HSA-212436	0.311636433992014	1.15301265761809	22/645	1	CDK1;CCNA2;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;CDC7;HDAC3;NFKB1;RELA;PPARA;GATAD2A;STAT1;E2F5;E2F4;EHMT2;GP1BA;SPI1
Germ layer formation at gastrulation R-HSA-9754189	1	0	0/11	1	
Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399	1	0	0/39	1	
Glucagon signaling in metabolic regulation R-HSA-163359	0.409122587631764	2.00003463165419	1/17	1	GNB2
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion R-HSA-381676	0.409122587631764	2.00003463165419	1/17	1	GNB2
Glucagon-type ligand receptors R-HSA-420092	0.351526138395097	2.4631234253845	1/14	1	GNB2
Glucocorticoid biosynthesis R-HSA-194002	1	0	0/1	1	
Gluconeogenesis R-HSA-70263	1	0	0/11	1	
Glucose metabolism R-HSA-70326	1	0	0/36	1	
Glucuronidation R-HSA-156588	1	0	0/2	1	
Glutamate Neurotransmitter Release Cycle R-HSA-210500	0.265984697433587	3.56074569329776	1/10	1	VAMP2
Glutamate and glutamine metabolism R-HSA-8964539	1	0	0/4	1	
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721	1	0	0/14	1	
Glutathione conjugation R-HSA-156590	1	0	0/22	1	
Glutathione synthesis and recycling R-HSA-174403	1	0	0/9	1	
Glycerophospholipid biosynthesis R-HSA-1483206	0.711076675005716	0.815925259643117	1/40	1	LPCAT1
Glycerophospholipid catabolism R-HSA-6814848	1	0	0/0	1	
Glycine degradation R-HSA-6783984	1	0	0/4	1	
Glycogen breakdown (glycogenolysis) R-HSA-70221	1	0	0/7	1	
Glycogen metabolism R-HSA-8982491	1	0	0/12	1	
Glycogen storage disease type 0 (liver GYS2) R-HSA-3858516	1	0	0/0	1	
Glycogen storage disease type 0 (muscle GYS1) R-HSA-3828062	1	0	0/2	1	
Glycogen storage disease type II (GAA) R-HSA-5357609	1	0	0/1	1	
Glycogen storage disease type IV (GBE1) R-HSA-3878781	1	0	0/0	1	
Glycogen storage disease type Ia (G6PC) R-HSA-3274531	1	0	0/0	1	
Glycogen storage disease type Ib (SLC37A4) R-HSA-3229133	1	0	0/1	1	
Glycogen storage disease type XV (GYG1) R-HSA-3814836	1	0	0/2	1	
Glycogen storage diseases R-HSA-3229121	1	0	0/8	1	
Glycogen synthesis R-HSA-3322077	1	0	0/7	1	
Glycolysis R-HSA-70171	1	0	0/32	1	
Glycoprotein hormones R-HSA-209822	1	0	0/3	1	
Glycosaminoglycan metabolism R-HSA-1630316	0.719952191732563	0.795326054757542	1/41	1	B4GALT2
Glycosphingolipid biosynthesis R-HSA-9840309	1	0	0/5	1	
Glycosphingolipid catabolism R-HSA-9840310	1	0	0/14	1	
Glycosphingolipid metabolism R-HSA-1660662	1	0	0/19	1	
Glycosphingolipid transport R-HSA-9845576	1	0	0/2	1	
Glyoxylate metabolism and glycine degradation R-HSA-389661	1	0	0/8	1	
Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658	0.219107742800551	4.57941075774204	1/8	1	CDK1
Golgi-to-ER retrograde transport R-HSA-8856688	0.650052482368673	0.909346948967421	2/72	1	KIF2A;COPB1
Growth hormone receptor signaling R-HSA-982772	0.164450951642977	2.92804075517087	2/24	1	STAT1;STAT3
HCN channels R-HSA-1296061	1	0	0/0	1	
HDL assembly R-HSA-8963896	1	0	0/8	1	
HDL clearance R-HSA-8964011	1	0	0/2	1	
HDL remodeling R-HSA-8964058	1	0	0/7	1	
HDMs demethylate histones R-HSA-3214842	0.682741498102979	0.884587686522424	1/37	1	H3C1
HDR through Homologous Recombination (HRR) R-HSA-5685942	1	0	0/31	1	
HDR through MMEJ (alt-NHEJ) R-HSA-5685939	1	0	0/6	1	
HDR through Single Strand Annealing (SSA) R-HSA-5685938	1	0	0/15	1	
HHAT G278V doesn't palmitoylate Hh-Np R-HSA-5658034	1	0	0/2	1	
HIV Infection R-HSA-162906	0.666556088686683	0.881676294984828	4/148	1	AP1M1;AP1S1;CD8B;CCR5
HIV Life Cycle R-HSA-162587	0.914934778427329	0.40390749383904	1/79	1	CCR5
HIV Transcription Elongation R-HSA-167169	1	0	0/26	1	
HIV Transcription Initiation R-HSA-167161	1	0	0/29	1	
HIV elongation arrest and recovery R-HSA-167287	1	0	0/24	1	
HS-GAG biosynthesis R-HSA-2022928	1	0	0/4	1	
HS-GAG degradation R-HSA-2024096	1	0	0/8	1	
HSF1 activation R-HSA-3371511	1	0	0/20	1	
HSF1-dependent transactivation R-HSA-3371571	1	0	0/28	1	
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497	1	0	0/46	1	
Hedgehog 'off' state R-HSA-5610787	1	0	0/91	1	
Hedgehog 'on' state R-HSA-5632684	1	0	0/69	1	
Hedgehog ligand biogenesis R-HSA-5358346	1	0	0/57	1	
Heme biosynthesis R-HSA-189451	1	0	0/5	1	
Heme degradation R-HSA-189483	1	0	0/9	1	
Heme signaling R-HSA-9707616	0.389102748052683	1.52634170734515	2/44	1	HDAC3;PPARA
Hemostasis R-HSA-109582	0.721160663849306	0.848853275333039	8/305	1	GNB2;H3C1;CDC42;INPP5D;KIF2A;PFN1;IRF1;GP1BA
Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1638091	1	0	0/14	1	
Hereditary fructose intolerance R-HSA-5657560	1	0	0/0	1	
Hh mutants abrogate ligand secretion R-HSA-5387390	1	0	0/56	1	
Hh mutants are degraded by ERAD R-HSA-5362768	1	0	0/54	1	
Highly calcium permeable nicotinic acetylcholine receptors R-HSA-629597	1	0	0/3	1	
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors R-HSA-629594	1	0	0/3	1	
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors R-HSA-629587	1	0	0/3	1	
Histamine receptors R-HSA-390650	1	0	0/0	1	
Histidine catabolism R-HSA-70921	0.116263980170045	10.686886668013	1/4	1	FTCD
Homologous DNA Pairing and Strand Exchange R-HSA-5693579	1	0	0/18	1	
Hormone ligand-binding receptors R-HSA-375281	1	0	0/2	1	
Host Interactions of HIV factors R-HSA-162909	0.557196833016728	1.04049370966662	3/95	1	AP1M1;AP1S1;CD8B
HuR (ELAVL1) binds and stabilizes mRNA R-HSA-450520	0.194567694860967	5.34322317913915	1/7	1	ELAVL1
Hyaluronan biosynthesis and export R-HSA-2142850	1	0	0/0	1	
Hyaluronan metabolism R-HSA-2142845	1	0	0/4	1	
Hyaluronan uptake and degradation R-HSA-2160916	1	0	0/4	1	
Hydrolysis of LPC R-HSA-1483115	1	0	0/4	1	
Hydrolysis of LPE R-HSA-1483152	1	0	0/0	1	
Hydroxycarboxylic acid-binding receptors R-HSA-3296197	1	0	0/0	1	
Hypusine synthesis from eIF5A-lysine R-HSA-204626	1	0	0/4	1	
IFNG signaling activates MAPKs R-HSA-9732724	1	0	0/8	1	
IGF1R signaling cascade R-HSA-2428924	0.566862249676667	1.22786129710518	1/27	1	FGF5
IKBKB deficiency causes SCID R-HSA-5602636	1	0	0/3	1	
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) R-HSA-5603027	1	0	0/3	1	
IKK complex recruitment mediated by RIP1 R-HSA-937041	1	0	0/20	1	
IL-6-type cytokine receptor ligand interactions R-HSA-6788467	0.310069139133716	2.91223689743989	1/12	1	TYK2
IRAK1 recruits IKK complex R-HSA-937039	1	0	0/11	1	
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation R-HSA-975144	1	0	0/11	1	
IRAK2 mediated activation of TAK1 complex R-HSA-937042	1	0	0/9	1	
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation R-HSA-975163	1	0	0/12	1	
IRAK4 deficiency (TLR2/4) R-HSA-5603041	1	0	0/13	1	
IRAK4 deficiency (TLR5) R-HSA-5603037	1	0	0/1	1	
IRE1alpha activates chaperones R-HSA-381070	1	0	0/24	1	
IRF3 mediated activation of type 1 IFN R-HSA-1606341	1	0	0/3	1	
IRF3-mediated induction of type I IFN R-HSA-3270619	1	0	0/6	1	
IRS activation R-HSA-74713	1	0	0/4	1	
IRS-mediated signalling R-HSA-112399	0.539077864968528	1.3308330535302	1/25	1	FGF5
IRS-related events triggered by IGF1R R-HSA-2428928	0.566862249676667	1.22786129710518	1/27	1	FGF5
ISG15 antiviral mechanism R-HSA-1169408	0.701922226532172	0.837608397236777	1/39	1	STAT1
Imatinib-resistant KIT mutants R-HSA-9669917	1	0	0/1	1	
Imatinib-resistant PDGFR mutants R-HSA-9674396	1	0	0/1	1	
Impaired BRCA2 binding to PALB2 R-HSA-9709603	1	0	0/14	1	
Impaired BRCA2 binding to RAD51 R-HSA-9709570	1	0	0/13	1	
Impaired BRCA2 binding to SEM1 (DSS1) R-HSA-9763198	1	0	0/1	1	
Impaired BRCA2 translocation to the nucleus R-HSA-9709275	1	0	0/1	1	
Inactivation of APC/C via direct inhibition of the APC/C complex R-HSA-141430	0.427170246365634	1.88200018344424	1/18	1	BUB3
Inactivation of CDC42 and RAC1 R-HSA-428543	0.143169804536155	8.01619116439233	1/5	1	CDC42
Inactivation, recovery and regulation of the phototransduction cascade R-HSA-2514859	1	0	0/9	1	
Incretin synthesis, secretion, and inactivation R-HSA-400508	0.288365431745851	3.20406387724278	1/11	1	DPP4
Induction of Cell-Cell Fusion R-HSA-9733458	1	0	0/4	1	
Infection with Mycobacterium tuberculosis R-HSA-9635486	1	0	0/16	1	
Influenza Infection R-HSA-168255	1	0	0/119	1	
Influenza Viral RNA Transcription and Replication R-HSA-168273	1	0	0/106	1	
Influenza Virus Induced Apoptosis R-HSA-168277	1	0	0/1	1	
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits R-HSA-997272	0.288365431745851	3.20406387724278	1/11	1	GNB2
Inhibition of Host mRNA Processing and RNA Silencing R-HSA-168315	1	0	0/0	1	
Inhibition of PKR R-HSA-169131	1	0	0/1	1	
Inhibition of Signaling by Overexpressed EGFR R-HSA-5638303	1	0	0/8	1	
Inhibition of TSC complex formation by PKB R-HSA-165181	1	0	0/3	1	
Inhibition of membrane repair R-HSA-9635644	1	0	0/1	1	
Inhibition of nitric oxide production R-HSA-9636249	1	0	0/3	1	
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components R-HSA-141405	0.427170246365634	1.88200018344424	1/18	1	BUB3
Initial triggering of complement R-HSA-166663	0.288365431745851	3.20406387724278	1/11	1	C3
Initiation of Nuclear Envelope (NE) Reformation R-HSA-2995383	0.219107742800551	4.57941075774204	1/8	1	CDK1
InlA-mediated entry of Listeria monocytogenes into host cells R-HSA-8876493	1	0	0/8	1	
InlB-mediated entry of Listeria monocytogenes into host cell R-HSA-8875360	0.265984697433587	3.56074569329776	1/10	1	CBL
Innate Immune System R-HSA-168249	0.887390759424297	0.723104954614868	12/522	1	C3;NFKB1;RELA;LPCAT1;AP1M1;CDC42;COPB1;CTSZ;RELB;IL1B;NFKB2;CPN2
Inositol transporters R-HSA-429593	1	0	0/0	1	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane R-HSA-9609523	0.331116137121452	2.66887927516196	1/13	1	VAMP2
Insulin effects increased synthesis of Xylulose-5-Phosphate R-HSA-163754	1	0	0/2	1	
Insulin processing R-HSA-264876	0.219107742800551	4.57941075774204	1/8	1	VAMP2
Insulin receptor recycling R-HSA-77387	1	0	0/16	1	
Insulin receptor signalling cascade R-HSA-74751	0.592984590746919	1.13959678006566	1/29	1	FGF5
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA R-HSA-428359	1	0	0/0	1	
Integration of provirus R-HSA-162592	1	0	0/7	1	
Integration of viral DNA into host genomic DNA R-HSA-175567	1	0	0/3	1	
Integrin cell surface interactions R-HSA-216083	1	0	0/50	1	
Integrin signaling R-HSA-354192	1	0	0/14	1	
Interaction With Cumulus Cells And The Zona Pellucida R-HSA-2534343	1	0	0/3	1	
Interaction between PHLDA1 and AURKA R-HSA-8854521	1	0	0/2	1	
Interactions of Rev with host cellular proteins R-HSA-177243	1	0	0/14	1	
Interactions of Tat with host cellular proteins R-HSA-176034	1	0	0/2	1	
Interactions of Vpr with host cellular proteins R-HSA-176033	1	0	0/14	1	
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate R-HSA-880009	1	0	0/3	1	
Interconversion of nucleotide di- and triphosphates R-HSA-499943	0.310069139133716	2.91223689743989	1/12	1	NME1
Interconversion of polyamines R-HSA-351200	1	0	0/0	1	
Interferon Signaling R-HSA-913531	0.480600178027964	1.09115377540303	6/182	1	CDK1;STAT1;STAT3;TYK2;IRF8;IRF1
Interferon gamma signaling R-HSA-877300	0.266552678900415	1.72514198601905	3/59	1	STAT1;IRF8;IRF1
Interleukin-1 family signaling R-HSA-446652	0.277052625296205	1.45424191170868	5/116	1	NFKB1;RELA;STAT3;IL1B;NFKB2
Interleukin-1 signaling R-HSA-9020702	0.341209557879043	1.38342893029523	4/97	1	NFKB1;RELA;IL1B;NFKB2
Interleukin-12 signaling R-HSA-9020591	0.208771518080006	2.47520065853483	2/28	1	CDC42;TYK2
Interleukin-15 signaling R-HSA-8983432	0.242905995435717	4.00656868135255	1/9	1	STAT3
Interleukin-17 signaling R-HSA-448424	0.807532073981004	0.609923680575005	1/53	1	NFKB1
Interleukin-18 signaling R-HSA-9012546	1	0	0/4	1	
Interleukin-2 signaling R-HSA-9020558	1	0	0/8	1	
Interleukin-33 signaling R-HSA-9014843	1	0	0/1	1	
Interleukin-36 pathway R-HSA-9014826	1	0	0/1	1	
Interleukin-37 signaling R-HSA-9008059	0.288365431745851	3.20406387724278	1/11	1	STAT3
Interleukin-38 signaling R-HSA-9007892	1	0	0/2	1	
Interleukin-7 signaling R-HSA-1266695	0.265554842205604	2.07354981970465	2/33	1	H3C1;STAT3
Intestinal absorption R-HSA-8963676	1	0	0/2	1	
Intestinal hexose absorption R-HSA-8981373	1	0	0/2	1	
Intestinal infectious diseases R-HSA-8942233	1	0	0/0	1	
Intestinal lipid absorption R-HSA-8963678	1	0	0/0	1	
Intestinal saccharidase deficiencies R-HSA-5659898	1	0	0/1	1	
Intra-Golgi and retrograde Golgi-to-ER traffic R-HSA-6811442	0.397191527958886	1.27123457662277	4/105	1	KIF2A;COPB1;MAN2A2;COG1
Intra-Golgi traffic R-HSA-6811438	0.175378720698121	2.80010201131709	2/25	1	MAN2A2;COG1
Intracellular metabolism of fatty acids regulates insulin secretion R-HSA-434313	1	0	0/1	1	
Intracellular oxygen transport R-HSA-8981607	1	0	0/0	1	
Intracellular signaling by second messengers R-HSA-9006925	0.815231358289032	0.723299268874493	5/222	1	FGF5;HDAC3;MTA1;GATAD2A;PIP5K1A
Intraflagellar transport R-HSA-5620924	1	0	0/30	1	
Intrinsic Pathway for Apoptosis R-HSA-109606	0.107418784437921	2.77455680257967	3/38	1	TFDP1;E2F1;STAT3
Intrinsic Pathway of Fibrin Clot Formation R-HSA-140837	0.310069139133716	2.91223689743989	1/12	1	GP1BA
Invadopodia formation R-HSA-8941237	1	0	0/3	1	
Inwardly rectifying K+ channels R-HSA-1296065	0.331116137121452	2.66887927516196	1/13	1	GNB2
Ion channel transport R-HSA-983712	0.890575988702246	0.450999629139426	1/71	1	TRPV1
Ion homeostasis R-HSA-5578775	1	0	0/27	1	
Ion influx/efflux at host-pathogen interface R-HSA-6803544	1	0	0/2	1	
Ion transport by P-type ATPases R-HSA-936837	1	0	0/19	1	
Ionotropic activity of kainate receptors R-HSA-451306	1	0	0/4	1	
Iron uptake and transport R-HSA-917937	1	0	0/31	1	
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 R-HSA-450321	1	0	0/21	1	
Josephin domain DUBs R-HSA-5689877	1	0	0/6	1	
KEAP1-NFE2L2 pathway R-HSA-9755511	0.865161542913499	0.56739714662136	2/113	1	NFKB1;RELA
KIT mutants bind TKIs R-HSA-9669921	1	0	0/1	1	
KSRP (KHSRP) binds and destabilizes mRNA R-HSA-450604	1	0	0/16	1	
KW2449-resistant FLT3 mutants R-HSA-9702569	1	0	0/0	1	
Keratan sulfate biosynthesis R-HSA-2022854	0.242905995435717	4.00656868135255	1/9	1	B4GALT2
Keratan sulfate degradation R-HSA-2022857	1	0	0/7	1	
Keratan sulfate/keratin metabolism R-HSA-1638074	0.310069139133716	2.91223689743989	1/12	1	B4GALT2
Keratinization R-HSA-6805567	1	0	0/11	1	
Kidney development R-HSA-9830369	1	0	0/21	1	
Killing mechanisms R-HSA-9664420	1	0	0/6	1	
Kinesins R-HSA-983189	0.580124869365433	1.18209488026364	1/28	1	KIF2A
L13a-mediated translational silencing of Ceruloplasmin expression R-HSA-156827	1	0	0/96	1	
L1CAM interactions R-HSA-373760	0.634684210192749	0.936572547329501	2/70	1	SPTBN2;SCN8A
LDL clearance R-HSA-8964038	1	0	0/8	1	
LDL remodeling R-HSA-8964041	1	0	0/3	1	
LGI-ADAM interactions R-HSA-5682910	1	0	0/1	1	
LGK974 inhibits PORCN R-HSA-5340573	1	0	0/0	1	
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-3134973	1	0	0/5	1	
LTC4-CYSLTR mediated IL4 production R-HSA-9664535	1	0	0/2	1	
Lactose synthesis R-HSA-5653890	1	0	0/0	1	
Lagging Strand Synthesis R-HSA-69186	1	0	0/7	1	
Laminin interactions R-HSA-3000157	1	0	0/17	1	
Late Phase of HIV Life Cycle R-HSA-162599	1	0	0/70	1	
Late SARS-CoV-2 Infection Events R-HSA-9772573	1	0	0/33	1	
Late endosomal microautophagy R-HSA-9615710	1	0	0/16	1	
Latent infection - Other responses of Mtb to phagocytosis R-HSA-1222499	1	0	0/0	1	
Leading Strand Synthesis R-HSA-69109	1	0	0/5	1	
Lectin pathway of complement activation R-HSA-166662	1	0	0/4	1	
Leishmania parasite growth and survival R-HSA-9664433	0.728557208074531	0.775731488317379	1/42	1	GNB2
Leishmania phagocytosis R-HSA-9664417	0.672697020436742	0.910090238988284	1/36	1	CDC42
Leukotriene receptors R-HSA-391906	1	0	0/1	1	
Lewis blood group biosynthesis R-HSA-9037629	1	0	0/3	1	
Ligand-receptor interactions R-HSA-5632681	1	0	0/5	1	
Linoleic acid (LA) metabolism R-HSA-2046105	1	0	0/3	1	
Lipid particle organization R-HSA-8964572	1	0	0/2	1	
Lipophagy R-HSA-9613354	1	0	0/4	1	
Listeria monocytogenes entry into host cells R-HSA-8876384	0.351526138395097	2.4631234253845	1/14	1	CBL
Localization of the PINCH-ILK-PARVIN complex to focal adhesions R-HSA-446343	1	0	0/4	1	
Long-term potentiation R-HSA-9620244	1	0	0/13	1	
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling R-HSA-2644607	1	0	0/5	1	
Loss of Function of SMAD2/3 in Cancer R-HSA-3304349	1	0	0/7	1	
Loss of Function of SMAD4 in Cancer R-HSA-3304347	1	0	0/3	1	
Loss of Function of TGFBR1 in Cancer R-HSA-3656534	1	0	0/7	1	
Loss of Function of TGFBR2 in Cancer R-HSA-3642278	1	0	0/3	1	
Loss of Function of TP53 in Cancer R-HSA-9723907	1	0	0/1	1	
Loss of MECP2 binding ability to 5hmC-DNA R-HSA-9022534	1	0	0/1	1	
Loss of MECP2 binding ability to 5mC-DNA R-HSA-9022538	1	0	0/3	1	
Loss of MECP2 binding ability to the NCoR/SMRT complex R-HSA-9022537	0.169262925120966	6.41229475066507	1/6	1	HDAC3
Loss of function of MECP2 in Rett syndrome R-HSA-9005891	0.265984697433587	3.56074569329776	1/10	1	HDAC3
Loss of function of TP53 in cancer due to loss of tetramerization ability R-HSA-9723905	1	0	0/1	1	
Loss of phosphorylation of MECP2 at T308 R-HSA-9022535	1	0	0/3	1	
Lysine catabolism R-HSA-71064	1	0	0/6	1	
Lysosomal oligosaccharide catabolism R-HSA-8853383	1	0	0/2	1	
Lysosphingolipid and LPA receptors R-HSA-419408	1	0	0/2	1	
M-decay: degradation of maternal mRNAs by maternally stored factors R-HSA-9820841	1	0	0/18	1	
MAP kinase activation R-HSA-450294	0.807532073981004	0.609923680575005	1/53	1	NFKB1
MAP2K and MAPK activation R-HSA-5674135	1	0	0/22	1	
MAP3K8 (TPL2)-dependent MAPK1/3 activation R-HSA-5684264	0.331116137121452	2.66887927516196	1/13	1	NFKB1
MAPK family signaling cascades R-HSA-5683057	0.65224788753611	0.901647172877396	5/181	1	CDK1;FGF5;SPTBN2;CDC42;TYK2
MAPK targets/ Nuclear events mediated by MAP kinases R-HSA-450282	1	0	0/25	1	
MAPK1 (ERK2) activation R-HSA-112411	0.219107742800551	4.57941075774204	1/8	1	TYK2
MAPK1/MAPK3 signaling R-HSA-5684996	0.706762698180011	0.833510831266915	4/156	1	CDK1;FGF5;SPTBN2;TYK2
MAPK6/MAPK4 signaling R-HSA-5687128	0.664908548813934	0.883633482273764	2/74	1	CDK1;CDC42
MASTL Facilitates Mitotic Progression R-HSA-2465910	0.265984697433587	3.56074569329776	1/10	1	CDK1
MDK and PTN in ALK signaling R-HSA-9851151	1	0	0/1	1	
MECP2 regulates neuronal receptors and channels R-HSA-9022699	1	0	0/9	1	
MECP2 regulates transcription factors R-HSA-9022707	1	0	0/4	1	
MECP2 regulates transcription of genes involved in GABA signaling R-HSA-9022927	1	0	0/1	1	
MECP2 regulates transcription of neuronal ligands R-HSA-9022702	1	0	0/5	1	
MET Receptor Activation R-HSA-6806942	1	0	0/1	1	
MET activates PI3K/AKT signaling R-HSA-8851907	1	0	0/5	1	
MET activates PTK2 signaling R-HSA-8874081	1	0	0/19	1	
MET activates PTPN11 R-HSA-8865999	1	0	0/4	1	
MET activates RAP1 and RAC1 R-HSA-8875555	1	0	0/7	1	
MET activates RAS signaling R-HSA-8851805	1	0	0/8	1	
MET interacts with TNS proteins R-HSA-8875513	1	0	0/2	1	
MET promotes cell motility R-HSA-8875878	1	0	0/25	1	
MET receptor recycling R-HSA-8875656	1	0	0/7	1	
MGMT-mediated DNA damage reversal R-HSA-5657655	1	0	0/0	1	
MITF-M-dependent gene expression R-HSA-9856651	1	0	0/47	1	
MITF-M-regulated melanocyte development R-HSA-9730414	1	0	0/64	1	
MPS I - Hurler syndrome R-HSA-2206302	1	0	0/1	1	
MPS II - Hunter syndrome R-HSA-2206296	1	0	0/0	1	
MPS IIIA - Sanfilippo syndrome A R-HSA-2206307	1	0	0/1	1	
MPS IIIB - Sanfilippo syndrome B R-HSA-2206282	1	0	0/1	1	
MPS IIIC - Sanfilippo syndrome C R-HSA-2206291	1	0	0/1	1	
MPS IIID - Sanfilippo syndrome D R-HSA-2206305	1	0	0/1	1	
MPS IV - Morquio syndrome A R-HSA-2206290	1	0	0/0	1	
MPS IV - Morquio syndrome B R-HSA-2206308	1	0	0/0	1	
MPS IX - Natowicz syndrome R-HSA-2206280	1	0	0/0	1	
MPS VI - Maroteaux-Lamy syndrome R-HSA-2206285	1	0	0/0	1	
MPS VII - Sly syndrome R-HSA-2206292	1	0	0/0	1	
MTF1 activates gene expression R-HSA-5660489	1	0	0/0	1	
MTOR signalling R-HSA-165159	1	0	0/34	1	
Macroautophagy R-HSA-1632852	0.725600037815683	0.783633055530781	2/83	1	ULK1;ATG101
Major pathway of rRNA processing in the nucleolus and cytosol R-HSA-6791226	1	0	0/118	1	
Malate-aspartate shuttle R-HSA-9856872	1	0	0/3	1	
Manipulation of host energy metabolism R-HSA-9636667	1	0	0/2	1	
Masitinib-resistant KIT mutants R-HSA-9669924	1	0	0/1	1	
Maturation of TCA enzymes and regulation of TCA cycle R-HSA-9854311	1	0	0/5	1	
Maturation of hRSV A proteins R-HSA-9828806	1	0	0/12	1	
Maturation of nucleoprotein R-HSA-9683610	1	0	0/8	1	
Maturation of nucleoprotein R-HSA-9694631	1	0	0/10	1	
Maturation of protein 3a R-HSA-9683673	1	0	0/4	1	
Maturation of protein 3a R-HSA-9694719	1	0	0/4	1	
Maturation of protein E R-HSA-9683683	1	0	0/4	1	
Maturation of protein E R-HSA-9694493	1	0	0/4	1	
Maturation of replicase proteins R-HSA-9694301	1	0	0/0	1	
Maturation of spike protein R-HSA-9683686	1	0	0/2	1	
Maturation of spike protein R-HSA-9694548	1	0	0/14	1	
Melanin biosynthesis R-HSA-5662702	1	0	0/1	1	
Membrane binding and targetting of GAG proteins R-HSA-174490	1	0	0/7	1	
Metabolic disorders of biological oxidation enzymes R-HSA-5579029	1	0	0/10	1	
Metabolism R-HSA-1430728	0.978271806651154	0.630482657000969	19/900	1	GNB2;VAMP2;HDAC3;PPARA;LPCAT1;SEC23A;INPP5D;CACNA1D;B4GALT2;NME1;INPPL1;FTCD;SYT5;PIP5K1A;ACSS3;MTHFS;TYMP;PI4K2A;SLC19A1
Metabolism of Angiotensinogen to Angiotensins R-HSA-2022377	0.194567694860967	5.34322317913915	1/7	1	CTSZ
Metabolism of RNA R-HSA-8953854	0.99999616273056	0.0757375782894026	1/384	1	ELAVL1
Metabolism of amine-derived hormones R-HSA-209776	1	0	0/5	1	
Metabolism of amino acids and derivatives R-HSA-71291	0.99894962790214	0.141320913438721	1/216	1	FTCD
Metabolism of carbohydrates R-HSA-71387	0.964907282274919	0.295058195084376	1/107	1	B4GALT2
Metabolism of cofactors R-HSA-8978934	1	0	0/6	1	
Metabolism of fat-soluble vitamins R-HSA-6806667	1	0	0/13	1	
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se R-HSA-2408550	1	0	0/3	1	
Metabolism of ingested MeSeO2H into MeSeH R-HSA-5263617	1	0	0/1	1	
Metabolism of ingested SeMet, Sec, MeSec into H2Se R-HSA-2408508	1	0	0/4	1	
Metabolism of lipids R-HSA-556833	0.576786051169356	0.977551282168992	9/302	1	HDAC3;PPARA;LPCAT1;SEC23A;INPP5D;INPPL1;PIP5K1A;ACSS3;PI4K2A
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131	1	0	0/7	1	
Metabolism of non-coding RNA R-HSA-194441	1	0	0/21	1	
Metabolism of nucleotides R-HSA-15869	0.344898736063965	1.68870765061749	2/40	1	NME1;TYMP
Metabolism of polyamines R-HSA-351202	1	0	0/51	1	
Metabolism of porphyrins R-HSA-189445	1	0	0/13	1	
Metabolism of proteins R-HSA-392499	0.319612459928554	1.12312962579648	33/998	1	GNB2;CDK1;CCNA2;VAMP2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;KLK2;H2BC14;C3;HDAC3;RELA;PPARA;SEC23A;SPTBN2;MTA1;STAT3;COPB1;MAN2A2;CTSZ;B4GALT2;COG1;NFKB2;TOP2A;H2AC12;ATXN7;HCFC1;H2AC13;GHRL;DPP4;PLA2G7
Metabolism of serotonin R-HSA-380612	1	0	0/1	1	
Metabolism of steroid hormones R-HSA-196071	1	0	0/7	1	
Metabolism of steroids R-HSA-8957322	0.473206431282382	1.27957997235896	2/52	1	PPARA;SEC23A
Metabolism of vitamin K R-HSA-6806664	1	0	0/0	1	
Metabolism of vitamins and cofactors R-HSA-196854	0.57681292405372	1.04593635072424	2/63	1	MTHFS;SLC19A1
Metabolism of water-soluble vitamins and cofactors R-HSA-196849	0.389102748052683	1.52634170734515	2/44	1	MTHFS;SLC19A1
Metal ion SLC transporters R-HSA-425410	1	0	0/3	1	
Metal sequestration by antimicrobial proteins R-HSA-6799990	1	0	0/3	1	
Metallothioneins bind metals R-HSA-5661231	1	0	0/0	1	
Methionine salvage pathway R-HSA-1237112	1	0	0/4	1	
Methylation R-HSA-156581	1	0	0/7	1	
Methylation of MeSeH for excretion R-HSA-2408552	1	0	0/1	1	
MicroRNA (miRNA) biogenesis R-HSA-203927	1	0	0/18	1	
Microbial modulation of RIPK1-mediated regulated necrosis R-HSA-9686347	1	0	0/4	1	
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane R-HSA-190840	1	0	0/20	1	
Mineralocorticoid biosynthesis R-HSA-193993	1	0	0/0	1	
Minus-strand DNA synthesis R-HSA-164516	1	0	0/1	1	
Miro GTPase Cycle R-HSA-9715370	1	0	0/1	1	
Miscellaneous substrates R-HSA-211958	1	0	0/5	1	
Miscellaneous transport and binding events R-HSA-5223345	1	0	0/8	1	
Mismatch Repair R-HSA-5358508	1	0	0/5	1	
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) R-HSA-5358606	1	0	0/4	1	
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) R-HSA-5358565	1	0	0/5	1	
Mitochondrial ABC transporters R-HSA-1369007	1	0	0/3	1	
Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289	1	0	0/21	1	
Mitochondrial RNA degradation R-HSA-9836573	1	0	0/0	1	
Mitochondrial Uncoupling R-HSA-166187	1	0	0/0	1	
Mitochondrial biogenesis R-HSA-1592230	0.316855504781762	1.55581748614081	3/65	1	HDAC3;PPARA;HCFC1
Mitochondrial calcium ion transport R-HSA-8949215	0.331116137121452	2.66887927516196	1/13	1	SLC8B1
Mitochondrial iron-sulfur cluster biogenesis R-HSA-1362409	1	0	0/1	1	
Mitochondrial protein degradation R-HSA-9837999	1	0	0/50	1	
Mitochondrial protein import R-HSA-1268020	1	0	0/26	1	
Mitochondrial tRNA aminoacylation R-HSA-379726	1	0	0/6	1	
Mitochondrial transcription initiation R-HSA-163282	1	0	0/2	1	
Mitochondrial transcription termination R-HSA-163316	1	0	0/0	1	
Mitochondrial translation R-HSA-5368287	1	0	0/55	1	
Mitochondrial translation elongation R-HSA-5389840	1	0	0/54	1	
Mitochondrial translation initiation R-HSA-5368286	1	0	0/54	1	
Mitochondrial translation termination R-HSA-5419276	1	0	0/53	1	
Mitophagy R-HSA-5205647	0.390511083989948	2.13379931391034	1/16	1	ULK1
Mitotic G2-G2/M phases R-HSA-453274	0.226846610125163	1.507250430275	6/135	1	CDK1;CCNA2;MAPRE1;CEP78;E2F3;E2F1
Mitotic Metaphase/Anaphase Transition R-HSA-68881	1	0	0/1	1	
Mitotic Telophase/Cytokinesis R-HSA-68884	0.288365431745851	3.20406387724278	1/11	1	WAPL
Modulation by Mtb of host immune system R-HSA-9637628	1	0	0/6	1	
Molecules associated with elastic fibres R-HSA-2129379	1	0	0/17	1	
Molybdenum cofactor biosynthesis R-HSA-947581	1	0	0/2	1	
Mtb iron assimilation by chelation R-HSA-1222449	1	0	0/0	1	
Mucopolysaccharidoses R-HSA-2206281	1	0	0/5	1	
Multifunctional anion exchangers R-HSA-427601	1	0	0/2	1	
Muscarinic acetylcholine receptors R-HSA-390648	1	0	0/0	1	
Muscle contraction R-HSA-397014	0.801535201515149	0.66573069407761	2/97	1	SCN8A;ANXA1
MyD88 cascade initiated on plasma membrane R-HSA-975871	0.400733011495214	1.33634717218537	3/75	1	NFKB1;RELA;NFKB2
MyD88 deficiency (TLR2/4) R-HSA-5602498	1	0	0/13	1	
MyD88 deficiency (TLR5) R-HSA-5602680	1	0	0/1	1	
MyD88 dependent cascade initiated on endosome R-HSA-975155	0.449824286144108	1.23165920141758	3/81	1	NFKB1;RELA;NFKB2
MyD88-independent TLR4 cascade  R-HSA-166166	0.520215582325284	1.10169051219261	3/90	1	NFKB1;RELA;NFKB2
MyD88:MAL(TIRAP) cascade initiated on plasma membrane R-HSA-166058	0.512624717606068	1.11479344598442	3/89	1	NFKB1;RELA;NFKB2
Myoclonic epilepsy of Lafora R-HSA-3785653	1	0	0/6	1	
Myogenesis R-HSA-525793	0.427170246365634	1.88200018344424	1/18	1	CDC42
N-glycan trimming and elongation in the cis-Golgi R-HSA-964739	1	0	0/0	1	
N-glycan trimming in the ER and Calnexin/Calreticulin cycle R-HSA-532668	1	0	0/19	1	
NADE modulates death signalling R-HSA-205025	1	0	0/4	1	
NADPH regeneration R-HSA-389542	1	0	0/0	1	
NCAM signaling for neurite out-growth R-HSA-375165	0.265554842205604	2.07354981970465	2/33	1	SPTBN2;CACNA1D
NCAM1 interactions R-HSA-419037	0.461641308516191	1.68306147966003	1/20	1	CACNA1D
NEIL3-mediated resolution of ICLs R-HSA-9636003	1	0	0/0	1	
NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-168333	1	0	0/11	1	
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 R-HSA-933543	1	0	0/11	1	
NFE2L2 regulates pentose phosphate pathway genes R-HSA-9818028	1	0	0/8	1	
NFE2L2 regulating ER-stress associated genes R-HSA-9818035	1	0	0/5	1	
NFE2L2 regulating MDR associated enzymes R-HSA-9818032	1	0	0/7	1	
NFE2L2 regulating TCA cycle genes R-HSA-9818025	1	0	0/1	1	
NFE2L2 regulating anti-oxidant/detoxification enzymes R-HSA-9818027	1	0	0/19	1	
NFE2L2 regulating inflammation associated genes R-HSA-9818026	1	0	0/5	1	
NFE2L2 regulating tumorigenic genes R-HSA-9818030	1	0	0/11	1	
NFG and proNGF binds to p75NTR R-HSA-205017	1	0	0/1	1	
NGF processing R-HSA-167060	1	0	0/2	1	
NGF-independant TRKA activation R-HSA-187024	1	0	0/3	1	
NGF-stimulated transcription R-HSA-9031628	1	0	0/36	1	
NIK-->noncanonical NF-kB signaling R-HSA-5676590	0.522166886045446	1.16178575844231	2/57	1	RELB;NFKB2
NOD1/2 Signaling Pathway R-HSA-168638	1	0	0/31	1	
NOSIP mediated eNOS trafficking R-HSA-203754	1	0	0/0	1	
NOSTRIN mediated eNOS trafficking R-HSA-203641	1	0	0/2	1	
NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947	0.774948028722295	0.675671133126489	1/48	1	HDAC3
NOTCH2 Activation and Transmission of Signal to the Nucleus R-HSA-2979096	1	0	0/13	1	
NOTCH2 intracellular domain regulates transcription R-HSA-2197563	1	0	0/12	1	
NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-9013507	1	0	0/16	1	
NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508	0.524529899197712	1.38901487616444	1/24	1	STAT1
NOTCH4 Activation and Transmission of Signal to the Nucleus R-HSA-9013700	1	0	0/8	1	
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695	1	0	0/20	1	
NPAS4 regulates expression of target genes R-HSA-9768919	1	0	0/13	1	
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  R-HSA-9632974	1	0	0/4	1	
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis R-HSA-9029558	1	0	0/5	1	
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose R-HSA-9031528	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis R-HSA-9623433	1	0	0/6	1	
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  R-HSA-9031525	1	0	0/4	1	
NR1H2 and NR1H3-mediated signaling R-HSA-9024446	0.509526609716264	1.45249715242618	1/23	1	HDAC3
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux R-HSA-9029569	0.461641308516191	1.68306147966003	1/20	1	HDAC3
NRIF signals cell death from the nucleus R-HSA-205043	1	0	0/12	1	
NS1 Mediated Effects on Host Pathways R-HSA-168276	1	0	0/14	1	
NTF3 activates NTRK2 (TRKB) signaling R-HSA-9025046	1	0	0/1	1	
NTF3 activates NTRK3 signaling R-HSA-9034013	1	0	0/0	1	
NTF4 activates NTRK2 (TRKB) signaling R-HSA-9026357	1	0	0/1	1	
NTRK2 activates RAC1 R-HSA-9032759	1	0	0/3	1	
NTRK3 as a dependence receptor R-HSA-9603505	1	0	0/1	1	
NVP-TAE684-resistant ALK mutants R-HSA-9717301	1	0	0/0	1	
Na+/Cl- dependent neurotransmitter transporters R-HSA-442660	1	0	0/4	1	
Nectin/Necl  trans heterodimerization R-HSA-420597	1	0	0/2	1	
Neddylation R-HSA-8951664	1	0	0/133	1	
Nef Mediated CD4 Down-regulation R-HSA-167590	1	0	0/6	1	
Nef Mediated CD8 Down-regulation R-HSA-182218	0.116263980170045	10.686886668013	1/4	1	CD8B
Nef and signal transduction R-HSA-164944	1	0	0/7	1	
Nef mediated downregulation of CD28 cell surface expression R-HSA-164939	1	0	0/1	1	
Negative feedback regulation of MAPK pathway R-HSA-5674499	1	0	0/4	1	
Negative regulation of FGFR2 signaling R-HSA-5654727	0.112156566647182	3.79370227959189	2/19	1	FGF5;CBL
Negative regulation of FGFR4 signaling R-HSA-5654733	0.409122587631764	2.00003463165419	1/17	1	CBL
Negative regulation of FLT3 R-HSA-9706369	0.219107742800551	4.57941075774204	1/8	1	CBL
Negative regulation of MAPK pathway R-HSA-5675221	1	0	0/21	1	
Negative regulation of MET activity R-HSA-6807004	0.331116137121452	2.66887927516196	1/13	1	CBL
Negative regulation of NMDA receptor-mediated neuronal transmission R-HSA-9617324	1	0	0/12	1	
Negative regulation of NOTCH4 signaling R-HSA-9604323	1	0	0/52	1	
Negative regulation of TCF-dependent signaling by DVL-interacting proteins R-HSA-5368598	1	0	0/2	1	
Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-3772470	1	0	0/6	1	
Negative regulation of activity of TFAP2 (AP-2) family transcription factors R-HSA-8866904	1	0	0/6	1	
Negative regulation of the PI3K/AKT network R-HSA-199418	0.585470340533808	1.02879336667891	2/64	1	FGF5;PIP5K1A
Negative regulators of DDX58/IFIH1 signaling R-HSA-936440	1	0	0/27	1	
Nephrin family interactions R-HSA-373753	1	0	0/15	1	
Nephron development R-HSA-9831926	1	0	0/7	1	
Nervous system development R-HSA-9675108	0.9266929493451	0.617688084356172	7/356	1	SPTBN2;CDC42;CACNA1D;ARHGEF11;NGEF;PFN1;SCN8A
Netrin mediated repulsion signals R-HSA-418886	1	0	0/5	1	
Netrin-1 signaling R-HSA-373752	0.427170246365634	1.88200018344424	1/18	1	CDC42
Neurexins and neuroligins R-HSA-6794361	1	0	0/16	1	
Neurodegenerative Diseases R-HSA-8863678	1	0	0/13	1	
Neurofascin interactions R-HSA-447043	1	0	0/4	1	
Neuronal System R-HSA-112316	0.931927570861733	0.45317164468252	2/140	1	GNB2;VAMP2
Neurophilin interactions with VEGF and VEGFR R-HSA-194306	1	0	0/2	1	
Neurotransmitter clearance R-HSA-112311	1	0	0/2	1	
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314	0.945319741199245	0.341201562752294	1/93	1	GNB2
Neurotransmitter release cycle R-HSA-112310	0.371318268662442	2.28665514754916	1/15	1	VAMP2
Neurotransmitter uptake and metabolism In glial cells R-HSA-112313	1	0	0/2	1	
Neutrophil degranulation R-HSA-6798695	0.533689806731934	1.02977646076341	6/192	1	C3;NFKB1;LPCAT1;AP1M1;COPB1;CTSZ
Nicotinamide salvaging R-HSA-197264	1	0	0/7	1	
Nicotinate metabolism R-HSA-196807	1	0	0/12	1	
Nilotinib-resistant KIT mutants R-HSA-9669926	1	0	0/1	1	
Nitric oxide stimulates guanylate cyclase R-HSA-392154	1	0	0/7	1	
Non-integrin membrane-ECM interactions R-HSA-3000171	1	0	0/33	1	
Noncanonical activation of NOTCH3 R-HSA-9017802	1	0	0/6	1	
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) R-HSA-975957	1	0	0/92	1	
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) R-HSA-975956	1	0	0/84	1	
Nonsense-Mediated Decay (NMD) R-HSA-927802	1	0	0/92	1	
Norepinephrine Neurotransmitter Release Cycle R-HSA-181430	0.169262925120966	6.41229475066507	1/6	1	VAMP2
Notch-HLH transcription pathway R-HSA-350054	0.580124869365433	1.18209488026364	1/28	1	HDAC3
NrCAM interactions R-HSA-447038	1	0	0/3	1	
Nuclear Envelope (NE) Reassembly R-HSA-2995410	0.736899902578986	0.757069815975627	1/43	1	CDK1
Nuclear Envelope Breakdown R-HSA-2980766	0.444671006349992	1.77698744688802	1/19	1	CDK1
Nuclear Events (kinase and transcription factor activation) R-HSA-198725	1	0	0/52	1	
Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854	0.310069139133716	2.91223689743989	1/12	1	CDK1
Nuclear Receptor transcription pathway R-HSA-383280	0.640631955377151	0.996158732799185	1/33	1	PPARA
Nuclear events mediated by NFE2L2 R-HSA-9759194	0.771564501065801	0.71171918984277	2/91	1	NFKB1;RELA
Nuclear events stimulated by ALK signaling in cancer R-HSA-9725371	0.566862249676667	1.22786129710518	1/27	1	STAT3
Nuclear import of Rev protein R-HSA-180746	1	0	0/12	1	
Nuclear signaling by ERBB4 R-HSA-1251985	0.494053866191027	1.52202475174719	1/22	1	STMN1
Nucleotide Excision Repair R-HSA-5696398	1	0	0/57	1	
Nucleotide biosynthesis R-HSA-8956320	1	0	0/5	1	
Nucleotide catabolism R-HSA-8956319	0.409122587631764	2.00003463165419	1/17	1	TYMP
Nucleotide catabolism defects R-HSA-9735786	1	0	0/1	1	
Nucleotide salvage R-HSA-8956321	0.242905995435717	4.00656868135255	1/9	1	TYMP
Nucleotide salvage defects R-HSA-9734207	1	0	0/1	1	
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-168643	0.185890008899366	2.10541716616761	3/49	1	NFKB1;RELA;NFKB2
Nucleotide-like (purinergic) receptors R-HSA-418038	1	0	0/5	1	
O-glycosylation of TSR domain-containing proteins R-HSA-5173214	1	0	0/15	1	
O-linked glycosylation R-HSA-5173105	1	0	0/38	1	
O-linked glycosylation of mucins R-HSA-913709	1	0	0/22	1	
O2/CO2 exchange in erythrocytes R-HSA-1480926	1	0	0/7	1	
OAS antiviral response R-HSA-8983711	1	0	0/5	1	
OGDH complex synthesizes succinyl-CoA from 2-OG R-HSA-9853506	1	0	0/2	1	
Oleoyl-phe metabolism R-HSA-9673163	1	0	0/0	1	
Olfactory Signaling Pathway R-HSA-381753	1	0	0/3	1	
Oligomerization of connexins into connexons R-HSA-190704	1	0	0/2	1	
Oncogenic MAPK signaling R-HSA-6802957	1	0	0/42	1	
Opioid Signalling R-HSA-111885	0.788591033174282	0.647762265480832	1/50	1	GNB2
Opsins R-HSA-419771	1	0	0/1	1	
Orexin and neuropeptides FF and QRFP bind to their respective receptors R-HSA-389397	1	0	0/3	1	
Organelle biogenesis and maintenance R-HSA-1852241	0.365145804474627	1.24591232292779	6/161	1	CDK1;MAPRE1;CEP78;HDAC3;PPARA;HCFC1
Organic anion transport R-HSA-561048	1	0	0/0	1	
Organic anion transporters R-HSA-428643	1	0	0/4	1	
Organic cation transport R-HSA-549127	1	0	0/4	1	
Organic cation/anion/zwitterion transport R-HSA-549132	1	0	0/4	1	
Other semaphorin interactions R-HSA-416700	1	0	0/13	1	
Ovarian tumor domain proteases R-HSA-5689896	0.55318421545593	1.27728821101974	1/26	1	CDK1
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha R-HSA-1234176	1	0	0/60	1	
P2Y receptors R-HSA-417957	1	0	0/3	1	
PAOs oxidise polyamines to amines R-HSA-141334	1	0	0/0	1	
PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801	1	0	0/8	1	
PCP/CE pathway R-HSA-4086400	0.906504974630008	0.420389867605124	1/76	1	PFN1
PD-1 signaling R-HSA-389948	0.427170246365634	1.88200018344424	1/18	1	CD3D
PDE3B signalling R-HSA-165160	1	0	0/2	1	
PDGFR mutants bind TKIs R-HSA-9674428	1	0	0/1	1	
PDH complex synthesizes acetyl-CoA from PYR R-HSA-9861559	1	0	0/2	1	
PECAM1 interactions R-HSA-210990	0.288365431745851	3.20406387724278	1/11	1	INPP5D
PERK regulates gene expression R-HSA-381042	0.580124869365433	1.18209488026364	1/28	1	CXCL8
PI and PC transport between ER and Golgi membranes R-HSA-1483196	1	0	0/0	1	
PI-3K cascade:FGFR1 R-HSA-5654689	0.194567694860967	5.34322317913915	1/7	1	FGF5
PI-3K cascade:FGFR2 R-HSA-5654695	0.242905995435717	4.00656868135255	1/9	1	FGF5
PI-3K cascade:FGFR3 R-HSA-5654710	0.194567694860967	5.34322317913915	1/7	1	FGF5
PI-3K cascade:FGFR4 R-HSA-5654720	1	0	0/7	1	
PI3K Cascade R-HSA-109704	0.47809710350936	1.59852000850236	1/21	1	FGF5
PI3K events in ERBB2 signaling R-HSA-1963642	1	0	0/11	1	
PI3K events in ERBB4 signaling R-HSA-1250342	1	0	0/6	1	
PI3K/AKT Signaling in Cancer R-HSA-2219528	0.88347534388671	0.464503786709172	1/69	1	FGF5
PI3K/AKT activation R-HSA-198203	1	0	0/8	1	
PI5P Regulates TP53 Acetylation R-HSA-6811555	1	0	0/6	1	
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558	0.540891939721465	1.12045318536671	2/59	1	FGF5;PIP5K1A
PINK1-PRKN Mediated Mitophagy R-HSA-5205685	1	0	0/10	1	
PIP3 activates AKT signaling R-HSA-1257604	0.728769109705681	0.818506221848234	5/198	1	FGF5;HDAC3;MTA1;GATAD2A;PIP5K1A
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884	1	0	0/18	1	
PKA activation R-HSA-163615	1	0	0/10	1	
PKA activation in glucagon signalling R-HSA-164378	1	0	0/8	1	
PKA-mediated phosphorylation of CREB R-HSA-111931	1	0	0/12	1	
PKA-mediated phosphorylation of key metabolic factors R-HSA-163358	1	0	0/5	1	
PKB-mediated events R-HSA-109703	1	0	0/2	1	
PKR-mediated signaling R-HSA-9833482	0.375739514355936	1.39550065298773	3/72	1	CDK1;STAT1;STAT3
PLC beta mediated events R-HSA-112043	1	0	0/28	1	
PLC-gamma1 signalling R-HSA-167021	1	0	0/2	1	
PLCG1 events in ERBB2 signaling R-HSA-1251932	1	0	0/3	1	
POLB-Dependent Long Patch Base Excision Repair R-HSA-110362	1	0	0/2	1	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation R-HSA-2892247	0.169262925120966	6.41229475066507	1/6	1	STAT3
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation R-HSA-2892245	1	0	0/4	1	
PP2A-mediated dephosphorylation of key metabolic factors R-HSA-163767	1	0	0/6	1	
PPARA activates gene expression R-HSA-1989781	0.610662287359965	0.980551419280864	2/67	1	HDAC3;PPARA
PTEN Loss of Function in Cancer R-HSA-5674404	1	0	0/1	1	
PTEN Regulation R-HSA-6807070	0.709274946480401	0.820076564269688	3/119	1	HDAC3;MTA1;GATAD2A
PTK6 Down-Regulation R-HSA-8849472	1	0	0/2	1	
PTK6 Expression R-HSA-8849473	1	0	0/5	1	
PTK6 Regulates Cell Cycle R-HSA-8849470	1	0	0/6	1	
PTK6 Regulates Proteins Involved in RNA Processing R-HSA-8849468	1	0	0/1	1	
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases R-HSA-8849471	1	0	0/12	1	
PTK6 promotes HIF1A stabilization R-HSA-8857538	1	0	0/6	1	
Paracetamol ADME R-HSA-9753281	1	0	0/12	1	
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955	1	0	0/27	1	
Parasite infection R-HSA-9664407	0.672697020436742	0.910090238988284	1/36	1	CDC42
Passive transport by Aquaporins R-HSA-432047	1	0	0/3	1	
Pausing and recovery of HIV elongation R-HSA-167290	1	0	0/24	1	
Pausing and recovery of Tat-mediated HIV elongation R-HSA-167238	1	0	0/22	1	
Pentose phosphate pathway R-HSA-71336	1	0	0/9	1	
Pentose phosphate pathway disease R-HSA-6791465	1	0	0/2	1	
Peptide chain elongation R-HSA-156902	1	0	0/81	1	
Peptide hormone biosynthesis R-HSA-209952	1	0	0/5	1	
Peroxisomal lipid metabolism R-HSA-390918	1	0	0/10	1	
Peroxisomal protein import R-HSA-9033241	1	0	0/25	1	
Pervasive developmental disorders R-HSA-9005895	0.265984697433587	3.56074569329776	1/10	1	HDAC3
Pexophagy R-HSA-9664873	1	0	0/9	1	
Phase 0 - rapid depolarisation R-HSA-5576892	0.390511083989948	2.13379931391034	1/16	1	SCN8A
Phase 1 - inactivation of fast Na+ channels R-HSA-5576894	1	0	0/0	1	
Phase 2 - plateau phase R-HSA-5576893	1	0	0/6	1	
Phase 3 - rapid repolarisation R-HSA-5576890	1	0	0/2	1	
Phase 4 - resting membrane potential R-HSA-5576886	1	0	0/4	1	
Phase I - Functionalization of compounds R-HSA-211945	1	0	0/26	1	
Phase II - Conjugation of compounds R-HSA-156580	1	0	0/47	1	
Phenylalanine and tyrosine metabolism R-HSA-8963691	1	0	0/4	1	
Phenylalanine metabolism R-HSA-8964208	1	0	0/3	1	
Phenylketonuria R-HSA-2160456	1	0	0/0	1	
Phosphate bond hydrolysis by NTPDase proteins R-HSA-8850843	1	0	0/3	1	
Phosphate bond hydrolysis by NUDT proteins R-HSA-2393930	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR2 R-HSA-5654221	0.143169804536155	8.01619116439233	1/5	1	FGF5
Phospholipase C-mediated cascade; FGFR4 R-HSA-5654228	1	0	0/3	1	
Phosphorylation of CD3 and TCR zeta chains R-HSA-202427	0.390511083989948	2.13379931391034	1/16	1	CD3D
Phosphorylation of Emi1 R-HSA-176417	0.116263980170045	10.686886668013	1/4	1	CDK1
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes R-HSA-69200	1	0	0/4	1	
Phosphorylation of the APC/C R-HSA-176412	0.461641308516191	1.68306147966003	1/20	1	CDK1
Physiological factors R-HSA-5578768	1	0	0/7	1	
Plasma lipoprotein assembly R-HSA-8963898	1	0	0/14	1	
Plasma lipoprotein assembly, remodeling, and clearance R-HSA-174824	1	0	0/42	1	
Plasma lipoprotein clearance R-HSA-8964043	1	0	0/19	1	
Plasma lipoprotein remodeling R-HSA-8963899	1	0	0/18	1	
Plasmalogen biosynthesis R-HSA-75896	1	0	0/0	1	
Platelet Adhesion to exposed collagen R-HSA-75892	0.265984697433587	3.56074569329776	1/10	1	GP1BA
Platelet Aggregation (Plug Formation) R-HSA-76009	0.461641308516191	1.68306147966003	1/20	1	GP1BA
Platelet activation, signaling and aggregation R-HSA-76002	0.544687130579373	1.03792067115758	4/127	1	GNB2;CDC42;PFN1;GP1BA
Platelet calcium homeostasis R-HSA-418360	1	0	0/12	1	
Platelet degranulation  R-HSA-114608	0.795101624791598	0.634644967427019	1/51	1	PFN1
Platelet homeostasis R-HSA-418346	0.692480154387814	0.86046333162253	1/38	1	GNB2
Platelet sensitization by LDL R-HSA-432142	1	0	0/12	1	
Plus-strand DNA synthesis R-HSA-164525	1	0	0/1	1	
Polo-like kinase mediated events R-HSA-156711	1	0	0/6	1	
Polymerase switching R-HSA-69091	1	0	0/5	1	
Polymerase switching on the C-strand of the telomere R-HSA-174411	1	0	0/6	1	
Post NMDA receptor activation events R-HSA-438064	1	0	0/57	1	
Post-chaperonin tubulin folding pathway R-HSA-389977	1	0	0/20	1	
Post-transcriptional silencing by small RNAs R-HSA-426496	1	0	0/1	1	
Post-translational modification: synthesis of GPI-anchored proteins R-HSA-163125	1	0	0/13	1	
Post-translational protein modification R-HSA-597592	0.193711651918529	1.25442176080716	24/659	1	CDK1;CCNA2;H2BC13;H2BC17;H2BC12;H2AC8;H2BC14;C3;RELA;PPARA;SEC23A;SPTBN2;MTA1;COPB1;MAN2A2;CTSZ;B4GALT2;COG1;NFKB2;TOP2A;H2AC12;ATXN7;HCFC1;H2AC13
Post-translational protein phosphorylation R-HSA-8957275	0.651652217029758	0.965730946513807	1/34	1	C3
Postmitotic nuclear pore complex (NPC) reformation R-HSA-9615933	1	0	0/12	1	
Postsynaptic nicotinic acetylcholine receptors R-HSA-622327	1	0	0/5	1	
Potassium Channels R-HSA-1296071	0.539077864968528	1.3308330535302	1/25	1	GNB2
Potassium transport channels R-HSA-1296067	1	0	0/1	1	
Potential therapeutics for SARS R-HSA-9679191	0.316855504781762	1.55581748614081	3/65	1	MTA1;GATAD2A;TYK2
Pre-NOTCH Processing in Golgi R-HSA-1912420	1	0	0/11	1	
Pre-NOTCH Processing in the Endoplasmic Reticulum R-HSA-1912399	1	0	0/5	1	
Prednisone ADME R-HSA-9757110	1	0	0/1	1	
Prefoldin mediated transfer of substrate  to CCT/TriC R-HSA-389957	1	0	0/28	1	
Pregnenolone biosynthesis R-HSA-196108	1	0	0/5	1	
Presynaptic depolarization and calcium channel opening R-HSA-112308	1	0	0/2	1	
Presynaptic function of Kainate receptors R-HSA-500657	0.219107742800551	4.57941075774204	1/8	1	GNB2
Presynaptic nicotinic acetylcholine receptors R-HSA-622323	1	0	0/5	1	
Presynaptic phase of homologous DNA pairing and strand exchange R-HSA-5693616	1	0	0/16	1	
Prevention of phagosomal-lysosomal fusion R-HSA-9636383	1	0	0/5	1	
Processing and activation of SUMO R-HSA-3215018	1	0	0/6	1	
Processing of Capped Intron-Containing Pre-mRNA R-HSA-72203	1	0	0/142	1	
Processing of Capped Intronless Pre-mRNA R-HSA-75067	1	0	0/15	1	
Processing of Intronless Pre-mRNAs R-HSA-77595	1	0	0/8	1	
Processing of SMDT1 R-HSA-8949664	1	0	0/9	1	
Processive synthesis on the C-strand of the telomere R-HSA-174414	1	0	0/7	1	
Processive synthesis on the lagging strand R-HSA-69183	1	0	0/6	1	
Programmed Cell Death R-HSA-5357801	0.471334425653361	1.11944029848007	5/148	1	TFDP1;E2F1;STAT3;IL1B;IRF1
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 R-HSA-964827	1	0	0/0	1	
Prolactin receptor signaling R-HSA-1170546	1	0	0/15	1	
Proline catabolism R-HSA-70688	1	0	0/0	1	
Prolonged ERK activation events R-HSA-169893	1	0	0/8	1	
Propionyl-CoA catabolism R-HSA-71032	1	0	0/4	1	
Prostacyclin signalling through prostacyclin receptor R-HSA-392851	0.219107742800551	4.57941075774204	1/8	1	GNB2
Prostanoid ligand receptors R-HSA-391908	1	0	0/0	1	
Protein folding R-HSA-391251	0.300020067778026	1.60849904179555	3/63	1	GNB2;HDAC3;STAT3
Protein hydroxylation R-HSA-9629569	1	0	0/7	1	
Protein lipoylation R-HSA-9857492	1	0	0/3	1	
Protein localization R-HSA-9609507	0.890575988702246	0.450999629139426	1/71	1	VAMP2
Protein methylation R-HSA-8876725	1	0	0/8	1	
Protein repair R-HSA-5676934	1	0	0/2	1	
Protein-protein interactions at synapses R-HSA-6794362	1	0	0/20	1	
Proton-coupled monocarboxylate transport R-HSA-433692	1	0	0/2	1	
Proton-coupled neutral amino acid transporters R-HSA-428559	1	0	0/0	1	
Proton/oligopeptide cotransporters R-HSA-427975	1	0	0/0	1	
Purine catabolism R-HSA-74259	1	0	0/9	1	
Purine ribonucleoside monophosphate biosynthesis R-HSA-73817	1	0	0/4	1	
Purine salvage R-HSA-74217	1	0	0/7	1	
Pyrimidine biosynthesis R-HSA-500753	1	0	0/1	1	
Pyrimidine catabolism R-HSA-73621	0.194567694860967	5.34322317913915	1/7	1	TYMP
Pyrophosphate hydrolysis R-HSA-71737	1	0	0/2	1	
Pyruvate metabolism R-HSA-70268	1	0	0/13	1	
RA biosynthesis pathway R-HSA-5365859	1	0	0/5	1	
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198	0.461641308516191	1.68306147966003	1/20	1	ULK1
RAB geranylgeranylation R-HSA-8873719	1	0	0/10	1	
RAC2 GTPase cycle R-HSA-9013404	0.719952191732563	0.795326054757542	1/41	1	CDC42
RAC3 GTPase cycle R-HSA-9013423	0.752829821086883	0.722290779559263	1/45	1	CDC42
RAF activation R-HSA-5673000	1	0	0/22	1	
RAF/MAP kinase cascade R-HSA-5673001	0.947585778021872	0.421438613369137	2/150	1	FGF5;SPTBN2
RAS GTPase cycle mutants R-HSA-9649913	1	0	0/3	1	
RAS processing R-HSA-9648002	1	0	0/13	1	
RAS signaling downstream of NF1 loss-of-function variants R-HSA-6802953	1	0	0/5	1	
RET signaling R-HSA-8853659	1	0	0/22	1	
RHO GTPase cycle R-HSA-9012999	0.183574477947201	1.46863699264144	9/209	1	CDC42;ARHGEF11;NGEF;IQGAP3;SPATA13;ARHGAP30;ARAP1;MCF2L;STMN2
RHO GTPases Activate NADPH Oxidases R-HSA-5668599	1	0	0/17	1	
RHO GTPases Activate ROCKs R-HSA-5627117	1	0	0/13	1	
RHO GTPases Activate Rhotekin and Rhophilins R-HSA-5666185	1	0	0/3	1	
RHO GTPases Activate WASPs and WAVEs R-HSA-5663213	0.539077864968528	1.3308330535302	1/25	1	CDC42
RHO GTPases activate CIT R-HSA-5625900	1	0	0/11	1	
RHO GTPases activate IQGAPs R-HSA-5626467	0.24275391009727	2.21769633049491	2/31	1	CDC42;IQGAP3
RHO GTPases activate KTN1 R-HSA-5625970	0.169262925120966	6.41229475066507	1/6	1	CDC42
RHO GTPases activate PAKs R-HSA-5627123	0.371318268662442	2.28665514754916	1/15	1	CDC42
RHO GTPases regulate CFTR trafficking R-HSA-5627083	1	0	0/1	1	
RHOBTB GTPase Cycle R-HSA-9706574	1	0	0/22	1	
RHOBTB1 GTPase cycle R-HSA-9013422	1	0	0/15	1	
RHOBTB2 GTPase cycle R-HSA-9013418	1	0	0/14	1	
RHOBTB3 ATPase cycle R-HSA-9706019	1	0	0/4	1	
RHOC GTPase cycle R-HSA-9013106	0.120552272828728	2.62332940435544	3/40	1	ARHGEF11;IQGAP3;MCF2L
RHOD GTPase cycle R-HSA-9013405	1	0	0/23	1	
RHOF GTPase cycle R-HSA-9035034	1	0	0/18	1	
RHOG GTPase cycle R-HSA-9013408	0.231384599512613	2.29732667992241	2/30	1	CDC42;MCF2L
RHOH GTPase cycle R-HSA-9013407	1	0	0/17	1	
RHOJ GTPase cycle R-HSA-9013409	0.254147963263314	2.14314560142854	2/32	1	CDC42;IQGAP3
RHOQ GTPase cycle R-HSA-9013406	0.220052670683796	2.38304343136663	2/29	1	CDC42;IQGAP3
RHOT1 GTPase cycle R-HSA-9013425	1	0	0/1	1	
RHOT2 GTPase cycle R-HSA-9013419	1	0	0/1	1	
RHOU GTPase cycle R-HSA-9013420	0.186419102783462	2.68269836762088	2/26	1	CDC42;ARHGAP30
RHOV GTPase cycle R-HSA-9013424	0.461641308516191	1.68306147966003	1/20	1	CDC42
RIPK1-mediated regulated necrosis R-HSA-5213460	1	0	0/25	1	
RMTs methylate histone arginines R-HSA-3214858	0.108282676233516	2.31920774925808	4/60	1	H3C1;H2AC8;H2AC12;H2AC13
RNA Pol II CTD phosphorylation and interaction with CE R-HSA-77075	1	0	0/19	1	
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection R-HSA-167160	1	0	0/19	1	
RNA Polymerase I Transcription Termination R-HSA-73863	1	0	0/15	1	
RNA Polymerase II HIV Promoter Escape R-HSA-167162	1	0	0/29	1	
RNA Polymerase II Pre-transcription Events R-HSA-674695	1	0	0/46	1	
RNA Polymerase II Promoter Escape R-HSA-73776	1	0	0/29	1	
RNA Polymerase II Transcription Elongation R-HSA-75955	1	0	0/34	1	
RNA Polymerase II Transcription Initiation And Promoter Clearance R-HSA-76042	1	0	0/29	1	
RNA Polymerase II Transcription Initiation R-HSA-75953	1	0	0/29	1	
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening R-HSA-73779	1	0	0/29	1	
RNA Polymerase II Transcription R-HSA-73857	0.48169410011913	1.03448871333994	22/704	1	CDK1;CCNA2;TFDP1;E2F1;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;CDC7;HDAC3;NFKB1;RELA;PPARA;GATAD2A;STAT1;E2F5;E2F4;EHMT2;GP1BA;SPI1
RNA Polymerase II Transcription Termination R-HSA-73856	1	0	0/30	1	
RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476	1	0	0/22	1	
RNA Polymerase III Chain Elongation R-HSA-73780	1	0	0/8	1	
RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061	1	0	0/15	1	
RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066	1	0	0/14	1	
RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071	1	0	0/12	1	
RNA Polymerase III Transcription Initiation R-HSA-76046	1	0	0/18	1	
RNA Polymerase III Transcription R-HSA-74158	1	0	0/22	1	
RNA Polymerase III Transcription Termination R-HSA-73980	1	0	0/12	1	
RNA polymerase II transcribes snRNA genes R-HSA-6807505	1	0	0/48	1	
RND1 GTPase cycle R-HSA-9696273	0.351526138395097	2.4631234253845	1/14	1	STMN2
RND2 GTPase cycle R-HSA-9696270	1	0	0/15	1	
RND3 GTPase cycle R-HSA-9696264	1	0	0/15	1	
ROBO receptors bind AKAP5 R-HSA-9010642	1	0	0/6	1	
RORA activates gene expression R-HSA-1368082	0.390511083989948	2.13379931391034	1/16	1	PPARA
ROS and RNS production in phagocytes R-HSA-1222556	1	0	0/16	1	
RPIA deficiency: failed conversion of R5P to RU5P R-HSA-5659996	1	0	0/1	1	
RPIA deficiency: failed conversion of RU5P to R5P R-HSA-6791461	1	0	0/1	1	
RSK activation R-HSA-444257	1	0	0/6	1	
RSV-host interactions R-HSA-9833110	0.879755506694409	0.471558161164725	1/68	1	TYK2
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) R-HSA-8877330	1	0	0/5	1	
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known R-HSA-8939243	1	0	0/28	1	
RUNX1 regulates estrogen receptor mediated transcription R-HSA-8931987	1	0	0/6	1	
RUNX1 regulates expression of components of tight junctions R-HSA-8935964	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in BCR signaling R-HSA-8939245	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in WNT signaling R-HSA-8939256	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes R-HSA-8939242	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246	1	0	0/6	1	
RUNX1 regulates transcription of genes involved in interleukin signaling R-HSA-8939247	1	0	0/4	1	
RUNX2 regulates bone development R-HSA-8941326	0.524529899197712	1.38901487616444	1/24	1	HDAC3
RUNX2 regulates chondrocyte maturation R-HSA-8941284	1	0	0/5	1	
RUNX2 regulates genes involved in cell migration R-HSA-8941332	1	0	0/7	1	
RUNX2 regulates genes involved in differentiation of myeloid cells R-HSA-8941333	1	0	0/4	1	
RUNX2 regulates osteoblast differentiation R-HSA-8940973	0.444671006349992	1.77698744688802	1/19	1	HDAC3
RUNX3 Regulates Immune Response and Cell Migration R-HSA-8949275	1	0	0/5	1	
RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-8952158	1	0	0/5	1	
RUNX3 regulates CDKN1A transcription R-HSA-8941855	1	0	0/7	1	
RUNX3 regulates NOTCH signaling R-HSA-8941856	1	0	0/14	1	
RUNX3 regulates RUNX1-mediated transcription R-HSA-8951911	1	0	0/3	1	
RUNX3 regulates WNT signaling R-HSA-8951430	1	0	0/8	1	
RUNX3 regulates YAP1-mediated transcription R-HSA-8951671	1	0	0/6	1	
RUNX3 regulates p14-ARF R-HSA-8951936	1	0	0/10	1	
Rab regulation of trafficking R-HSA-9007101	0.276963320841088	2.00829883504425	2/34	1	ULK1;TBC1D14
Rap1 signalling R-HSA-392517	1	0	0/8	1	
Ras activation upon Ca2+ influx through NMDA receptor R-HSA-442982	1	0	0/14	1	
Reactions specific to the hybrid N-glycan synthesis pathway R-HSA-975574	1	0	0/0	1	
Receptor Mediated Mitophagy R-HSA-8934903	0.219107742800551	4.57941075774204	1/8	1	ULK1
Receptor-type tyrosine-protein phosphatases R-HSA-388844	1	0	0/3	1	
Recognition of DNA damage by PCNA-containing replication complex R-HSA-110314	1	0	0/15	1	
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks R-HSA-5693565	0.108282676233516	2.31920774925808	4/60	1	H2BC13;H2BC17;H2BC12;H2BC14
Recruitment of NuMA to mitotic centrosomes R-HSA-380320	0.241777605514148	1.82407496576738	3/56	1	CDK1;MAPRE1;CEP78
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270	0.127331973640782	2.55375756187567	3/41	1	CDK1;MAPRE1;CEP78
Recycling of bile acids and salts R-HSA-159418	1	0	0/7	1	
Recycling of eIF2:GDP R-HSA-72731	1	0	0/3	1	
Recycling pathway of L1 R-HSA-437239	1	0	0/36	1	
Reduction of cytosolic Ca++ levels R-HSA-418359	1	0	0/7	1	
Reelin signalling pathway R-HSA-8866376	1	0	0/3	1	
Regorafenib-resistant KIT mutants R-HSA-9669929	1	0	0/1	1	
Regorafenib-resistant PDGFR mutants R-HSA-9674403	1	0	0/1	1	
Regulated Necrosis R-HSA-5218859	0.333681412902203	1.73477977110316	2/39	1	IL1B;IRF1
Regulation by TREX1 R-HSA-3248023	1	0	0/0	1	
Regulation by c-FLIP R-HSA-3371378	1	0	0/10	1	
Regulation of APC/C activators between G1/S and early anaphase R-HSA-176408	0.409007387916476	1.31770440488116	3/76	1	BUB3;CDK1;CCNA2
Regulation of Apoptosis R-HSA-169911	1	0	0/49	1	
Regulation of BACH1 activity R-HSA-9708530	1	0	0/9	1	
Regulation of CDH11 Expression and Function R-HSA-9759475	1	0	0/12	1	
Regulation of CDH11 function R-HSA-9762292	1	0	0/6	1	
Regulation of CDH11 gene transcription R-HSA-9762293	1	0	0/6	1	
Regulation of CDH11 mRNA translation by microRNAs R-HSA-9759811	1	0	0/2	1	
Regulation of CDH19 Expression and Function R-HSA-9764302	1	0	0/3	1	
Regulation of Complement cascade R-HSA-977606	0.132525408652829	3.3926410524654	2/21	1	C3;CPN2
Regulation of Expression and Function of Type II Classical Cadherins R-HSA-9764260	1	0	0/12	1	
Regulation of FOXO transcriptional activity by acetylation R-HSA-9617629	1	0	0/10	1	
Regulation of FZD by ubiquitination R-HSA-4641263	1	0	0/13	1	
Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-170822	1	0	0/10	1	
Regulation of HMOX1 expression and activity R-HSA-9707587	1	0	0/4	1	
Regulation of HSF1-mediated heat shock response R-HSA-3371453	1	0	0/38	1	
Regulation of Homotypic Cell-Cell Adhesion R-HSA-9759476	1	0	0/12	1	
Regulation of IFNA/IFNB signaling R-HSA-912694	0.186419102783462	2.68269836762088	2/26	1	STAT1;TYK2
Regulation of IFNG signaling R-HSA-877312	0.351526138395097	2.4631234253845	1/14	1	STAT1
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-381426	0.389102748052683	1.52634170734515	2/44	1	KLK2;C3
Regulation of KIT signaling R-HSA-1433559	0.331116137121452	2.66887927516196	1/13	1	CBL
Regulation of MECP2 expression and activity R-HSA-9022692	0.461641308516191	1.68306147966003	1/20	1	HDAC3
Regulation of MITF-M dependent genes involved in invasion R-HSA-9854909	1	0	0/2	1	
Regulation of MITF-M dependent genes involved in metabolism R-HSA-9854907	1	0	0/3	1	
Regulation of MITF-M-dependent genes involved in DNA damage repair and senescence R-HSA-9825895	1	0	0/2	1	
Regulation of MITF-M-dependent genes involved in apoptosis R-HSA-9824594	1	0	0/7	1	
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation R-HSA-9825892	1	0	0/12	1	
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy R-HSA-9857377	1	0	0/13	1	
Regulation of MITF-M-dependent genes involved in pigmentation R-HSA-9824585	1	0	0/16	1	
Regulation of NF-kappa B signaling R-HSA-9758274	1	0	0/15	1	
Regulation of NPAS4 gene expression R-HSA-9768759	1	0	0/4	1	
Regulation of NPAS4 gene transcription R-HSA-9768777	1	0	0/3	1	
Regulation of NPAS4 mRNA translation R-HSA-9768778	1	0	0/1	1	
Regulation of PAK-2p34 activity by PS-GAP/RHG10 R-HSA-211728	1	0	0/1	1	
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942	0.185890008899366	2.10541716616761	3/49	1	CDK1;MAPRE1;CEP78
Regulation of PTEN gene transcription R-HSA-8943724	0.25825518999791	1.75695133863982	3/58	1	HDAC3;MTA1;GATAD2A
Regulation of PTEN localization R-HSA-8948747	1	0	0/7	1	
Regulation of PTEN mRNA translation R-HSA-8943723	1	0	0/2	1	
Regulation of PTEN stability and activity R-HSA-8948751	1	0	0/59	1	
Regulation of RAS by GAPs R-HSA-5658442	1	0	0/56	1	
Regulation of RUNX1 Expression and Activity R-HSA-8934593	1	0	0/10	1	
Regulation of RUNX2 expression and activity R-HSA-8939902	0.867874577942296	0.494038764472477	1/65	1	STAT1
Regulation of RUNX3 expression and activity R-HSA-8941858	1	0	0/54	1	
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7  R-HSA-9824878	1	0	0/11	1	
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation R-HSA-9828211	1	0	0/10	1	
Regulation of TLR by endogenous ligand R-HSA-5686938	1	0	0/13	1	
Regulation of TNFR1 signaling R-HSA-5357905	0.640631955377151	0.996158732799185	1/33	1	ULK1
Regulation of TP53 Activity R-HSA-5633007	0.334213310481122	1.39882521944729	4/96	1	CDK1;CCNA2;GATAD2A;EHMT2
Regulation of TP53 Activity through Acetylation R-HSA-6804758	0.509526609716264	1.45249715242618	1/23	1	GATAD2A
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759	1	0	0/7	1	
Regulation of TP53 Activity through Methylation R-HSA-6804760	0.310069139133716	2.91223689743989	1/12	1	EHMT2
Regulation of TP53 Activity through Phosphorylation R-HSA-6804756	0.807532073981004	0.609923680575005	1/53	1	CCNA2
Regulation of TP53 Degradation R-HSA-6804757	0.254147963263314	2.14314560142854	2/32	1	CDK1;CCNA2
Regulation of TP53 Expression R-HSA-6804754	1	0	0/2	1	
Regulation of TP53 Expression and Degradation R-HSA-6806003	0.265554842205604	2.07354981970465	2/33	1	CDK1;CCNA2
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482	0.672697020436742	0.910090238988284	1/36	1	CDC42
Regulation of activated PAK-2p34 by proteasome mediated degradation R-HSA-211733	1	0	0/49	1	
Regulation of beta-cell development R-HSA-186712	1	0	0/21	1	
Regulation of cholesterol biosynthesis by SREBP (SREBF) R-HSA-1655829	0.24275391009727	2.21769633049491	2/31	1	PPARA;SEC23A
Regulation of commissural axon pathfinding by SLIT and ROBO R-HSA-428542	1	0	0/5	1	
Regulation of cortical dendrite branching R-HSA-8985801	1	0	0/2	1	
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components R-HSA-446388	1	0	0/5	1	
Regulation of expression of SLITs and ROBOs R-HSA-9010553	1	0	0/143	1	
Regulation of gap junction activity R-HSA-191650	1	0	0/2	1	
Regulation of gene expression by Hypoxia-inducible Factor R-HSA-1234158	1	0	0/8	1	
Regulation of gene expression in beta cells R-HSA-210745	1	0	0/8	1	
Regulation of gene expression in early pancreatic precursor cells R-HSA-210747	1	0	0/1	1	
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells R-HSA-210746	1	0	0/0	1	
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells R-HSA-210744	1	0	0/12	1	
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism R-HSA-9634600	1	0	0/8	1	
Regulation of innate immune responses to cytosolic DNA R-HSA-3134975	1	0	0/9	1	
Regulation of lipid metabolism by PPARalpha R-HSA-400206	0.62680657761796	0.950794698749953	2/69	1	HDAC3;PPARA
Regulation of localization of FOXO transcription factors R-HSA-9614399	1	0	0/12	1	
Regulation of mRNA stability by proteins that bind AU-rich elements R-HSA-450531	0.920131253621501	0.393605940982901	1/81	1	ELAVL1
Regulation of mitotic cell cycle R-HSA-453276	0.225090154250366	1.70028433027889	4/80	1	BUB3;CDK1;PTTG1;CCNA2
Regulation of necroptotic cell death R-HSA-5675482	1	0	0/25	1	
Regulation of ornithine decarboxylase (ODC) R-HSA-350562	1	0	0/49	1	
Regulation of pyruvate dehydrogenase (PDH) complex R-HSA-204174	1	0	0/5	1	
Regulation of pyruvate metabolism R-HSA-9861718	1	0	0/10	1	
Regulation of signaling by CBL R-HSA-912631	0.444671006349992	1.77698744688802	1/19	1	CBL
Regulation of signaling by NODAL R-HSA-1433617	1	0	0/2	1	
Regulation of the apoptosome activity R-HSA-9627069	1	0	0/5	1	
Regulation of thyroid hormone activity R-HSA-350864	1	0	0/0	1	
Relaxin receptors R-HSA-444821	1	0	0/0	1	
Release of Hh-Np from the secreting cell R-HSA-5362798	1	0	0/3	1	
Release of apoptotic factors from the mitochondria R-HSA-111457	1	0	0/3	1	
Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-159782	1	0	0/3	1	
Removal of the Flap Intermediate R-HSA-69166	1	0	0/6	1	
Removal of the Flap Intermediate from the C-strand R-HSA-174437	1	0	0/6	1	
Replication of the SARS-CoV-1 genome R-HSA-9682706	1	0	0/4	1	
Replication of the SARS-CoV-2 genome R-HSA-9694686	1	0	0/4	1	
Repression of WNT target genes R-HSA-4641265	1	0	0/13	1	
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250	1	0	0/2	1	
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249	1	0	0/2	1	
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251	1	0	0/2	1	
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246	1	0	0/2	1	
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247	1	0	0/2	1	
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244	1	0	0/2	1	
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245	1	0	0/2	1	
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233	1	0	0/2	1	
Resolution of AP sites via the multiple-nucleotide patch replacement pathway R-HSA-110373	1	0	0/9	1	
Resolution of AP sites via the single-nucleotide replacement pathway R-HSA-110381	1	0	0/2	1	
Resolution of Abasic Sites (AP sites) R-HSA-73933	1	0	0/12	1	
Resolution of D-Loop Structures R-HSA-5693537	1	0	0/18	1	
Resolution of D-loop Structures through Holliday Junction Intermediates R-HSA-5693568	1	0	0/18	1	
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554	1	0	0/15	1	
Respiratory Syncytial Virus Infection Pathway R-HSA-9820952	0.9295980964325	0.374474344148747	1/85	1	TYK2
Respiratory electron transport R-HSA-611105	1	0	0/70	1	
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. R-HSA-163200	1	0	0/85	1	
Respiratory syncytial virus (RSV) attachment and entry R-HSA-9820960	1	0	0/9	1	
Respiratory syncytial virus (RSV) genome replication, transcription and translation R-HSA-9820965	1	0	0/15	1	
Respiratory syncytial virus genome replication R-HSA-9834752	1	0	0/2	1	
Respiratory syncytial virus genome transcription R-HSA-9828642	1	0	0/1	1	
Response of EIF2AK1 (HRI) to heme deficiency R-HSA-9648895	1	0	0/14	1	
Response of EIF2AK4 (GCN2) to amino acid deficiency R-HSA-9633012	1	0	0/92	1	
Response of Mtb to phagocytosis R-HSA-9637690	1	0	0/14	1	
Response to elevated platelet cytosolic Ca2+ R-HSA-76005	0.819214172889441	0.587033339053753	1/55	1	PFN1
Response to metal ions R-HSA-5660526	1	0	0/0	1	
Retinoid cycle disease events R-HSA-2453864	1	0	0/1	1	
Retinoid metabolism and transport R-HSA-975634	1	0	0/13	1	
Retinoid metabolism disease events R-HSA-6809583	1	0	0/0	1	
Retrograde neurotrophin signalling R-HSA-177504	1	0	0/8	1	
Retrograde transport at the Trans-Golgi-Network R-HSA-6811440	0.55318421545593	1.27728821101974	1/26	1	COG1
Reuptake of GABA R-HSA-888593	1	0	0/2	1	
Rev-mediated nuclear export of HIV RNA R-HSA-165054	1	0	0/12	1	
Reversal of alkylation damage by DNA dioxygenases R-HSA-73943	1	0	0/0	1	
Reverse Transcription of HIV RNA R-HSA-162589	1	0	0/1	1	
Reversible hydration of carbon dioxide R-HSA-1475029	1	0	0/7	1	
Rhesus blood group biosynthesis R-HSA-9037628	1	0	0/0	1	
Rhesus glycoproteins mediate ammonium transport. R-HSA-444411	1	0	0/0	1	
Ribavirin ADME R-HSA-9755088	0.143169804536155	8.01619116439233	1/5	1	NME1
Ribosomal scanning and start codon recognition R-HSA-72702	1	0	0/47	1	
Role of ABL in ROBO-SLIT signaling R-HSA-428890	1	0	0/6	1	
Role of LAT2/NTAL/LAB on calcium mobilization R-HSA-2730905	1	0	0/12	1	
Role of phospholipids in phagocytosis R-HSA-2029485	1	0	0/16	1	
Role of second messengers in netrin-1 signaling R-HSA-418890	1	0	0/2	1	
SARS-CoV Infections R-HSA-9679506	0.686862809347477	0.874900452841704	7/260	1	NFKB1;RELA;SEC23A;MTA1;GATAD2A;STAT1;TYK2
SARS-CoV-1 Genome Replication and Transcription R-HSA-9679514	1	0	0/4	1	
SARS-CoV-1 Infection R-HSA-9678108	0.851265973802354	0.589223962578993	2/109	1	NFKB1;RELA
SARS-CoV-1 activates/modulates innate immune responses R-HSA-9692916	0.288362833393462	1.94697633481788	2/35	1	NFKB1;RELA
SARS-CoV-1 modulates host translation machinery R-HSA-9735869	1	0	0/33	1	
SARS-CoV-1 targets PDZ proteins in cell-cell junction R-HSA-9692912	1	0	0/0	1	
SARS-CoV-1 targets host intracellular signalling and regulatory pathways R-HSA-9735871	1	0	0/16	1	
SARS-CoV-1-host interactions R-HSA-9692914	0.743679454907314	0.7550604748929	2/86	1	NFKB1;RELA
SARS-CoV-1-mediated effects on programmed cell death R-HSA-9692913	1	0	0/3	1	
SARS-CoV-2 Genome Replication and Transcription R-HSA-9694682	1	0	0/4	1	
SARS-CoV-2 Infection R-HSA-9694516	0.918180379640963	0.528856299568394	3/180	1	SEC23A;STAT1;TYK2
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671	0.457858556659216	1.21575689007654	3/82	1	SEC23A;STAT1;TYK2
SARS-CoV-2 modulates autophagy R-HSA-9754560	1	0	0/2	1	
SARS-CoV-2 modulates host translation machinery R-HSA-9754678	1	0	0/42	1	
SARS-CoV-2 targets PDZ proteins in cell-cell junction R-HSA-9705677	1	0	0/1	1	
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779	1	0	0/12	1	
SARS-CoV-2-host interactions R-HSA-9705683	0.798876420157076	0.701155009897285	3/138	1	SEC23A;STAT1;TYK2
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577	0.835431229472101	0.555709308990429	1/58	1	CCNA2
SCF-beta-TrCP mediated degradation of Emi1 R-HSA-174113	1	0	0/52	1	
SDK interactions R-HSA-373756	1	0	0/0	1	
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion R-HSA-399955	1	0	0/5	1	
SHC-mediated cascade:FGFR1 R-HSA-5654688	0.194567694860967	5.34322317913915	1/7	1	FGF5
SHC-mediated cascade:FGFR2 R-HSA-5654699	0.242905995435717	4.00656868135255	1/9	1	FGF5
SHC-mediated cascade:FGFR3 R-HSA-5654704	0.194567694860967	5.34322317913915	1/7	1	FGF5
SHC-mediated cascade:FGFR4 R-HSA-5654719	1	0	0/7	1	
SHC-related events triggered by IGF1R R-HSA-2428933	1	0	0/7	1	
SHC1 events in EGFR signaling R-HSA-180336	1	0	0/13	1	
SHC1 events in ERBB2 signaling R-HSA-1250196	1	0	0/15	1	
SHC1 events in ERBB4 signaling R-HSA-1250347	1	0	0/9	1	
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840	1	0	0/5	1	
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs R-HSA-77588	1	0	0/8	1	
SLBP independent Processing of Histone Pre-mRNAs R-HSA-111367	1	0	0/7	1	
SLC transporter disorders R-HSA-5619102	1	0	0/37	1	
SLC-mediated transmembrane transport R-HSA-425407	0.903514884115055	0.426180939558451	1/75	1	SLC8B1
SLIT2:ROBO1 increases RHOA activity R-HSA-8985586	1	0	0/3	1	
SMAC (DIABLO) binds to IAPs  R-HSA-111463	1	0	0/2	1	
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  R-HSA-111464	1	0	0/2	1	
SMAC, XIAP-regulated apoptotic response R-HSA-111469	1	0	0/2	1	
SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3315487	1	0	0/3	1	
SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3304356	1	0	0/6	1	
SMAD4 MH2 Domain Mutants in Cancer R-HSA-3311021	1	0	0/3	1	
SOS-mediated signalling R-HSA-112412	1	0	0/7	1	
SRP-dependent cotranslational protein targeting to membrane R-HSA-1799339	1	0	0/94	1	
STAT5 Activation R-HSA-9645135	1	0	0/5	1	
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518	1	0	0/8	1	
STAT6-mediated induction of chemokines R-HSA-3249367	1	0	0/3	1	
STING mediated induction of host immune responses R-HSA-1834941	1	0	0/8	1	
SUMO E3 ligases SUMOylate target proteins R-HSA-3108232	0.325102151230855	1.35366807463641	5/124	1	RELA;PPARA;MTA1;NFKB2;TOP2A
SUMO is conjugated to E1 (UBA2:SAE1) R-HSA-3065676	1	0	0/4	1	
SUMO is proteolytically processed R-HSA-3065679	1	0	0/4	1	
SUMO is transferred from E1 to E2 (UBE2I, UBC9) R-HSA-3065678	1	0	0/5	1	
SUMOylation R-HSA-2990846	0.337283427099101	1.33061028004815	5/126	1	RELA;PPARA;MTA1;NFKB2;TOP2A
SUMOylation of DNA damage response and repair proteins R-HSA-3108214	1	0	0/44	1	
SUMOylation of DNA methylation proteins R-HSA-4655427	1	0	0/14	1	
SUMOylation of DNA replication proteins R-HSA-4615885	0.427170246365634	1.88200018344424	1/18	1	TOP2A
SUMOylation of RNA binding proteins R-HSA-4570464	1	0	0/24	1	
SUMOylation of SUMOylation proteins R-HSA-4085377	1	0	0/12	1	
SUMOylation of chromatin organization proteins R-HSA-4551638	1	0	0/45	1	
SUMOylation of intracellular receptors R-HSA-4090294	0.494053866191027	1.52202475174719	1/22	1	PPARA
SUMOylation of nuclear envelope proteins R-HSA-9793242	1	0	0/2	1	
SUMOylation of transcription cofactors R-HSA-3899300	1	0	0/35	1	
SUMOylation of transcription factors R-HSA-3232118	0.331116137121452	2.66887927516196	1/13	1	MTA1
SUMOylation of ubiquitinylation proteins R-HSA-3232142	1	0	0/15	1	
Scavenging by Class A Receptors R-HSA-3000480	1	0	0/11	1	
Scavenging by Class B Receptors R-HSA-3000471	1	0	0/5	1	
Scavenging by Class F Receptors R-HSA-3000484	1	0	0/3	1	
Scavenging by Class H Receptors R-HSA-3000497	1	0	0/2	1	
Scavenging of heme from plasma R-HSA-2168880	1	0	0/5	1	
Sealing of the nuclear envelope (NE) by ESCRT-III R-HSA-9668328	1	0	0/25	1	
Selective autophagy R-HSA-9663891	0.801413295252564	0.622041995126336	1/52	1	ULK1
Selenoamino acid metabolism R-HSA-2408522	1	0	0/95	1	
Selenocysteine synthesis R-HSA-2408557	1	0	0/83	1	
Sema3A PAK dependent Axon repulsion R-HSA-399954	1	0	0/10	1	
Sema4D in semaphorin signaling R-HSA-400685	0.390511083989948	2.13379931391034	1/16	1	ARHGEF11
Sema4D induced cell migration and growth-cone collapse R-HSA-416572	0.331116137121452	2.66887927516196	1/13	1	ARHGEF11
Sema4D mediated inhibition of cell attachment and migration R-HSA-416550	1	0	0/6	1	
Semaphorin interactions R-HSA-373755	0.719952191732563	0.795326054757542	1/41	1	ARHGEF11
Sensing of DNA Double Strand Breaks R-HSA-5693548	1	0	0/5	1	
Sensory perception of salty taste R-HSA-9730628	1	0	0/4	1	
Sensory perception of sour taste R-HSA-9729555	1	0	0/0	1	
Sensory perception of sweet, bitter, and umami (glutamate) taste R-HSA-9717207	1	0	0/3	1	
Sensory perception of taste R-HSA-9717189	1	0	0/7	1	
Serine biosynthesis R-HSA-977347	1	0	0/2	1	
Serotonin Neurotransmitter Release Cycle R-HSA-181429	0.143169804536155	8.01619116439233	1/5	1	VAMP2
Serotonin and melatonin biosynthesis R-HSA-209931	1	0	0/1	1	
Serotonin clearance from the synaptic cleft R-HSA-380615	1	0	0/1	1	
Serotonin receptors R-HSA-390666	1	0	0/0	1	
Severe congenital neutropenia type 4 (G6PC3) R-HSA-3282872	1	0	0/1	1	
Sialic acid metabolism R-HSA-4085001	1	0	0/11	1	
Signal amplification R-HSA-392518	0.427170246365634	1.88200018344424	1/18	1	GNB2
Signal attenuation R-HSA-74749	1	0	0/8	1	
Signal regulatory protein family interactions R-HSA-391160	1	0	0/10	1	
Signal transduction by L1 R-HSA-445144	1	0	0/14	1	
Signaling by ALK R-HSA-201556	0.153653508635811	3.06815879653561	2/23	1	HDAC3;STAT3
Signaling by ALK fusions and activated point mutants R-HSA-9725370	0.283240365097686	1.66481113755537	3/61	1	STAT1;STAT3;TYK2
Signaling by ALK in cancer R-HSA-9700206	0.283240365097686	1.66481113755537	3/61	1	STAT1;STAT3;TYK2
Signaling by AMER1 mutants R-HSA-4839748	1	0	0/10	1	
Signaling by APC mutants R-HSA-4839744	1	0	0/10	1	
Signaling by AXIN mutants R-HSA-4839735	1	0	0/10	1	
Signaling by Activin R-HSA-1502540	1	0	0/12	1	
Signaling by BMP R-HSA-201451	1	0	0/16	1	
Signaling by BRAF and RAF1 fusions R-HSA-6802952	1	0	0/35	1	
Signaling by CTNNB1 phospho-site mutants R-HSA-4839743	1	0	0/11	1	
Signaling by EGFR R-HSA-177929	0.322411215564087	1.78340811275239	2/38	1	CDC42;CBL
Signaling by EGFR in Cancer R-HSA-1643713	0.509526609716264	1.45249715242618	1/23	1	CBL
Signaling by EGFRvIII in Cancer R-HSA-5637812	0.331116137121452	2.66887927516196	1/13	1	CBL
Signaling by ERBB2 ECD mutants R-HSA-9665348	1	0	0/13	1	
Signaling by ERBB2 KD Mutants R-HSA-9664565	1	0	0/18	1	
Signaling by ERBB2 R-HSA-1227986	1	0	0/38	1	
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686	1	0	0/15	1	
Signaling by ERBB2 in Cancer R-HSA-1227990	1	0	0/18	1	
Signaling by ERBB4 R-HSA-1236394	0.692480154387814	0.86046333162253	1/38	1	STMN1
Signaling by Erythropoietin R-HSA-9006335	1	0	0/19	1	
Signaling by FGFR R-HSA-190236	0.452804580184052	1.33356733080554	2/50	1	FGF5;CBL
Signaling by FGFR in disease R-HSA-1226099	0.148451146416024	2.36508367547374	3/44	1	FGF5;STAT1;STAT3
Signaling by FGFR1 R-HSA-5654736	0.208771518080006	2.47520065853483	2/28	1	FGF5;CBL
Signaling by FGFR1 amplification mutants R-HSA-1839120	1	0	0/0	1	
Signaling by FGFR2 IIIa TM R-HSA-8851708	1	0	0/17	1	
Signaling by FGFR2 R-HSA-5654738	0.410722559200386	1.45623842332562	2/46	1	FGF5;CBL
Signaling by FGFR2 amplification mutants R-HSA-2023837	1	0	0/1	1	
Signaling by FGFR2 fusions R-HSA-8853333	1	0	0/1	1	
Signaling by FGFR2 in disease R-HSA-5655253	0.580124869365433	1.18209488026364	1/28	1	FGF5
Signaling by FGFR3 R-HSA-5654741	0.175378720698121	2.80010201131709	2/25	1	FGF5;CBL
Signaling by FGFR3 fusions in cancer R-HSA-8853334	1	0	0/0	1	
Signaling by FGFR3 in disease R-HSA-5655332	0.288365431745851	3.20406387724278	1/11	1	FGF5
Signaling by FGFR4 R-HSA-5654743	0.539077864968528	1.3308330535302	1/25	1	CBL
Signaling by FGFR4 in disease R-HSA-5655291	1	0	0/10	1	
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648	1	0	0/14	1	
Signaling by FLT3 fusion proteins R-HSA-9703465	1	0	0/15	1	
Signaling by GSK3beta mutants R-HSA-5339716	1	0	0/11	1	
Signaling by Hedgehog R-HSA-5358351	1	0	0/110	1	
Signaling by Hippo R-HSA-2028269	1	0	0/11	1	
Signaling by Insulin receptor R-HSA-74752	0.744988208498203	0.739275965658045	1/44	1	FGF5
Signaling by KIT in disease R-HSA-9669938	0.122235265192212	3.58184073123517	2/20	1	STAT1;STAT3
Signaling by LRP5 mutants  R-HSA-5339717	1	0	0/2	1	
Signaling by LTK R-HSA-9842663	1	0	0/9	1	
Signaling by LTK in cancer R-HSA-9842640	1	0	0/7	1	
Signaling by Leptin R-HSA-2586552	0.242905995435717	4.00656868135255	1/9	1	STAT3
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815	0.409122587631764	2.00003463165419	1/17	1	CBL
Signaling by MAP2K mutants R-HSA-9652169	1	0	0/2	1	
Signaling by MAPK mutants R-HSA-9652817	1	0	0/2	1	
Signaling by MET R-HSA-6806834	0.431967430264998	1.39223098909235	2/48	1	STAT3;CBL
Signaling by MRAS-complex mutants R-HSA-9660537	1	0	0/5	1	
Signaling by MST1 R-HSA-8852405	1	0	0/1	1	
Signaling by NODAL R-HSA-1181150	1	0	0/12	1	
Signaling by NOTCH1 HD Domain Mutants in Cancer R-HSA-2691230	1	0	0/9	1	
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer R-HSA-2894858	0.788591033174282	0.647762265480832	1/50	1	HDAC3
Signaling by NOTCH1 PEST Domain Mutants in Cancer R-HSA-2644602	0.788591033174282	0.647762265480832	1/50	1	HDAC3
Signaling by NOTCH1 R-HSA-1980143	0.835431229472101	0.555709308990429	1/58	1	HDAC3
Signaling by NOTCH1 in Cancer R-HSA-2644603	0.788591033174282	0.647762265480832	1/50	1	HDAC3
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660825	1	0	0/4	1	
Signaling by NOTCH2 R-HSA-1980145	1	0	0/24	1	
Signaling by NOTCH3 R-HSA-9012852	0.701922226532172	0.837608397236777	1/39	1	STAT1
Signaling by NOTCH4 R-HSA-9013694	1	0	0/77	1	
Signaling by NTRK1 (TRKA) R-HSA-187037	0.931785374568091	0.369972765185837	1/86	1	STAT3
Signaling by NTRK2 (TRKB) R-HSA-9006115	1	0	0/17	1	
Signaling by NTRK3 (TRKC) R-HSA-9034015	1	0	0/11	1	
Signaling by NTRKs R-HSA-166520	0.947022011974364	0.337444923312185	1/94	1	STAT3
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927	0.120552272828728	2.62332940435544	3/40	1	STAT3;CBL;ARAP1
Signaling by Nuclear Receptors R-HSA-9006931	0.320626067065454	1.26091568304033	8/213	1	GNB2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3
Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-5638302	1	0	0/8	1	
Signaling by PDGF R-HSA-186797	0.431967430264998	1.39223098909235	2/48	1	STAT1;STAT3
Signaling by PTK6 R-HSA-8848021	0.120552272828728	2.62332940435544	3/40	1	STAT3;CBL;ARAP1
Signaling by RAF1 mutants R-HSA-9656223	1	0	0/24	1	
Signaling by RAS GAP mutants R-HSA-9753510	1	0	0/3	1	
Signaling by RAS GTPase mutants R-HSA-9753512	1	0	0/3	1	
Signaling by RAS mutants R-HSA-6802949	1	0	0/27	1	
Signaling by RNF43 mutants R-HSA-5340588	1	0	0/5	1	
Signaling by ROBO receptors R-HSA-376176	0.969272917994759	0.369304689367042	2/170	1	CDC42;PFN1
Signaling by Receptor Tyrosine Kinases R-HSA-9006934	0.880725986612059	0.679129823974325	7/327	1	FGF5;HDAC3;CDC42;STAT1;STAT3;CBL;STMN1
Signaling by Retinoic Acid R-HSA-5362517	1	0	0/15	1	
Signaling by TCF7L2 mutants R-HSA-5339700	1	0	0/3	1	
Signaling by TGF-beta Receptor Complex R-HSA-170834	0.12393863316231	1.9833158630039	5/87	1	TFDP1;STAT1;CBL;E2F5;E2F4
Signaling by TGF-beta Receptor Complex in Cancer R-HSA-3304351	1	0	0/8	1	
Signaling by TGFB family members R-HSA-9006936	0.181839014717417	1.72481534050855	5/99	1	TFDP1;STAT1;CBL;E2F5;E2F4
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192	0.566862249676667	1.22786129710518	1/27	1	FGF5
Signaling by VEGF R-HSA-194138	0.906504974630008	0.420389867605124	1/76	1	CDC42
Signaling by WNT R-HSA-195721	0.376743141457003	1.18736210263197	8/225	1	GNB2;H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;PFN1
Signaling by WNT in cancer R-HSA-4791275	1	0	0/21	1	
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins R-HSA-9673766	1	0	0/0	1	
Signaling by extracellular domain mutants of KIT R-HSA-9680187	1	0	0/1	1	
Signaling by high-kinase activity BRAF mutants R-HSA-6802948	1	0	0/19	1	
Signaling by juxtamembrane domain KIT mutants R-HSA-9669935	1	0	0/1	1	
Signaling by kinase domain mutants of KIT R-HSA-9669933	1	0	0/1	1	
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB R-HSA-9673768	1	0	0/2	1	
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946	1	0	0/27	1	
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439	0.122235265192212	3.58184073123517	2/20	1	STAT1;STAT3
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336	1	0	0/1	1	
Signaling by the B Cell Receptor (BCR) R-HSA-983705	0.32722505696734	1.41455984567472	4/95	1	REL;NFKBIE;NFKB1;RELA
Signaling downstream of RAS mutants R-HSA-9649948	1	0	0/27	1	
Signalling to ERK5 R-HSA-198765	1	0	0/2	1	
Signalling to ERKs R-HSA-187687	1	0	0/21	1	
Signalling to RAS R-HSA-167044	1	0	0/13	1	
Signalling to p38 via RIT and RIN R-HSA-187706	1	0	0/3	1	
Small interfering RNA (siRNA) biogenesis R-HSA-426486	1	0	0/3	1	
Smooth Muscle Contraction R-HSA-445355	0.509526609716264	1.45249715242618	1/23	1	ANXA1
Sodium-coupled phosphate cotransporters R-HSA-427652	1	0	0/2	1	
Sodium-coupled sulphate, di- and tri-carboxylate transporters R-HSA-433137	1	0	0/2	1	
Sodium/Calcium exchangers R-HSA-425561	0.194567694860967	5.34322317913915	1/7	1	SLC8B1
Sodium/Proton exchangers R-HSA-425986	1	0	0/5	1	
Somitogenesis R-HSA-9824272	1	0	0/47	1	
Sorafenib-resistant KIT mutants R-HSA-9669936	1	0	0/1	1	
Sorafenib-resistant PDGFR mutants R-HSA-9674404	1	0	0/1	1	
Specification of primordial germ cells R-HSA-9827857	1	0	0/5	1	
Specification of the neural plate border R-HSA-9834899	1	0	0/9	1	
Sperm Motility And Taxes R-HSA-1300642	1	0	0/0	1	
Sphingolipid catabolism R-HSA-9845614	1	0	0/6	1	
Sphingolipid de novo biosynthesis R-HSA-1660661	1	0	0/14	1	
Sphingolipid metabolism R-HSA-428157	1	0	0/39	1	
Spry regulation of FGF signaling R-HSA-1295596	0.371318268662442	2.28665514754916	1/15	1	CBL
Stabilization of p53 R-HSA-69541	1	0	0/56	1	
Sterols are 12-hydroxylated by CYP8B1 R-HSA-211994	1	0	0/0	1	
Stimulation of the cell death response by PAK-2p34 R-HSA-211736	1	0	0/1	1	
Stimuli-sensing channels R-HSA-2672351	0.728557208074531	0.775731488317379	1/42	1	TRPV1
Striated Muscle Contraction R-HSA-390522	1	0	0/28	1	
Sulfide oxidation to sulfate R-HSA-1614517	1	0	0/3	1	
Sulfur amino acid metabolism R-HSA-1614635	1	0	0/14	1	
Sunitinib-resistant KIT mutants R-HSA-9669934	1	0	0/1	1	
Sunitinib-resistant PDGFR mutants R-HSA-9674401	1	0	0/1	1	
Suppression of apoptosis R-HSA-9635465	1	0	0/3	1	
Suppression of autophagy R-HSA-9636569	1	0	0/1	1	
Suppression of phagosomal maturation R-HSA-9637687	1	0	0/8	1	
Surfactant metabolism R-HSA-5683826	1	0	0/7	1	
Synaptic adhesion-like molecules R-HSA-8849932	1	0	0/4	1	
Syndecan interactions R-HSA-3000170	1	0	0/15	1	
Synthesis And Processing Of GAG, GAGPOL Polyproteins R-HSA-174495	1	0	0/7	1	
Synthesis and processing of ENV and VPU R-HSA-171286	1	0	0/1	1	
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) R-HSA-2142816	1	0	0/3	1	
Synthesis of 12-eicosatetraenoic acid derivatives R-HSA-2142712	1	0	0/3	1	
Synthesis of 15-eicosatetraenoic acid derivatives R-HSA-2142770	1	0	0/4	1	
Synthesis of 5-eicosatetraenoic acids R-HSA-2142688	1	0	0/5	1	
Synthesis of CL R-HSA-1483076	1	0	0/1	1	
Synthesis of Dolichyl-phosphate R-HSA-446199	1	0	0/1	1	
Synthesis of GDP-mannose R-HSA-446205	1	0	0/2	1	
Synthesis of Hepoxilins (HX) and Trioxilins (TrX) R-HSA-2142696	1	0	0/0	1	
Synthesis of IP2, IP, and Ins in the cytosol R-HSA-1855183	1	0	0/6	1	
Synthesis of IPs in the ER lumen R-HSA-1855231	1	0	0/1	1	
Synthesis of IPs in the nucleus R-HSA-1855191	1	0	0/0	1	
Synthesis of Leukotrienes (LT) and Eoxins (EX) R-HSA-2142691	1	0	0/10	1	
Synthesis of Lipoxins (LX) R-HSA-2142700	1	0	0/2	1	
Synthesis of PA R-HSA-1483166	0.331116137121452	2.66887927516196	1/13	1	LPCAT1
Synthesis of PC R-HSA-1483191	0.242905995435717	4.00656868135255	1/9	1	LPCAT1
Synthesis of PE R-HSA-1483213	1	0	0/3	1	
Synthesis of PG R-HSA-1483148	1	0	0/3	1	
Synthesis of PI R-HSA-1483226	1	0	0/3	1	
Synthesis of PIPs at the ER membrane R-HSA-1483248	1	0	0/4	1	
Synthesis of PIPs at the Golgi membrane R-HSA-1660514	0.288365431745851	3.20406387724278	1/11	1	PI4K2A
Synthesis of PIPs at the early endosome membrane R-HSA-1660516	0.265984697433587	3.56074569329776	1/10	1	PI4K2A
Synthesis of PIPs at the late endosome membrane R-HSA-1660517	1	0	0/9	1	
Synthesis of PIPs in the nucleus R-HSA-8847453	1	0	0/2	1	
Synthesis of PS R-HSA-1483101	1	0	0/2	1	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) R-HSA-2162123	1	0	0/4	1	
Synthesis of UDP-N-acetyl-glucosamine R-HSA-446210	1	0	0/1	1	
Synthesis of active ubiquitin: roles of E1 and E2 enzymes R-HSA-8866652	1	0	0/19	1	
Synthesis of bile acids and bile salts R-HSA-192105	1	0	0/10	1	
Synthesis of bile acids and bile salts via 24-hydroxycholesterol R-HSA-193775	1	0	0/2	1	
Synthesis of bile acids and bile salts via 27-hydroxycholesterol R-HSA-193807	1	0	0/5	1	
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol R-HSA-193368	1	0	0/9	1	
Synthesis of diphthamide-EEF2 R-HSA-5358493	1	0	0/4	1	
Synthesis of dolichyl-phosphate mannose R-HSA-162699	1	0	0/2	1	
Synthesis of dolichyl-phosphate-glucose R-HSA-480985	1	0	0/1	1	
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) R-HSA-2142670	1	0	0/2	1	
Synthesis of glycosylphosphatidylinositol (GPI) R-HSA-162710	1	0	0/8	1	
Synthesis of pyrophosphates in the cytosol R-HSA-1855167	1	0	0/2	1	
Synthesis of substrates in N-glycan biosythesis R-HSA-446219	1	0	0/19	1	
Synthesis of very long-chain fatty acyl-CoAs R-HSA-75876	1	0	0/8	1	
Synthesis of wybutosine at G37 of tRNA(Phe) R-HSA-6782861	1	0	0/1	1	
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771	0.265984697433587	3.56074569329776	1/10	1	DPP4
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511	0.194567694860967	5.34322317913915	1/7	1	DPP4
TAK1-dependent IKK and NF-kappa-B activation   R-HSA-445989	0.107418784437921	2.77455680257967	3/38	1	NFKB1;RELA;NFKB2
TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P R-HSA-6791462	1	0	0/1	1	
TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P R-HSA-6791055	1	0	0/1	1	
TCF dependent signaling in response to WNT R-HSA-201681	0.43696656036464	1.14556273206696	6/174	1	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14
TCR signaling R-HSA-202403	0.383224968421761	1.29758693629234	4/103	1	NFKB1;RELA;INPP5D;CD3D
TET1,2,3 and TDG demethylate DNA R-HSA-5221030	1	0	0/1	1	
TFAP2 (AP-2) family regulates transcription of cell cycle factors R-HSA-8866911	1	0	0/4	1	
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-8866910	1	0	0/9	1	
TFAP2 (AP-2) family regulates transcription of other transcription factors R-HSA-8866906	1	0	0/3	1	
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation R-HSA-8869496	1	0	0/4	1	
TGF-beta receptor signaling activates SMADs R-HSA-2173789	0.719952191732563	0.795326054757542	1/41	1	CBL
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) R-HSA-2173791	1	0	0/15	1	
TGFBR1 KD Mutants in Cancer R-HSA-3656532	1	0	0/6	1	
TGFBR1 LBD Mutants in Cancer R-HSA-3656535	1	0	0/4	1	
TGFBR2 Kinase Domain Mutants in Cancer R-HSA-3645790	1	0	0/3	1	
TGFBR2 MSI Frameshift Mutants in Cancer R-HSA-3642279	1	0	0/2	1	
TICAM1 deficiency - HSE R-HSA-5602566	1	0	0/2	1	
TICAM1, RIP1-mediated IKK complex recruitment R-HSA-168927	1	0	0/19	1	
TICAM1,TRAF6-dependent induction of TAK1 complex R-HSA-9014325	1	0	0/10	1	
TICAM1-dependent activation of IRF3/IRF7 R-HSA-9013973	1	0	0/12	1	
TLR3 deficiency - HSE R-HSA-5602410	1	0	0/1	1	
TLR3-mediated TICAM1-dependent programmed cell death R-HSA-9013957	1	0	0/6	1	
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway R-HSA-5676594	1	0	0/9	1	
TNF signaling R-HSA-75893	0.711076675005716	0.815925259643117	1/40	1	ULK1
TNFR1-induced NF-kappa-B signaling pathway R-HSA-5357956	1	0	0/22	1	
TNFR1-induced proapoptotic signaling R-HSA-5357786	1	0	0/14	1	
TNFR1-mediated ceramide production R-HSA-5626978	1	0	0/5	1	
TNFR2 non-canonical NF-kB pathway R-HSA-5668541	0.650052482368673	0.909346948967421	2/72	1	RELB;NFKB2
TNFs bind their physiological receptors R-HSA-5669034	1	0	0/7	1	
TP53 Regulates Metabolic Genes R-HSA-5628897	1	0	0/59	1	
TP53 Regulates Transcription of Caspase Activators and Caspases R-HSA-6803207	1	0	0/9	1	
TP53 Regulates Transcription of Cell Death Genes R-HSA-5633008	1	0	0/25	1	
TP53 Regulates Transcription of DNA Repair Genes R-HSA-6796648	1	0	0/38	1	
TP53 Regulates Transcription of Death Receptors and Ligands R-HSA-6803211	1	0	0/6	1	
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release R-HSA-6803204	1	0	0/13	1	
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain R-HSA-6804115	1	0	0/14	1	
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain R-HSA-6803205	1	0	0/6	1	
TRAF3 deficiency - HSE R-HSA-5602571	1	0	0/3	1	
TRAF3-dependent IRF activation pathway R-HSA-918233	1	0	0/13	1	
TRAF6 mediated IRF7 activation R-HSA-933541	1	0	0/27	1	
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling R-HSA-975110	1	0	0/12	1	
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-975138	0.441743712164616	1.24797446783809	3/80	1	NFKB1;RELA;NFKB2
TRAF6-mediated induction of TAK1 complex within TLR4 complex R-HSA-937072	1	0	0/12	1	
TRAIL  signaling R-HSA-75158	1	0	0/5	1	
TRIF (TICAM1)-mediated TLR4 signaling  R-HSA-937061	0.520215582325284	1.10169051219261	3/90	1	NFKB1;RELA;NFKB2
TRIF-mediated programmed cell death R-HSA-2562578	1	0	0/7	1	
TRKA activation by NGF R-HSA-187042	1	0	0/1	1	
TRP channels R-HSA-3295583	0.219107742800551	4.57941075774204	1/8	1	TRPV1
TWIK related potassium channel (TREK) R-HSA-1299503	1	0	0/0	1	
TWIK-related alkaline pH activated K+ channel (TALK) R-HSA-1299361	1	0	0/0	1	
TWIK-related spinal cord K+ channel (TRESK) R-HSA-1299344	1	0	0/0	1	
TWIK-releated acid-sensitive K+ channel (TASK) R-HSA-1299316	1	0	0/1	1	
TYSND1 cleaves peroxisomal proteins R-HSA-9033500	1	0	0/2	1	
Tachykinin receptors bind tachykinins R-HSA-380095	1	0	0/1	1	
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) R-HSA-1299308	1	0	0/1	1	
Tandem pore domain halothane-inhibited K+ channel (THIK) R-HSA-1299287	1	0	0/1	1	
Tandem pore domain potassium channels R-HSA-1296346	1	0	0/3	1	
Tat-mediated HIV elongation arrest and recovery R-HSA-167243	1	0	0/22	1	
Tat-mediated elongation of the HIV-1 transcript R-HSA-167246	1	0	0/26	1	
Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417	1	0	0/10	1	
Telomere C-strand synthesis initiation R-HSA-174430	1	0	0/2	1	
Telomere Extension By Telomerase R-HSA-171319	0.194567694860967	5.34322317913915	1/7	1	CCNA2
Terminal pathway of complement R-HSA-166665	1	0	0/4	1	
Termination of O-glycan biosynthesis R-HSA-977068	1	0	0/11	1	
Termination of translesion DNA synthesis R-HSA-5656169	1	0	0/17	1	
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151	1	0	0/5	1	
The AIM2 inflammasome R-HSA-844615	1	0	0/2	1	
The IPAF inflammasome R-HSA-844623	1	0	0/2	1	
The NLRP1 inflammasome R-HSA-844455	1	0	0/2	1	
The activation of arylsulfatases R-HSA-1663150	1	0	0/1	1	
The canonical retinoid cycle in rods (twilight vision) R-HSA-2453902	1	0	0/4	1	
The fatty acid cycling model R-HSA-167826	1	0	0/0	1	
The phototransduction cascade R-HSA-2514856	1	0	0/10	1	
The proton buffering model R-HSA-167827	1	0	0/0	1	
The retinoid cycle in cones (daylight vision) R-HSA-2187335	1	0	0/1	1	
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276	0.672146234767872	0.871304971093496	2/75	1	CDK1;MAPRE1
Threonine catabolism R-HSA-8849175	1	0	0/3	1	
Thrombin signalling through proteinase activated receptors (PARs) R-HSA-456926	0.409122587631764	2.00003463165419	1/17	1	GNB2
Thromboxane signalling through TP receptor R-HSA-428930	0.310069139133716	2.91223689743989	1/12	1	GNB2
Thyroxine biosynthesis R-HSA-209968	1	0	0/3	1	
Tie2 Signaling R-HSA-210993	1	0	0/15	1	
Tight junction interactions R-HSA-420029	1	0	0/6	1	
Toll Like Receptor 10 (TLR10) Cascade R-HSA-168142	0.400733011495214	1.33634717218537	3/75	1	NFKB1;RELA;NFKB2
Toll Like Receptor 2 (TLR2) Cascade R-HSA-181438	0.512624717606068	1.11479344598442	3/89	1	NFKB1;RELA;NFKB2
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164	0.504972247931686	1.12819892816965	3/88	1	NFKB1;RELA;NFKB2
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016	0.657392831053544	0.89114433515197	3/110	1	NFKB1;RELA;NFKB2
Toll Like Receptor 5 (TLR5) Cascade R-HSA-168176	0.400733011495214	1.33634717218537	3/75	1	NFKB1;RELA;NFKB2
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181	0.449824286144108	1.23165920141758	3/81	1	NFKB1;RELA;NFKB2
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138	0.46584426059713	1.20025205011157	3/83	1	NFKB1;RELA;NFKB2
Toll Like Receptor TLR1:TLR2 Cascade R-HSA-168179	0.512624717606068	1.11479344598442	3/89	1	NFKB1;RELA;NFKB2
Toll Like Receptor TLR6:TLR2 Cascade R-HSA-168188	0.512624717606068	1.11479344598442	3/89	1	NFKB1;RELA;NFKB2
Toll-like Receptor Cascades R-HSA-168898	0.703818225828018	0.827423820702957	3/118	1	NFKB1;RELA;NFKB2
Toxicity of botulinum toxin type A (botA) R-HSA-5250968	1	0	0/0	1	
Toxicity of botulinum toxin type C (botC) R-HSA-5250971	1	0	0/0	1	
Toxicity of botulinum toxin type E (botE) R-HSA-5250992	1	0	0/0	1	
Trafficking and processing of endosomal TLR R-HSA-1679131	1	0	0/4	1	
Trafficking of AMPA receptors R-HSA-399719	1	0	0/14	1	
Trafficking of GluR2-containing AMPA receptors R-HSA-416993	1	0	0/7	1	
Trafficking of myristoylated proteins to the cilium R-HSA-5624138	1	0	0/0	1	
Transcription from mitochondrial promoters R-HSA-75944	1	0	0/2	1	
Transcription of the HIV genome R-HSA-167172	1	0	0/41	1	
Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827	1	0	0/42	1	
Transcriptional  activation of  cell cycle inhibitor p21  R-HSA-69895	1	0	0/2	1	
Transcriptional Regulation by MECP2 R-HSA-8986944	0.640631955377151	0.996158732799185	1/33	1	HDAC3
Transcriptional Regulation by NPAS4 R-HSA-9634815	1	0	0/17	1	
Transcriptional Regulation by TP53 R-HSA-3700989	0.546712266507708	1.01029636031951	7/228	1	CDK1;CCNA2;TFDP1;E2F1;GATAD2A;E2F4;EHMT2
Transcriptional activation of p53 responsive genes   R-HSA-69560	1	0	0/2	1	
Transcriptional and post-translational regulation of MITF-M expression and activity R-HSA-9856649	1	0	0/21	1	
Transcriptional regulation by RUNX1 R-HSA-8878171	0.223716962837785	1.42079841331958	8/191	1	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;GP1BA;SPI1
Transcriptional regulation by RUNX2 R-HSA-8878166	0.606043295216879	0.965159709051968	3/102	1	CDK1;HDAC3;STAT1
Transcriptional regulation by RUNX3 R-HSA-8878159	1	0	0/92	1	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-8864260	1	0	0/21	1	
Transcriptional regulation of pluripotent stem cells R-HSA-452723	0.331116137121452	2.66887927516196	1/13	1	STAT3
Transcriptional regulation of testis differentiation R-HSA-9690406	1	0	0/7	1	
Transfer of LPS from LBP carrier to CD14 R-HSA-166020	1	0	0/0	1	
Transferrin endocytosis and recycling R-HSA-917977	1	0	0/15	1	
Translation R-HSA-72766	1	0	0/181	1	
Translation initiation complex formation R-HSA-72649	1	0	0/48	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9679504	1	0	0/5	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9694676	1	0	0/5	1	
Translation of Structural Proteins R-HSA-9683701	1	0	0/18	1	
Translation of Structural Proteins R-HSA-9694635	1	0	0/29	1	
Translesion Synthesis by POLH R-HSA-110320	1	0	0/10	1	
Translesion synthesis by POLI R-HSA-5656121	1	0	0/10	1	
Translesion synthesis by POLK R-HSA-5655862	1	0	0/10	1	
Translesion synthesis by REV1 R-HSA-110312	1	0	0/10	1	
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template R-HSA-110313	1	0	0/21	1	
Translocation of SLC2A4 (GLUT4) to the plasma membrane R-HSA-1445148	0.767802599587768	0.690535483996664	1/47	1	VAMP2
Translocation of ZAP-70 to Immunological synapse R-HSA-202430	0.390511083989948	2.13379931391034	1/16	1	CD3D
Transmission across Chemical Synapses R-HSA-112315	0.86180260288271	0.572705054766485	2/112	1	GNB2;VAMP2
Transmission across Electrical Synapses  R-HSA-112307	1	0	0/1	1	
Transport and synthesis of PAPS R-HSA-174362	1	0	0/5	1	
Transport of Mature Transcript to Cytoplasm R-HSA-72202	1	0	0/32	1	
Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159231	1	0	0/15	1	
Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159236	1	0	0/27	1	
Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-159234	1	0	0/16	1	
Transport of RCbl within the body R-HSA-9758890	1	0	0/3	1	
Transport of Ribonucleoproteins into the Host Nucleus R-HSA-168271	1	0	0/11	1	
Transport of bile salts and organic acids, metal ions and amine compounds R-HSA-425366	1	0	0/15	1	
Transport of connexins along the secretory pathway R-HSA-190827	1	0	0/2	1	
Transport of connexons to the plasma membrane R-HSA-190872	1	0	0/20	1	
Transport of fatty acids R-HSA-804914	1	0	0/4	1	
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159763	1	0	0/2	1	
Transport of glycerol from adipocytes to the liver by Aquaporins R-HSA-432030	1	0	0/1	1	
Transport of inorganic cations/anions and amino acids/oligopeptides R-HSA-425393	0.711076675005716	0.815925259643117	1/40	1	SLC8B1
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane R-HSA-83936	1	0	0/3	1	
Transport of nucleotide sugars R-HSA-727802	1	0	0/4	1	
Transport of organic anions R-HSA-879518	1	0	0/5	1	
Transport of small molecules R-HSA-382551	0.996787967886109	0.295398665927077	3/309	1	GNB2;TRPV1;SLC8B1
Transport of the SLBP Dependant Mature mRNA R-HSA-159230	1	0	0/13	1	
Transport of the SLBP independent Mature mRNA R-HSA-159227	1	0	0/12	1	
Transport of vitamins, nucleosides, and related molecules R-HSA-425397	1	0	0/17	1	
Triglyceride biosynthesis R-HSA-75109	1	0	0/6	1	
Triglyceride catabolism R-HSA-163560	1	0	0/14	1	
Triglyceride metabolism R-HSA-8979227	1	0	0/20	1	
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA R-HSA-450513	1	0	0/14	1	
Truncations of AMER1 destabilize the destruction complex R-HSA-5467348	1	0	0/10	1	
Tryptophan catabolism R-HSA-71240	1	0	0/5	1	
Type I hemidesmosome assembly R-HSA-446107	1	0	0/6	1	
Type II Na+/Pi cotransporters R-HSA-427589	1	0	0/1	1	
Tyrosine catabolism R-HSA-8963684	1	0	0/1	1	
UCH proteinases R-HSA-5689603	0.225090154250366	1.70028433027889	4/80	1	H2AC8;H2AC12;HCFC1;H2AC13
UNC93B1 deficiency - HSE R-HSA-5602415	1	0	0/1	1	
Ubiquinol biosynthesis R-HSA-2142789	1	0	0/1	1	
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A R-HSA-69601	1	0	0/50	1	
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815	1	0	0/51	1	
Unblocking of NMDA receptors, glutamate binding and activation R-HSA-438066	1	0	0/11	1	
Uncoating of the HIV Virion R-HSA-162585	1	0	0/1	1	
Unfolded Protein Response (UPR) R-HSA-381119	0.830192627304675	0.565777798120714	1/57	1	CXCL8
Uptake and actions of bacterial toxins R-HSA-5339562	0.390511083989948	2.13379931391034	1/16	1	VAMP2
Uptake and function of anthrax toxins R-HSA-5210891	1	0	0/8	1	
Uptake and function of diphtheria toxin R-HSA-5336415	1	0	0/5	1	
Uptake of dietary cobalamins into enterocytes R-HSA-9758881	1	0	0/2	1	
Urea cycle R-HSA-70635	1	0	0/4	1	
Utilization of Ketone Bodies R-HSA-77108	1	0	0/0	1	
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399	1	0	0/4	1	
VEGF ligand-receptor interactions R-HSA-194313	1	0	0/4	1	
VEGFA-VEGFR2 Pathway R-HSA-4420097	0.897247246898852	0.438245618834123	1/73	1	CDC42
VEGFR2 mediated cell proliferation R-HSA-5218921	1	0	0/17	1	
VEGFR2 mediated vascular permeability R-HSA-5218920	1	0	0/21	1	
VLDL assembly R-HSA-8866423	1	0	0/3	1	
VLDL clearance R-HSA-8964046	1	0	0/4	1	
VLDLR internalisation and degradation R-HSA-8866427	1	0	0/12	1	
Variant SLC6A14 may confer susceptibility towards obesity R-HSA-5619094	1	0	0/0	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5619101	1	0	0/1	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5660686	1	0	0/1	1	
Vasopressin regulates renal water homeostasis via Aquaporins R-HSA-432040	0.444671006349992	1.77698744688802	1/19	1	GNB2
Vasopressin-like receptors R-HSA-388479	1	0	0/1	1	
Vif-mediated degradation of APOBEC3G R-HSA-180585	1	0	0/53	1	
Viral Infection Pathways R-HSA-9824446	0.193047494727053	1.27254128400689	21/567	1	H2BC13;H2BC17;H3C1;H2BC12;H2AC8;H2BC14;HDAC3;NFKB1;RELA;AP1M1;SEC23A;AP1S1;CD8B;MTA1;CEBPD;GATAD2A;STAT1;CCR5;H2AC12;H2AC13;TYK2
Viral Messenger RNA Synthesis R-HSA-168325	1	0	0/23	1	
Viral RNP Complexes in the Host Cell Nucleus R-HSA-168330	1	0	0/1	1	
Viral mRNA Translation R-HSA-192823	1	0	0/81	1	
Virus Assembly and Release R-HSA-168268	1	0	0/2	1	
Visual phototransduction R-HSA-2187338	1	0	0/26	1	
Vitamin B1 (thiamin) metabolism R-HSA-196819	1	0	0/0	1	
Vitamin B2 (riboflavin) metabolism R-HSA-196843	1	0	0/3	1	
Vitamin B5 (pantothenate) metabolism R-HSA-199220	1	0	0/5	1	
Vitamin B6 activation to pyridoxal phosphate R-HSA-964975	1	0	0/0	1	
Vitamin C (ascorbate) metabolism R-HSA-196836	1	0	0/2	1	
Vitamin D (calciferol) metabolism R-HSA-196791	1	0	0/3	1	
Vitamin E R-HSA-8877627	1	0	0/0	1	
Vitamins R-HSA-211916	1	0	0/0	1	
Voltage gated Potassium channels R-HSA-1296072	1	0	0/7	1	
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization R-HSA-180897	1	0	0/1	1	
Vpr-mediated nuclear import of PICs R-HSA-180910	1	0	0/13	1	
Vpu mediated degradation of CD4 R-HSA-180534	1	0	0/51	1	
VxPx cargo-targeting to cilium R-HSA-5620916	1	0	0/10	1	
WNT ligand biogenesis and trafficking R-HSA-3238698	1	0	0/9	1	
WNT mediated activation of DVL R-HSA-201688	1	0	0/5	1	
WNT5:FZD7-mediated leishmania damping R-HSA-9673324	1	0	0/6	1	
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 R-HSA-5140745	1	0	0/9	1	
WNT5A-dependent internalization of FZD4 R-HSA-5099900	1	0	0/8	1	
Wax and plasmalogen biosynthesis R-HSA-8848584	1	0	0/1	1	
Wax biosynthesis R-HSA-9640463	1	0	0/1	1	
XAV939 stabilizes AXIN R-HSA-5545619	1	0	0/1	1	
XBP1(S) activates chaperone genes R-HSA-381038	1	0	0/22	1	
Xenobiotics R-HSA-211981	1	0	0/7	1	
YAP1- and WWTR1 (TAZ)-stimulated gene expression R-HSA-2032785	1	0	0/10	1	
Z-decay: degradation of maternal mRNAs by zygotically expressed factors R-HSA-9820865	1	0	0/9	1	
Zinc efflux and compartmentalization by the SLC30 family R-HSA-435368	1	0	0/0	1	
Zinc influx into cells by the SLC39 gene family R-HSA-442380	1	0	0/0	1	
Zinc transporters R-HSA-435354	1	0	0/0	1	
Zygotic genome activation (ZGA) R-HSA-9819196	1	0	0/8	1	
activated TAK1 mediates p38 MAPK activation R-HSA-450302	1	0	0/22	1	
alectinib-resistant ALK mutants R-HSA-9717316	1	0	0/0	1	
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism R-HSA-2046104	1	0	0/5	1	
alpha-linolenic acid (ALA) metabolism R-HSA-2046106	1	0	0/5	1	
betaKlotho-mediated ligand binding R-HSA-1307965	1	0	0/1	1	
brigatinib-resistant ALK mutants R-HSA-9717319	1	0	0/0	1	
cGMP effects R-HSA-418457	1	0	0/5	1	
ceritinib-resistant ALK mutants R-HSA-9717323	1	0	0/0	1	
crenolanib-resistant FLT3 mutants R-HSA-9702581	1	0	0/0	1	
crizotinib-resistant ALK mutants R-HSA-9717326	1	0	0/0	1	
eNOS activation R-HSA-203615	1	0	0/6	1	
gilteritinib-resistant FLT3 mutants R-HSA-9702590	1	0	0/0	1	
lestaurtinib-resistant FLT3 mutants R-HSA-9702596	1	0	0/0	1	
linifanib-resistant FLT3 mutants R-HSA-9702998	1	0	0/0	1	
lorlatinib-resistant ALK mutants R-HSA-9717329	1	0	0/0	1	
mRNA 3'-end processing R-HSA-72187	1	0	0/23	1	
mRNA Capping R-HSA-72086	1	0	0/20	1	
mRNA Editing R-HSA-75072	1	0	0/0	1	
mRNA Editing: A to I Conversion R-HSA-75064	1	0	0/0	1	
mRNA Editing: C to U Conversion R-HSA-72200	1	0	0/0	1	
mRNA Splicing - Major Pathway R-HSA-72163	1	0	0/108	1	
mRNA Splicing - Minor Pathway R-HSA-72165	1	0	0/37	1	
mRNA Splicing R-HSA-72172	1	0	0/114	1	
mRNA decay by 3' to 5' exoribonuclease R-HSA-429958	1	0	0/10	1	
mRNA decay by 5' to 3' exoribonuclease R-HSA-430039	1	0	0/11	1	
mTORC1-mediated signalling R-HSA-166208	1	0	0/22	1	
midostaurin-resistant FLT3 mutants R-HSA-9702600	1	0	0/0	1	
mitochondrial fatty acid beta-oxidation of saturated fatty acids R-HSA-77286	1	0	0/6	1	
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids R-HSA-77288	1	0	0/3	1	
p130Cas linkage to MAPK signaling for integrins R-HSA-372708	1	0	0/7	1	
p38MAPK events R-HSA-171007	1	0	0/10	1	
p53-Dependent G1 DNA Damage Response R-HSA-69563	0.859314358539223	0.510238114116233	1/63	1	CCNA2
p53-Dependent G1/S DNA damage checkpoint R-HSA-69580	0.859314358539223	0.510238114116233	1/63	1	CCNA2
p53-Independent DNA Damage Response R-HSA-69610	1	0	0/50	1	
p53-Independent G1/S DNA damage checkpoint R-HSA-69613	1	0	0/50	1	
p75NTR negatively regulates cell cycle via SC1 R-HSA-193670	0.116263980170045	10.686886668013	1/4	1	HDAC3
p75NTR recruits signalling complexes R-HSA-209543	1	0	0/12	1	
p75NTR regulates axonogenesis R-HSA-193697	1	0	0/2	1	
pexidartinib-resistant FLT3 mutants R-HSA-9702605	1	0	0/0	1	
phospho-PLA2 pathway R-HSA-111995	1	0	0/2	1	
ponatinib-resistant FLT3 mutants R-HSA-9702614	1	0	0/0	1	
quizartinib-resistant FLT3 mutants R-HSA-9702620	1	0	0/0	1	
rRNA modification in the mitochondrion R-HSA-6793080	1	0	0/0	1	
rRNA modification in the nucleus and cytosol R-HSA-6790901	1	0	0/22	1	
rRNA processing R-HSA-72312	1	0	0/125	1	
rRNA processing in the mitochondrion R-HSA-8868766	1	0	0/1	1	
rRNA processing in the nucleus and cytosol R-HSA-8868773	1	0	0/124	1	
semaxanib-resistant FLT3 mutants R-HSA-9702577	1	0	0/0	1	
snRNP Assembly R-HSA-191859	1	0	0/21	1	
sorafenib-resistant FLT3 mutants R-HSA-9702624	1	0	0/0	1	
sunitinib-resistant FLT3 mutants R-HSA-9702632	1	0	0/0	1	
t(4;14) translocations of FGFR3 R-HSA-2033515	1	0	0/0	1	
tRNA Aminoacylation R-HSA-379724	1	0	0/11	1	
tRNA modification in the mitochondrion R-HSA-6787450	1	0	0/2	1	
tRNA modification in the nucleus and cytosol R-HSA-6782315	1	0	0/10	1	
tRNA processing R-HSA-72306	1	0	0/33	1	
tRNA processing in the mitochondrion R-HSA-6785470	1	0	0/1	1	
tRNA processing in the nucleus R-HSA-6784531	1	0	0/21	1	
tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis R-HSA-9708296	1	0	0/0	1	
tamatinib-resistant FLT3 mutants R-HSA-9703009	1	0	0/0	1	
tandutinib-resistant FLT3 mutants R-HSA-9702636	1	0	0/0	1	
vRNA Synthesis R-HSA-192814	1	0	0/1	1	
vRNP Assembly R-HSA-192905	1	0	0/1	1	
